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Diabetes mellitus is associated with an increased risk of microvascular and
macrovascular complications, such as retinopathy, nephropathy, neuropathy and
atherosclerosis, which account for the increased morbidity and mortality associated
with this disease. There is considerable evidence that these complications are the
result of vascular dysfunction, which is closely related to poor glycaemic control.
This thesis studied the hypothesis that the vascular abnormalities in diabetes are the
consequence of exposure to elevated blood glucose concentrations.
To date the majority of studies of vascular function in diabetes have been performed
using animal models. However, results from such studies have produced conflicting
results and are difficult to relate to the human condition. Therefore, it would be
advantageous if vascular function could be studied in vessels isolated from a human
source. Due to the irregular and unpredictable nature of obtaining human vessels it
was first necessary to develop protocols using animal vessels. Vessel structure was
studied using a combination of histological and immunological techniques and this
was complemented by functional studies using small vessel myography. Preliminary
data demonstrated that storing vessels in a physiological salt solution at 4°C did not
alter endothelial or vascular smooth muscle cell function and therefore human
vessels could be stored for subsequent functional analysis in the knowledge that this
does not adversely affect vascular function. Exposure of rat mesenteric resistance
arteries to elevated glucose had no adverse effect on endothelium-dependent
relaxation. However, a selective attenuation of endothelin-1 (ET-l)-induced
contraction was demonstrated, perhaps indicating alterations in ET-1 receptors.
ii
Relatively few studies have investigated vascular function in human subcutaneous
resistance arteries, hence it was necessary to develop techniques to characterise these
vessels. This investigation demonstrated the existence of three distinct vessel types,
large and small resistance arteries and veins, which can be distinguished on the basis
of physical appearance, differences in response to transmural stretch and functional
reactivity. Furthermore, endothelium-dependent relaxation in human subcutaneous
resistance arteries was shown to be predominately mediated by an endothelium-
derived hyperpolarising factor (EDHF), with little or no contribution from nitric
oxide (NO) or prostacyclin (PGI2). Functional investigations in resistance arteries
isolated from Type 1 and Type 2 diabetic patients demonstrated unaltered
endothelium-dependent and endothelium-independent relaxation. However, there
was a selective alteration in contractile function which was related to the type of
diabetes.
In conclusion, this study has shown that although diabetes is associated with changes
in contractile function there was no evidence of impaired endothelial-dependent
relaxation. The changes seen in vessels from diabetic patients did not mimic those
produced by acute exposure to elevated concentrations of glucose. This suggests that
if the vascular alterations observed in diabetes are due to exposure to high glucose
concentrations in vivo, prolonged exposure (or factors not present in vitro) are
required for abnormalities to develop.
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Figure 1.1. Schematic longitudinal section of a small artery showing the three layers
of the vascular wall.
Figure 1.2. Generation of nitric oxide (NO) in the vascular endothelium.
Figure 1.3. Mechanisms of contraction in vascular smooth muscle cells.
Figure 1.4. Mechanisms of agonist-induced relaxation in vascular smooth muscle
cells.
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Table 1.1. Investigation of human endothelial function in Type 1 diabetic subjects,
studied by venous occlusion plethysmography (VOP),vascular ultrasound (US)
and isolated vessel techniques, mainly small vessel myography (SVM).
Table 1.2. Investigation of human endothelial function in Type 2 diabetic subjects,
studied by venous occlusion plethysmography (VOP), vascular ultrasound (US)
and isolated vessel techniques, mainly small vessel myography (SVM).
CHAPTER TWO
Figures
Figure 2.1. Schematic diagram of the wire myograph, where vessel segments are
threaded on two 40pm stainless steel wires that are fastened to a micrometer
and a force transducer, for measurement of isometric tension. (Figure taken
from Mulvany & Aalkjaer, 1990).
Figure 2.2. Schematic diagram showing the three-step indirect avidin biotinylated
enzyme complex (ABC) immunohistochemical technique. The primary
antibody (1° Ab), directed against the antigen (Ag), is incubated overnight at
4°C. A secondary biotinylated antibody (2° Ab) is added, followed by addition
of the preformed ABC conjugated to peroxidase (A). To visualise the sites of
positive binding, the chromagen 3,3-diaminobenzidine tetrahydrochloride




Table 2.1 A list of the drugs used throughout the course of this thesis.
Table 2.2 A list of the antibodies used for immunohistochemical staining of the
endothelium, vascular smooth muscle and localisation ofET-1.
CHAPTER THREE
Figures
Figure 3.1. The effect of cold storage on the cumulative concentration response
curves to (a) acetylcholine (ACh; 1CT9-3x10~5M) and (b) 3-
morpholinosydnonimine (SIN-1; 10~9-10"4M) in rat mesenteric resistance
arteries. Each point represents mean±s.e.mean, n=10. ■ Day 0, O Day 4.
Tables
Table 3.1. The effect of prolonged cold storage on the viability of rat mesenteric
resistance arteries. Values are mean ± s.e.mean, n numbers in parentheses.
Table 3.2. The effects of cold storage on the (a) maximum contraction (mN/mm)
and (b) sensitivity (pD2) of rat 3rd order mesenteric arteries to vasoconstrictors.
Results are shown as mean ± s.e.mean, n=T0.
Table 3.3. The effect of prolonged cold storage on the magnitude of
noradrenaline (3pM)-induced precontraction obtained in the construction of
CCRC's to the vasodilators ACh and SIN-1 in rat mesenteric resistance artery.
Table 3.4. The effect of prolonged cold storage on (a) maximum relaxation (%)
and (b) sensitivity (-loglCso) of rat 3rd order mesenteric arteries to vasodilators.
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Figure 4.1. Concentration-response curves to (a) endothelin-1, (b) noradrenaline and
(c) potassium in rat mesenteric resistance arteries following lhr incubation in
normal PSS (5.5mM (A), n=l 1-13) or PSS containing elevated concentrations
of glucose (15mM (□), n=10; 20mM (O), n=9-10; 44mM (A), n=10) or
mannitol (20mM (O), n=6-9). Each point represents mean ± s.e.mean.
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Figure 4.2. Concentration-response curves to (a) acetylcholine, (b) A23187 and (c)
3'-morpholinosydnonimine (SIN-1) in rat mesenteric resistance arteries
following lhr incubation in normal PSS (5.5mM (A), n= 11-13) or PSS
containing elevated concentrations of glucose (15mM (□), n=10; 20mM (O),
n=6-10; 44mM (A), n^-lO) or mannitol (20mM (O), n=5-9). Each point
represents mean ± s.e.mean and is expressed as % relaxation of 3pM NA-
induced tone.
Figure 4.3. Concentration-response curves to the vasoconstrictors (a) endothelin-1,
(b) noradrenaline and (c) K+ in rat mesenteric resistance arteries following lhr
incubation in normal PSS (a, n=10-12) or PSS containing an elevated
concentration (1000mU/l) of insulin (□, n=10-12) Each point represents mean ±
s.e.mean.
Figure 4.4. Concentration-response curves to the vasodilators (a) acetylcholine, (b)
A23187 and (c) 3'-morpholinosydnonimine (SIN-1) in rat mesenteric resistance
arteries following lhr incubation in normal PSS (a, n=10-12) or PSS containing
1000mU/l of insulin (□, n=10-12) Each point represents mean ± s.e.mean.
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Table 4.1. Maximum contraction (Emax., mN/mm) and sensitivity (pD2) to
vasoconstrictor agonists in rat mesenteric resistance arteries following (a) 1 hr
or (b) 4 hr incubation in normal PSS or PSS containing elevated concentrations
of glucose or mannitol.
Table 4.2. Maximum relaxation (Emax., % reversal of 3pM NA-induced
precontraction) and sensitivity (-loglCso) to vasodilator agonists in rat mesenteric
resistance arteries following (a) lhr or (b) 4hr incubation in normal PSS or PSS
containing elevated concentrations of glucose or mannitol.
Table 4.3. Maximum contraction (Emax., mN/mm) and sensitivity (PD2) to
vasoconstrictor agonists in rat mesenteric resistance arteries following
incubation in normal PSS or PSS containing an elevated concentration of
insulin (1000mU/l).
Table 4.4. Maximum relaxation (Emax., % reversal of NA-induced
precontraction) and sensitivity (-loglCso) to vasodilator agonists in rat
Xll
mesenteric resistance arteries following lhr incubation in normal PSS or PSS
containing an elevated concentration of insulin (1000mU/l).
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Figures
Figure 5.1. Physical and morphological differences between small resistance arteries
(A), veins (B) and large resistance arteries (C) isolated from human
subcutaneous fat biopsies, (i) light microscopy showing differences in physical
characteristics between the three vessel types, (ii) haematoxylin and eosin
staining showing media (M), lumen (L) and adventitia (A), (iii) and (iv)
immunohistochemical localisation of smooth muscle (SM) and endothelium (E)
using monoclonal antibodies against a-smooth muscle actin and ulex europaeus
agglutinin, respectively. Magnification x200.
Figure 5.2. Concentration-response curves to (a) noradrenaline, (b) endothelin-1 and
(c) K+ in small resistance arteries (•, n=7), veins (A, n=5) and large resistance
arteries (■, n=7) isolated from human subcutaneous fat biopsies. Each point
represents mean ± s.e.mean.
Figure 5.3. Concentration-response curves to the vasodilators (a) acetylcholine, (b)
bradykinin, (c) A23187 and (d) 3'-morpholinosydnonimine (SIN-1) in small
resistance arteries (#, n=7), veins (A, n=5) and large resistance arteries (■,
n=7) isolated from human subcutaneous fat biopsies. Each point represents
mean ± s.e.mean.
Figure 5.4. Trace demonstraing the effect of acetylcholine (ACh) in a human small
resistance artery submaximally precontracted with noradrenaline (NA) before
(a) and after (b) removal of the endothelium. W-washout.
Figure 5.5. Concentration-response curves to acetylcholine in isolated human
resistance arteries before (■) and after (O) incubation with either (a)
indomethacin (lOpM for 45min), (b) L-NOARG (lOOpM for 45min) or (c) L-
NOARG plus ChTx (50nM for lOmin) and apamin (30nM for lOmin). Each
point represents mean ± s.e.mean, n=6 for each group.
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Table 5.1. Maximum contraction (Emax) of small and large resistance arteries and
veins to noradrenlaine (NA), endothelin-1 (ET-1) and KPSS.
Table 5.2. Magnitude of precontraction to NA (3pM), in human small resistance
arteries, before and after incubation with either indomethacin (10pM for
45min), L-NOARG (lOOpM for 45min) or L-NOARG plus ChTx (50nM for
lOmin) and apamin (30nM for lOmin).
CHAPTER SIX
Figures
Figure 6.1. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh; n=12), (b) bradykinin (BK; n=8), (c) A23187 (n=8-10) and
(d) SIN-1 (n= 11-12) in human resistance arteries isolated from patients with
type 1 diabetes (O) and from non-diabetic controls (■). Results as expressed as
% relaxation of vessels initially precontracted with 3pM NA and shown as
mean ± s.e.mean.
Figure 6.2. Cumulative concentration-response curves to vasoconstrictor agonists (a)
endothelin-1 (ET-1), (b) noradrenaline (NA) and (c) potassium (K+) in human
resistance arteries isolated from patients with type 1 diabetes (□) and non-
diabetic controls (■). Each point represents mean ± s.e.mean, n=12.
Figure 6.3. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh), (b) bradykinin (BK) and (c) SIN-1, in resistance arteries
isolated from healthy volunteers and incubated in the presence of 5.5.mM
(Control, ■ n=6) or 20mM (□, n=6) glucose. Results are expressed as %
relaxation of vessels initially precontracted with 3pM NA and shown as mean ±
s.e.mean.
Figure 6.4. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh), (b) bradykinin (BK) and (c) SIN-1 in resistance arteries
isolated from patients with type 1 diabetes incubated in the presence of 5.5mM
(•; control) and 20mM (O; elevated) glucose. Results are expressed as %
relaxation of vessels initially precontracted with 3pM NA and shown as mean ±
s.e.mean, n=8.
xiv
Figure 6.5. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-1 and (c) high potassium, in resistance arteries
isolated from healthy volunteers and incubated in the presence of 5.5.mM
(Control, ■ n=6) or 20mM (□, n=6) glucose for lhr. Results are expressed as
force per unit length of tissues (mN/mm) and shown as mean ± s.e.mean.
Figure 6.6. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-1 and (c) high potassium, in resistance arteries
isolated from patients with type 1 diabetes and incubated in the presence of
5.5.mM (Control, O n=8) or 20mM (#, n=8) glucose. Results are expressed as
force per unit length of tissues (mN/mm) and shown as mean ± s.e.mean.
Figure 6.7. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine, (b) bradykinin, (c) A23187 and (d) SIN-1 in human resistance
arteries isolated from patients with type 2 diabetes (O, n=8) and non-diabetic
controls (■, n=10). Results as expressed as % relaxation of vessels initially
precontracted with 3pM NA and shown as mean ± s.e.mean.
Figure 6.8. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-1 and (c) high potassium, in resistance arteries
isolated from patients with type 2 diabetes (O, n=8) and non-diabetic controls
(■, n=10). Results are expressed as force per unit length of tissues (mN/mm)
and shown as mean ± s.e.mean.
Tables
Table 6.1. Baseline characteristics of control subjects and patients with type 1
diabetes.
Table 6.2. Maximum relaxation (% reversal of 3pM NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to the
vasodilator agonists in arteries from patients with type 1 diabetes and controls.
Table 6.3. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated
from patients with type 1 diabetes and non-diabetic controls.
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Table 6.4. Characteristics of non-diabetic control subjects (n=6) and patients with
type 1 diabetes (n=8) who provided vessels for incubation with control
(5.5mM) and elevated (20mM) glucose.
Table 6.5. Maximum relaxation (% reversal of 3p,M NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to
the vasodilator agonists in arteries from (a) non-diabetic control subjects (n=6)
and (b) patients with type 1 diabetes (n=8) after incubation with either normal
(5mM) or elevated (20mM) glucose.
Table 6.6. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated
from non-diabetic controls incubated with either normal (5mM) or high
(20mM) glucose for 1 hour.
Table 6.7. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated
from patients with type 1 diabetes incubated with either normal (5mM) or high
(20mM) glucose for 1 hour.
Table 6.8. Baseline characteristics of 8 male patients with type 2 diabetes and 10 age
and sex-matched non-diabetic control subjects.
Table 6.9. Maximum relaxation (% reversal of 3juM NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to
the vasodilator agonists in the arteries from patients with type 2 diabetes and
controls.
Table 6.10. Maximum contraction (a) and sensitivity (b) to vasoconstrictor agonists
in isolated resistance arteries from patients with type 2 diabetes (n=8) and non-
diabetic control subjects (n=10).
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The development of diabetes mellitus results in vascular damage which underlies
many of the major complications (eg. atherosclerosis, ulceration, peripheral vascular
disease, retinopathy, hypertension) associated with this condition. These
complications contribute significantly to the morbidity and mortality caused by
diabetes. Consequently, they have a significant impact on patient suffering and health
care expenditure world-wide. The cause of diabetic vascular disease, however, is not
understood, despite extensive investigations in animals and man.
The aim of the research described in this thesis is to assess the effects of diabetes on
human microvascular function. Therefore, in order to gain a better understanding of
the vascular alterations that may occur in diabetes, it is first necessary to describe
normal vascular structure and function. The first part of the introduction will describe
the architecture of the vessel wall and the regulation of vascular smooth muscle cell
relaxation and contraction. As endothelial cell dysfunction is thought to be central to
vascular abnormalities in diabetes, this section will focus on the endothelium-derived
relaxing factors (nitric oxide (NO), prostacyclin (PGI2) and endothelium-derived
hyperpolarizing factor (EDHF)) and the endothelium-derived contracting factor
(EDCF), endothelin-1 (ET-1). The second part of the introduction will concentrate on
the pathology of diabetes mellitus and discuss the mechanisms that may contribute to
the altered vascular function in this condition.
1.1. Structure of the vessel wall
With the exception of the capillaries, the vascular wall is composed of three
morphologically distinct layers: an inner tunica intima, a central tunica media and an









Figure 1.1. Schematic longitudinal section of a small artery showing the three layers
of the vascular wall. IEL, internal elastic lamina; EEL, external elastic lamina.
3
1.1.1. Adventitia
The tunica adventitia is the outermost layer of the vascular wall and consists of dense
fibroelastic tissue without smooth muscle cells. It harbours nutrient vessels (vasa
vasorum) of the vascular wall, nerves and fibroblasts. Its function is to confer rigidity
on the vessel wall, carry nutrients to the smooth muscle cells of the media and add
stability by connecting the blood vessel to its surrounding tissues.
1.1.2. Media
The tunica media, the middle layer of the vascular wall, consists of smooth muscle
cells surrounded by elastic sheets (laminae), collagen, and a network of elastic fibrils
and proteoglycans (mucopolysaccharides). It is separated from the intima and the
adventitia by the internal (IEL) and external (EEL) elastic laminae, respectively. The
medial smooth muscle cells provide the vessel with the ability to contract or relax in
response to a variety of stimuli.
1.1.3. Intima
The intima is the innermost layer of all blood vessels, and is in direct contact with the
flowing blood. It consists of (1) a continuous monolayer of endothelial cells lining
the vascular wall, (2) a subendothelial layer composed of collagenous bundles,
elastic fibrils, smooth muscle cells and some fibroblasts and (3) the IEL (Ross &
Glomsett, 1976; Badimon et al., 1993). The composition of the intima varies
between blood vessels. For example, the sub-endothelial layer is present in some
elastic (e.g. aorta) and muscular (e.g. coronary) arteries, whilst in others the intima
consists of only endothelial cells and basal lamina.
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The vascular endothelium consists of a continuous, obligate, monolayer of squamous
cells lining the luminal surface of blood vessels. Until the 1980s, it was regarded as
an inert layer acting as a barrier between the blood and the procoagulant contents of
the vessel wall. Since the pioneering work of Furchgott and Zawadski (1980),
however, it has become apparent that the endothelium has a central role in the control
of a variety of physiological processes, including; inflammation, coagulation, smooth
muscle cell tone and smooth muscle cell proliferation. (Belloni et al., 1992; Ross,
1993 (a&b)).
1.2. The Influence of the Endothelium on Vascular Tone
The vascular endothelium plays a central role in the regulation of blood flow and
vascular tone through the synthesis of several potent vasoactive substances. These
substances include the vasodilators nitric oxide (NO; Furchgott & Zawadzki, 1980),
prostacyclin (PGB, Moncada et al., 1976) and endothelium-derived hyperpolarizing
factor (EDHF; Bolton et al., 1984) and the vasoconstrictors endothelin-1 (ET-1;
Yanagisawa et al., 1988), angiotensin II (All; Webb & Cockcroft, 1990), and
thromboxane A2 (TXA2; Auch-Schwelk et al., 1990).
1.2.1. Endothelium-derived relaxingfactors
1.2.1.1. Nitric oxide
The demonstration by Furchgott and Zawadski (1980) that acetylcholine (ACh)-
mediated relaxation of isolated arteries was dependent upon an intact endothelium
led to the proposal of the existence of an endothelium-derived relaxing factor
(EDRF; Furchgott et al., 1984). EDRF was shown to be a diffusible substance that
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was eventually identified as NO (Palmer et al., 1987; Ignarro et al., 1987). NO has a
half-life of a few seconds and is rapidly oxidised to nitrate by oxygenated
haemoglobin, molecular oxygen and superoxide anions, before being excreted in the
urine (Moncada & Higgs, 1983; Wennmalm et al., 1993). As well as being a potent
vasodilator, endothelium-derived NO has anti-atherogenic properties, including
decreasing platelet and leucocyte adhesion to the endothelium and inhibiting vascular
smooth muscle cell migration (Moncada et al., 1991).
NO is synthesised within the vascular endothelium by the enzyme nitric oxide
synthase (NOS) which converts the amino acid, L-arginine (Palmer et al., 1988a;
1988b) into L-citrulline and NO (Figure 1.2). NOS is an NADPH-dependent
dioxygenase which has at least four isoforms, including: a constitutive
Ca2+/calmodulin-dependent NOS (eNOS or NOS III), which is mainly present in
endothelial cells, and a Ca2+-independent inducible NOS (iNOS or NOS II), which is
found in cytokine-activated cells (predominantly macrophages and smooth muscle
cells, but also in endothelial cells). Both isoforms require NADPH, FAD and FMN
as cofactors and tetrahydrobiopterin potentiates their activity (Forstermann et al.,
1991).
NO released under physiological conditions contributes to the regulation of blood
flow in healthy individuals (Vallance et al., 1989). Under basal conditions, NO is
released spontaneously from the endothelium, in addition, NO synthesis can be
stimulated by a number of physical and biochemical stimuli. These activate






(e.g acetylcholine, bradykinin) (e.g Ca -ionophore, stress)
Figure 1.2. Generation of nitric oxide (NO) in the vascular endothelium. NO is
produced from the enzymatic conversion of L-arginine to L-citrulline by NO
synthase (NOS). After diffusing to the underlying smooth muscle, NO activates
soluble guanylate cyclase (sGC), leading to the accumulation of cyclic guanosine
monophosphate (cGMP). cGMP-dependent protein kinases then mediate smooth
muscle relaxation. Synthesis of NO can be inhibited (broken line) by analogues
of L-arginine, such as N -monomethyl L-arginine (L-NMMA) and N -nitro-L-
arginine methyl ester (L-NAME). R, receptor, CaM, calmodulin.
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cell. Such stimuli include shear stress, pulsatile flow and hypoxia (Lamotagne et al.,
1992; Pohl & Busse, (1989), as well as receptor-dependent agonists (e.g.
acetylcholine, bradykinin) and (receptor independent) calcium ionophores, such as
A23187.
Once formed, NO diffuses to the underlying smooth muscle, where it stimulates
soluble guanylate cyclase through which it causes relaxation by reducing
intracellular calcium concentrations (See Chapter 1.3.2). Analogues of L-arginine,
such as L-Ng monomethyl arginine (L-NMMA), act as inhibitors of NOS and have
been found to cause vasoconstriction (Vallance et al., 1989), indicating that NO
exerts a tonic dilator action opposing constrictor influences in the arterial circulation.
Most veins produce little, if any, NO under resting conditions and are very sensitive
to exogenous NO in the form of nitrovasodilators (Vallance et al., 1989).
1.2.1.2. Prostacyclin
Prostacyclin, or prostaglandin I2 (PGI2), was first identified in 1976 by Moncada and
colleagues (Moncada et al., 1976). It is generated predominantly in endothelial cells
(although it can also be formed in the smooth muscle) where it is produced from
arachidonic acid through the action of the enzymes cyclooxygenase and prostacyclin
synthase. Once bound to its receptor (see review by Pierce et al., 1995), the
vasodilatory and anti-aggregatory effects of PGB are mediated through a rise in
intracellular cyclic AMP concentrations (see Chapter 1.3.2) in smooth muscle cells
and platelets, respectively (Tateson et al., 1997). Pulsatile flow and vasoactive
mediators such as bradykinin and thrombin stimulate PGI2 synthesis (Piper & Vane,
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1977). It appears that arteries can synthesise three to ten times more PGI2 than veins
(Skidgel & Printz, 1978), and larger vessels produce more PGP than the
microvasculature (Maclntyre et al., 1978).
1.2.1.3. Endothelium-derived hyperpolarising factor.
In some vessels, particularly those with a small diameter (Shimokawa et al., 1996), a
component of the endothelium-dependent relaxation is insensitive to NO synthase
and cyclooxygenase inhibition (Nagao et al., 1992; Brandes et al., 1997). This NO-
and prostanoid-independent component appears to be mediated by hyperpolarization
of the vascular smooth muscle cells (Brayden, 1990), suggesting the existence of a
distinct endothelium-derived hyperpolarizing factor (EDHF) (Taylor & Weston,
1988; Feletou & Vanhoutte, 1997).
The identity of EDHF has yet to be confirmed, although activity of this factor has
been attributed to epoxyeicosatrienoic acids (Hecker et al., 1994),
endocannabionoids (Randall et al., 1996), hydrogen peroxide (Matoba et al., 2000),
the presence of myoendothelial gap junctions (Chaytoe et al., 1998) and release of
K+ into the myoendothelial space (Edwards et al., 1998).
1.2.2. Endothelium-derived vasoconstrictors
Although the endothelium can release several distinct vasoconstrictors (ET-1, TxA2,
All) it is endothelin (ET) that has most relevance to the work described in this thesis.
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1.2.2.1. Endothelin
Endothelin was originally identified as a 21 amino acid vasoconstrictor peptide in the
cultured supernatant of porcine aortic endothelial cells (Yanagisawa et al., 1988). ET
exists as a family of three isopeptides: ET-1, the isoform originally identified by
Yanagisawa et al., (1988), and ET-2 and ET-3, which are structurally and
pharmacologically distinct (Inoue et al., 1989). ET-1 is the major form produced by
vascular endothelial cells in humans, and is generated in response to hypoxia,
vascular shear stress, and a range of other vasoactive mediators (Yanagisawa et al.,
1988). It is synthesised by transcription and translation of a 212-amino acid
prepropeptide (prepro ET) which is proteolytically cleaved to produce the 38 amino
acid intermediate, big endothelin-1 (big ET-1). This is subsequently converted to
mature ET-1 by ET-converting enzyme (ECE).
ET-1 binds to specific G-protein-coupled cell surface receptors located both on
endothelial cells and vascular smooth muscle cells. There are at least two distinct
receptor subtypes, designated ETa and ETB. ETA and ETB receptors are expressed on
vascular smooth muscle cells where they mediate vasoconstriction. The ETB receptor
is also expressed on endothelial cells where it mediates vasodilatation. The primary
target of ET-1 is the vasculature where it evokes transient vasodilatation mediated by
endothelial ETB receptors, followed by slow-onset and sustained contraction
mediated by ETA and ETB receptors located on vascular smooth muscle cells. The
functional response to ET-1 varies between vessels and species due to differences in
distribution and expression of these two receptor subtypes (Haynes & Webb, 1993).
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1.3. Regulation of vascular tone
1.3.1. Smooth muscle cell contraction
9+
The intracellular concentration of free calcium ([Ca ];) is a primary determinant of
contractile activity in smooth muscle cells (Figure 1.3) (Filo et al., 1965). Increases
in [Ca2+]i levels in smooth muscle cells triggers the activation of Ca2+-calmodulin-
dependent myosin light chain kinase (MLCK), which in turn activates myosin light
chain kinase to phosphorylate the light chain sub-unit of myosin, resulting in an
increase in actin-activated myosin Mg-ATPase activity (Dabrowska et al., 1978).
This enables myosin to interact with actin, thereby initiating the contractile process
(Cohen, 1993).
Smooth muscle [Ca2+]j increases during contraction either as a consequence of influx
of Ca2+ from the extracellular space or release of Ca2+ from the sarcoplasmic
reticulum. Influx of Ca2+ from the extracellular space occurs through voltage-
operated channels (VOC), receptor-operated channels (ROC) and non-selective
cation channels (NSCC) and by a reversed Na+/Ca2+ exchange mechanism
(Vanhoutte, 1990). Ca2+ release from intracellular stores proceeds through inositol
2_|_ 2+
1,4,5-trisphosphate (IP3)-regulated channels or by Ca -induced Ca release,
generally via ryanodine receptor-regulated channels (Herrmann-Frank et al., 1991).
Voltage-operated channels are selectively permeable to Ca2+ and are activated by
membrane depolarization; repolarization and hyperpolarization result in deactivation













Figure 1.3. Mechanisms of contraction in vascular smooth muscle cells. Contraction
occurs when intracellular Ca2+ and calmodulin combine to activate
phosphorylation of myosin light chain kinase (MLCK), leading to actin-myosin
cycling which generates active tension. Vasoconstrictors can act by increasing
[Ca2+]i in various ways (1) stimulating receptors coupled to phospholipase C
(PLC), which hydrolyses phosphatidylinositol bisphosphate (PIP2), leading to
inositol triphosphate (IP3) and diacylglycerol (DAG) production and the release
of stored Ca2+ from the sarcoplasmic reticulum (SR). (2) Stimulating receptor-
operated channels (ROC) and non-specific cation channels (NSCC), which allow
Ca2+ entry and also cause depolarization. (3) Stimulating voltage-operated Ca2+
channels (VOC), which open in response to depolarization and may also be
2_j_facilitated indirectly by agonists. Release of Ca from SR produces a transitory
contraction, whilst extracellular Ca2+ is required for maintenance of a sustained
response.
12
extracellular K+ or by agonist-induced activation of receptor-operated channels
(Walsh, 1994).
The stimulation of various receptors (e.g. adrenergic, purinergic, cholinergic,
2+
histaminergic, serotonergic, endothelin, stretch) by agonists can increase [Ca ]j via
two mechanisms. Firstly, G-protein-coupled receptor stimulation activates
phospholipase C (PLC), which, in turn, hydrolyses phosphatidylinositol 4,5
bisphosphate (PIP2), leading to the generation of two intracellular second
messengers, inositol triphosphate (IP3) and 1,2-diacylglycerol (DAG). IP3 diffuses to
2+the sarcoplasmic reticulum, where it induces the release of intracellular Ca . DAG
production leads to the stimulation of protein kinase C (PKC), which induces
2"F
opening of Ca channels. The second receptor-dependent mechanism involves
9+
activation of either receptor-operated G-protein-dependent Ca channels or receptor-
operated non-specific cation channels (Reviewed in Rembold, 1992; Cohen, 1993).
The contractile response of vascular smooth muscle occurs in two phases, (1) the
initial (phasic) component and (2) the sustained (tonic) component. It has been
demonstrated that the initial (phasic) contraction is produced by the release of
intracellular Ca2+, while the sustained (tonic) contraction is induced by the influx of
Ca2+ via activation of membrane channels. As vascular smooth muscle can remain in
a contracted state for prolonged periods of time, the contraction is generally tonic in
nature and therefore Ca2+ influx, rather than release, is the most important for
maintaining tone (Bosnjak, 1993).
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1.3.2. Smooth muscle cell relaxation
Vascular smooth muscle relaxes when [Ca2+]; falls below a threshold level. The
removal of Ca2+ from the cytoplasm is controlled by a combination of Ca2+
accumulation into the sarcoplasmic reticulum and extrusion from the cell across the
plasma membrane (Figure 1.4). The major route of Ca2+ removal is the uptake of
Ca2+ into the sarcoplasmic reticulum, which occurs via a Ca2+, Mg2+-ATPase pump
that undergoes Ca2+-dependent phosphorylation. The activity of the pump is
regulated by phospholamban, a protein localised to the sarcoplasmic reticulum, as
well as cyclic nucleotide-dependent phosphorylation (Tada & Katz, 1982). The
plasma membrane contains a Ca2+, Mg2+-ATPase pump, distinct from that found in
2+the sarcoplasmic reticulum, which extrudes Ca from the cell. This ATPase is
stimulated by calmodulin when [Ca2+]j rises (Missiaen et al., 1992). Smooth muscle
membranes may also contain a Na+, Ca2+ exchanger, which may contribute to Ca2+
extrusion in some blood vessels. The relative contribution of each of these processes,
however, may vary among different vascular beds (Reviewed in Gurney, 1994)
2+Since the opening of Ca channels requires membrane depolarization, agents that
produce hyperpolarization will cause Ca2+ channels to close, which in turn will
reduce Ca2+ influx and promote muscle relaxation (Nelson et al., 1990). The
endothelium of a number of arteries releases a substance that evokes
hyperpolarization of vascular smooth muscle cells and relaxation. Although NO can
cause hyperpolarization of vascular smooth muscle cells (Plane et al., 1996),
endothelium-dependent hyperpolarizations are mediated mainly by a distinct NO-
independent EDHF (Bolton et al., 1984).
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Figure 1.4. Mechanisms of agonist-induced relaxation in vascular smooth muscle
cells. Relaxation occurs when [Ca2+]i falls below a threshold level. Vasodilators
may work by reducing [Ca2+]i or directly on the contractile machinery and can be
achieved by: (1) opening of K+ channels, causing hyperpolarization, and thus
preventing voltage-gated Ca2+ channels from opening. (2) receptors coupled to
adenylate cyclase (AC), activation of which cause increased cAMP production.
This acts via a cAMP-dependent protein kinase (cAMP PK) and myosin light
chain kinase (MLCK) to inhibit contraction. (3) stimulation of soluble (sGC) or
particulate (pGC) guanylate cyclase increases cGMP formation. This acts via a
cGMP-dependent protein kinase (cGMP PK) to cause relaxation by stimulating
both Ca2+ uptake into the SR (via a phospholamban-mediated Ca2+Mg2+ ATPase)
and extrusion of Ca2+ across the cell membrane via a calmodulin-sensitive
Ca2+Mg2+ ATPase pump and Na+Ca2+ exchange mechanism. It also reduces the
Ca2+ sensitivity of contractile proteins. ANP, atrial natriuretic peptide; EDHF,
endothelium-derived hyperpolarising factor; NO; nitric oxide; PGI2,
prostacyclin.
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Relaxation induced by NO and NO releasing drugs is preceded by an elevation of
intracellular cGMP levels in vascular smooth muscle. NO and NO-releasing
compounds such as sodium nitroprusside (SNP), activate soluble guanylate cyclase
(sGC), which stimulates the production of cGMP from GTP (Rapaport et al., 1983).
The effects of cGMP are mediated through cGMP-dependent protein kinase, which is
known to phoshorylate smooth muscle cell proteins. The main effect of cGMP-
9+
dependent vasodilators is to lower [Ca ]i, which can be achieved by a number of
different mechanisms (reviewed in Gurney, 1994; Walsh, 1993):- (1) inhibition of
2_|_
voltage- and receptor-operated channels, (2) hyperpolarization, (3) inhibition of Ca
release from the sarcoplasmic reticulum, by inhibiting PLC and the production of IP3
(4) stimulation of both Ca2+ uptake by the sarcoplasmic reticulum and membrane
Ca2+, Mg2+-ATPase, which pumps Ca2+ out of the cell and (5) reduction in sensitivity
of contractile proteins to Ca2+ (Figure 1.4). Since nitrovasodilators inhibit agonist-
induced contractions more effectively than depolarization-induced contractions, the
major pathway for relaxation appears to be inhibition of receptor-dependent
contractions. Receptor-operated Ca2+ channels are inhibited, decreasing Ca2+ influx,
and cGMP-dependent protein kinase phosphorylates phospholambon, an endogenous
regulator of the sarcoplasmic reticulum Ca2+, Mg2+- ATPase, which enhances uptake
2+of Ca by the sarcoplasmic reticulum. In addition, cGMP may inhibit agonist-
induced release of Ca2T by the sarcoplasmic reticulum by inhibition of PLC and the
production of IP3. Several additional mechanisms may also explain cGMP-dependent
2+vasodilation. These include decreased sensitivity of contractile proteins to Ca , by a
mechanism linked to cGMP-dependent phosphorylation of MLCK, and stimulation
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of a membrane Ca2+, Mg2+-ATPase pump which pumps Ca2+ out of the smooth
muscle cell.
1.4. Diabetes Mellitus
Diabetes mellitus is a syndrome with characteristic hyperglycaemia, which results
from a deficiency (either relative or absolute) in insulin (World Health Organisation
(WHO), 1985). The clinical diagnosis of diabetes is often indicated by the presence
of symptoms such as polyuria, polydipsia, blurring of vision and unexplained weight
loss, and in severe cases, drowsiness and coma and is confirmed by measurement of
abnormal hyperglycaemia. The ranges of blood glucose indicative of diabetes
mellitus are random venous plasma glucose >ll.lmmol/l or fasting plasma glucose
>7.0mmol/l or plasma glucose >ll.lmmol/l two hours after a 75g oral glucose load
(the oral glucose tolerance test) (WHO, 1999).
There are two distinct types of primary diabetes: Type 1 (previously referred to as
insulin-dependent diabetes mellitus, IDDM), and Type 2 (previously referred to as
non-insulin-dependent diabetes mellitus, NIDDM). Although the exact aetiology for
both types of primary diabetes mellitus is improperly understood, it is clear that
interactions between environmental and genetic factors determine both whether an
individual will develop diabetes and the timing of disease onset (Rossini et al.,
1993).
1.4.1. Type 1 Diabetes Mellitus
Type 1 diabetes mellitus usually appears before the age of 40, often in childhood and
adolescence. The onset of symptoms may be abrupt, with thirst, excessive urination,
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increased appetite, and weight loss developing over a period of days to weeks.
Characteristically, a total deficiency in pancreatic [3-cells in Type 1 diabetes leads to
an absolute deficiency of insulin and elevated glucagon levels. This type of diabetes
is unresponsive to treatment with oral antidiabetic drugs and, therefore, insulin
therapy is always required for patients with Type 1 diabetes (Frier et al., 1999).
Type 1 diabetes has a polygenic inheritance with 33% of cases having a genetic
component (Atkinson & Eisenbarth, 2001). However, studies in identical twins have
shown concordance lower than 40%, indicating that environmental factors (e.g.
viruses, diet, stress) play an important role in disease development (Olmos et al.,
1988). There is also evidence that Type 1 diabetes is a chronic, T-cell mediated,
autoimmune disease with destruction of insulin secreting cells in the pancreas
occurring over many years (Atkinson & Eisenbarth, 2001).
1.4.2. Type 2 Diabetes Mellitus
Unlike Type 1, Type 2 diabetes mellitus usually occurs in middle or later life
(although earlier forms, such as maturity onset diabetes of the young (MODY) are
known (Guazzarotti et al., 1999)). It is commonly diagnosed in obese, insulin
resistant patients but these factors only cause diabetes if accompanied by impaired p
cell function. Symptoms begin more gradually than in Type 1 (developing over
months-years) and, in direct contrast, plasma insulin levels are elevated. Patients
often present with chronic fatigue and malaise but much Type 2 diabetes is
undetected and it is often only diagnosed serendipitously (Frier et al., 1999).
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Genetics are more important in the development of Type 2 diabetes with almost
100% concordance in identical twins (some forms, including MODY, result from a
single gene defect but these account for <5% of cases (Hattersley, 1998)). Most cases
are multi-factorial, resulting from an interaction between environmental and genetic
factors. Environmental factors include lifestyle (over-eating, obesity, under-activity),
malnutrition in utero (inverse relationship between birth weight and Type 2
diabetes), age (more than 70% of cases occur in individuals over the age of 50) and
pregnancy. Obesity is a major risk factor for the insulin resistance and higher plasma
insulin concentrations seen before and after the development of hyperglycaemia
(Truglia et ai, 1985). It is for this reason that although Type 2 diabetes is responsive
to treatment with oral anti-diabetic drugs, many patients are treatable with diet and
exercise alone. However, in some cases where hyperglycaemic control is not
achievable, a combination of oral anti-diabetic drugs with insulin is useful for the
treatment of Type 2 diabetes (Simpson et al., 1990).
1.4.3. The Pathophysiology ofDiabetes Mellitus.
The tight regulation of blood glucose in the range 3.5-6.5mmol/ 1 is important for
normal metabolism, especially for the brain which uses glucose as its principal
metabolic fuel. Blood glucose concentrations reflect a balance between glucose
entering the circulation (from the liver as a result of gluconeogenesis and
glycogenolysis but also from the gut following meals) and uptake in peripheral
tissues (particularly skeletal muscle). Insulin, which is secreted into the portal blood
from pancreatic p-cells, reduces blood glucose by suppressing hepatic glucose
production and stimulating uptake (mainly by skeletal muscle and fat). Insulin also
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prevents catabolism of fats (non-esterified fatty acids (NEFAs) and glycerol) by
stimulating lipogenesis and inhibiting lipolysis in the adipocytes and liver. Lipolysis
liberates NEFAs which provide energy for gluconeogenesis, producing ketone bodies
as a by-product (Frier et al., 1999). Consequently, in the face of insulin deficiency,
inhibition of lipolysis is reduced, resulting in hyperketonaemia,
Hyperglycaemia develops as a consequence of absolute (Type 1 diabetes) or relative
(Type 2 diabetes) insulin deficiency. This high concentration of blood glucose, and
other biochemical abnormalities, results from a deficiency in pancreatic P-cells
and/or from an impaired sensitivity to insulin in target cells (World Health
Organisation (WHO) Study Group, 1985).
1.4.4. Complications ofDiabetes Mellitus
Lack of insulin interferes with carbohydrate, protein and fat metabolism and causes a
severe disturbance of water and electrolyte balance (Frier et al., 1999). Death can
occur from acute metabolic decompensation whereas chronic metabolic
abnormalities are often associated with permanent and irreversible changes in the
function and structure of cells. Vascular cells are particularly susceptible to these
changes and this results in the complications of diabetes which characteristically
affect the eye, the kidney and the nervous system (Kohner et al., 1995). Diabetes is
associated with an excess mortality of between 3-5 times the non-diabetic




Diabetes is an important and independent risk factor for the development of coronary
artery disease and peripheral vascular disease, which are the principal causes of death
and disability in patients with this condition (Head & Fuller, 1990). Atherogenesis
follows a pattern similar to that in the non-diabetic patient but lesions develop earlier
and are both more extensive and more severe. Diabetes enhances the effect of other
risk factors (smoking, hypertension, hypercholesterolaemia) whilst
hyperinsulinaemia may raise arterial blood pressure and may also promote
atherogenic changes in blood lipids and coagulability (Morrish et al., 1991).
1.4.4.2. Microvascular Disease.
Small blood vessel disease (diabetic microangiopathy) is a specific complication of
diabetes. Diabetes is associated with microvascular complications in the retina,
kidney and peripheral nervous system, which contribute significantly to morbidity
and mortality (Eurodiab IDDM Complications Study Group, 1994). The classical
features of diabetic microangiopathy, a marked thickening of the capillary basement
membrane and an increase in vascular permeability, are found in all vascular beds
(Tooke, 1996). The imposition of tissue and organ specific factors on this general
vascular injury lead to the development of the clinical symptoms: retinopathy,
nephropathy and neuropathy.
1.4.4.2.1. Diabetic Retinopathy
In the retina, the vascular pathologies are found mostly in the microvessels. Among
the earliest detectable histological changes is a loss of retinal pericytes (Chibber et
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al., 1994; Kohner et al., 1995). Other changes include increased capillary diameter,
basement membrane thickening, changes in retinal blood flow, increased vascular
permeability and formation of microaneurysms, all of which could be consequences
of pericyte loss (Parving et al., 1983; Kohner et al., 1995). Once formed, the
abnormal blood vessel appears to lose its ability to regulate blood flow; the
capillaries in turn lose their ability to receive blood, which leads to formation of
ghost capillaries (Kohner et al., 1995). The increased haemorrhages and exudates
combine with the formation of ghost vessels to produce large areas of anoxia, leading
to the more serious stage of diabetic retinopathy, proliferative retinopathy (Aiello et
al, 1998).
Proliferative retinopathy is characterised by neovascularisation of retinal capillaries
both intraretinally and in the vitreous; this leads to increased risk of bleeding and,
with healing, to the formation of fibrosis in the retina that enhances the potential for
retinal detachment and visual loss. Overall, diabetic retinopathy is the most common
cause of blindness in adults aged 20-74 years (American Diabetes Association,
2002(a)).
1.4.4.2.2 Diabetic Nephropathy
Diabetic nephropathy is a significant cause of morbidity and mortality: renal failure
accounts for 40-50% of deaths in those developing diabetes before age 15 and is
among the most common causes of end-stage renal failure (American Diabetes
Association, 2002(b)). Approximately 30% of patients with type 1 diabetes will
develop nephropathy within 20 years and its treatment is difficult. In the kidney,
22
increased renal blood flow contributes to the glomerular hyperfdtration and
hypertension which results in diabetic nephropathy (Hostetter et al., 1982), diagnosis
ofwhich is indicated by the development of microalbuminuria and proteinuria.
1.4.4.2.3. Diabetic Neuropathy
In diabetic neuropathy (Stevens et al., 1995; Malik et al., 1993) (a common, early
complication affecting -30% of patients), capillary lesions may be found in both
afferent and efferent, somatic and autonomic nerves. The manifestations of this
complication include loss of sensation, paresthesia (abnormal sensation), weakness,
difficulty in walking and autonomic dysfunction (e.g. urinary retention, impotence
and orthostatic hypotension).
1.5. Evidence of Vascular Dysfunction in Diabetes Mellitus
The pathogenesis of the vascular complications of diabetes mellitus is not completely
understood. However, there is considerable evidence to indicate that both
macrovascular and microvascular complications are the result of impaired function
of vascular cells (Tooke, 1996). The "haemodynamic hypothesis" of the
pathogenesis of diabetic microangiopathy in type I diabetes argues that in the early
stages of diabetes microvascular pressure and flow are increased, resulting in an
injury response in the microvasculature with a concomitant thickening of the
basement membrane. This in turn limits the vasodilatory capacity of the
microvasculature impairing maximal hyperaemia as well as interfering with the
ability of the microcirculation to autoregulate (Parving et al., 1983).
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Early in the course of type 1 diabetes there is an increase in retinal, renal, skeletal
muscle and skin blood flow, which is associated with poor glycaemic control
(reviewed Tooke, 1986). Nailfold capillary pressure is increased early during the
course of diabetes and is related to the degree of hyperglycaemia (Sandeman et al.,
1992). Furthermore, capillary pressure is elevated in type 1 patients with
microalbuminuria (Shore et al., 1992), compared with age- and sex-matched patients
of similar disease duration and glycaemic control without clinical evidence of
microvascular complications.
In contrast to type 1 diabetes, the major abnormality of microvascular function found
in the skin of patients with type 2 diabetes is a marked impairment of microvascular
vasodilatation. This is present at the time of diagnosis (Sandeman et al., 1991) and
may be related to the effects of hyperinsulinaemia in the pre-diabetic state (Jaap &
Tooke, 1995). Despite the marked changes described in type 1 diabetes, skin nailfold
capillary pressure appears to be normal in normotensive patients with type 2 diabetes
(Shore et al., 1994).
The ability to measure human microvascular function directly is crucial in
understanding the pathophysiology of diabetic microangiopathy. Results from such
studies have provided a pathophysiological framework which suggests that there are
differences between the pathogenesis of vascular alterations between the two major
forms of diabetes (Tooke, 1995), and this is pertinent to understanding the
underlying mechanisms which ascribe a pivotal role for the vascular endothelium.
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1.5.1. Endothelium-Dependent Vascular Responses in Diabetes
Studies of vascular function in diabetes are complicated by the recognised difficulties
of analysing vascular function in vivo and isolating tissue from patients for study in
vitro (Benjamin et al., 1995). Functional investigations of endothelial cell function in
diabetic patients have provided conflicting results. The discrepancies between studies
could be attributed to variations in a number of factors, including differences in the
duration and degree of the diabetic state, degree of acute hyperglycaemia, insulin
concentrations, and the presence or absence of diabetic complications.
1.5.2. Human Studies
1.5.2.1. In vivo studies
In vivo studies of vascular function in diabetes are contradictory, and the nature of
the functional alterations remains unclear (Flopfner & Gopalakrishnan, 1999; Porta et
al., 1987). Less invasive methods have been employed to determine whether
endothelium-dependent vasodilator function is compromised in diabetic subjects.
The techniques used include the measurement of forearm blood flow (FBF) using
venous occlusion plethysmography (Johnstone et al., 1995), measurement of forearm
skin erythrocyte flux to iontophoresis of charged substances using laser doppler
perfusion imaging (Morris et al., 1995) and measurement of artery diameter and
blood flow velocity, using high-resolution Doppler ultrasound (Zenere et al., 1995).
Venous occlusion plethysmography, which measures total forearm blood flow, is a
widely used, safe and accurate technique in which endothelium-dependent
vasodilatation of human resistance arteries is assessed by intra-arterial infusion of
25
muscarinic agonists such as ACh, methacholine or carbachol (Benjamin et al., 1995).
In Type 1 diabetes the majority of in vivo studies have failed to confirm the defect
reported in the isolated subcutaneous arteries (McNally et al., 1994). Responses to
infused muscarinic agonists, including ACh, have been no different from that of non-
diabetic subjects (Halkin et al., 1991; Calver et al., 1992; Elliott et al., 1993; Smits et
al., 1993). However, the NO-mediated component of dilatation was reduced in
patients with microalbuminuria (Elliott et al., 1993), and two of the studies reported
reduced basal NO release (Calver et al., 1992; Elliott et al., 1993). In patients with
Type 2 diabetes, impaired responses to ACh have been observed in the forearm
together with blunted responses to NO donors such as GTN and SNP (McVeigh et
al., 1992; Watts et al., 1996). These results are challenged, however, by similar
investigations demonstrating that endothelium-dependent relaxation is unchanged
(Avogaro et al., 1997; Cockcroft et al., 1998) or enhanced (Cipolla et al., 1996)
(Tables 1.1; Table 1.2).
The technique of venous occlusion plethysmography has some potential problems,
especially when comparing responses between healthy control subjects and patients.
Differences in starting conditions, including basal blood flow, arterial pressure and
forearm size, can all affect the response to drugs and can result in misleading
conclusions being drawn (Benjamin et al., 1995). Furthermore, small alterations in
arterial pressure and sympathetic arousal must be controlled for by using the
noncannulated arm as an in-built control and by expressing data as percentage
change in the of forearm blood flow in the two arms (Benjamin et al., 1995).
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Table 1.1. Investigation of human endothelial function in Type 1 diabetic subjects,
studied by venous occlusion plethysmography (VOP), vascular ultrasound (US)
and isolated vessel techniques, mainly small vessel myography (SVM).
Endothelium- Endothelium- Method Disease HbAlc Reference
dependent independent Duration (%)
relaxation relaxations (yrs)
Reduced Reduced (GTN) US 10±1 7.710.2 Zenere et al (1995)
Reduced (GTN) US 13±8 9.512.2 Clarkson et al (1996)
Unaltered (SNP) FBF 14+2 11.910.6 Johnstone et al
(1993)
Unaltered (SNP) FBF 18±2 8.310.4 O'Driscoll et al
(1997)
Unaltered (ISDN) US 12.9+8.4 6.511.5 Lekakis et al (1997)
Unaltered (GTN) US 26.912.0 9.610.3 Meeking et al (1999)
Reduced (ACh) Unaltered (SNP) SVM 18.111.3 9.510.5 McNally et al (1994)
Unaltered (BK)
Unaltered Unaltered (SNP) FBF 12.018.0 N/A Halkin et al (1991)
Unaltered FBF Recent onset 6.710.5 Calver et al (1992)
(verapamil)
Reduced (SNP)
Unaltered (SNP) FBF 15.118.2 9.210.9 Smits et al (1993)
Unaltered (SNP) FBF 20.7 N/A Elliot et al (1993)
Unaltered (GTN) US 14.918 7.911.2 Lambert et al (1996)
Unaltered (SNP) FBF 1813 8.610.3 Makimattila et al
(1997)
Unaltered (GTN) US 21.5110.2 8.011.1 Enderle et al (1998)
Unaltered (SNP) FBF 17 8.98 Huvers et al (1999)
Reduced (SNP) FBF 10.812.7 9.610.7 Khan et al (1996)
Enhanced (SNP) SVM 24.9±11.0 Malik et al (1999)
ACh, acetylcholine, BK, bradykinin, FBF, fore-arm blood flow, GTN, glyceryl
trinitrate, SNP, sodium nitroprusside, FIbAlc, glycosylated haemoglobin.
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Table 1.2. Investigation of human endothelial function in Type 2 diabetic subjects,
studied by venous occlusion plethysmography (VOP), vascular ultrasound (US)
and isolated vessel techniques, mainly small vessel myography (SVM).
Endothelium- Endothelium- Method Disease HbAlc Reference
dependent independent Duration (%)
relaxation relaxations (yrs)
Reduced Reduced (GTN) FBF 5.2 9.7 McVeigh et al
(1992)
Reduced (SNP) US 9.1 ±1.9 6.5±0.2 Morris et al (1995)
Reduced (SNP) FBF 3.6 7.5 Watts et al (1996)
Unaltered (SNP) FBF 3.2 7.9±0.7 Ting et al (1996)
Unaltered (GTN) US 7.4±6.0 9.1±2.4 Enderle et al {1998)
Unaltered (SNP) FBF Up to 1 Oyrs 10.3±0.7 Hogikyan et al
(1998)
Reduced (ACh) Unaltered (SNP) FBF 4.6±2.7 6.9+1.4 Gazis et al (1998)
Unaltered (BK)
Unaltered Unaltered (SNP) FBF N/A 7.0+1.5 Cockcroft et al
(1998)
Unaltered (SNP) FBF 1+2 8.7+0.6 Avogaro et al (1997)
Unaltered (ACh) Increased (SNP) SVM N/A N/A Lawrence et al
Increased (BK) (1994)
Increased Unaltered (SNP) PM N/A N/A Cipolla et al (1996)
ACh, acetylcholine, BK, bradykinin, FBF, fore-arm blood flow, GTN, glyceryl
trinitrate, SNP, sodium nitroprusside, FIbAlc, glycosylated haemoglobin.
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However, this does not fully compensate for differences in starting conditions
between groups and this is of particular relevance in diabetes as, in this condition,
basal blood flow is influenced by the degree of glycaemic control (Elliott et al.,
1993).
The techniques of laser Doppler perfusion imaging and iontophoresis have been
combined, enabling the reproducible measurement of skin blood flow responses to
vasoactive agents (Morris et al., 1995). Iontophoresis is a non-invasive method of
drug application, which allows the local transfer of charged substances across the
skin using a small electric current. A laser Doppler perfusion imager allows the
measurement of skin erythrocyte flux directly over the site of drug application.
Impaired responses of the skin microcirculation to iontophertically applied ACh and
SNP have been demonstrated in patients with both Type 1 and Type 2 diabetes
(Morris et al., 1995; Lim et al., 1999; Katz et al., 2001).
More recently, the development of a second non-invasive technique, the
measurement of artery diameter and blood flow velocity, using high-resolution
Doppler ultrasound has enabled further assessment of endothelial function of conduit
vessels (mainly the brachial artery) in humans (Celermajer, 1998). The method has
been used to evaluate the response to an increase in flow generated by a period of
hyperaemia, which is considered to lead to flow mediated NO release (Sorenson et
al., 1995). The results from such studies are again contradictory with endothelium-
dependent vascular responses shown to be impaired (Zenere et al., 1995; Lekakis et
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al., 1997; Morris et al., 1995; Enderle et al., 1998) or unchanged (Lambert et al.,
1996; Enderle et al., 1998).
The conflicting data obtained in human in vivo studies could be attributed to a
number of factors including methodological differences (e.g method of study,
agonists used) and variations in patient selection (e.g. sex differences, presence or
absence of diabetic complications). The mechanisms whereby diabetes is associated
with endothelial dysfunction are complex and not completely understood and are
probably multiple and composed of both systemic and local factors. It has been
demonstrated that patients with strict glycaemic control have a lower incidence of
vascular complications (Diabetes Control and Complications Trial Group, 1993),
thereby implicating hyperglycaemia as an independent risk factor for the
development of cardiovascular disease. The mechanism by which elevated glucose
contributes to the pathogenesis of vascular dysfunction is not completely understood
but there is much evidence to suggest that the action of both glucose and insulin can
directly alter the function of cells in the vascular wall (Hopfner & Gopalakrishnan,
1995; Porta et al., 1987).
1.5.2.2. In vitro studies
Analysis of arteries isolated from patients with diabetes is complicated by the
difficulties associated with obtaining suitable, viable tissue. Consequently, there have
been relatively few in vitro studies of vascular function in diabetes using human
vessels. Those investigations that have been performed have used sub-cutaneous
resistance arteries taken from biopsies of the gluteal region (McNally et al., 1995) or
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lower extremities (Cipolla et al., 1996). Resistance artery function can be studied
using the technique of small vessel myography (Mulvany & Halpern, 1977) and has
the advantage of using resistance vessels which have a major influence on the
maintenance of peripheral resistance. These have produced contradictory results and,
thus, have failed to confirm the influence of diabetes on either contraction or
relaxation of resistance arteries. For example, both impaired (McNally et al., 1995)
and normal (Malik et al., 1999) endothelium-dependent relaxation in response to
ACh has been reported in arteries from Type 1 diabetic patients. The normal
response observed in the latter study was despite an enhanced relaxation to an NO
donor (SNP). Similarly, relaxation to ACh has also been reported to be normal, or
even enhanced (Cipolla et al., 1996) in vessels isolated from patients with Type 2
diabetes (Lawrence et al., 1994). Intriguingly, the relaxation reported by McNally et
al. (1995) was selective for ACh, with responses to bradykinin and SNP unaltered.
This suggests a selective abnormality in the muscarinic receptors rather than a
generalised endothelial cell dysfunction or impaired sensitivity to NO.
The effect of diabetes on contractile function is also unclear. One study reported a
general impairment in contraction in arteries from patients with Type 1 diabetes
(McNally et al., 1995) whereas another found a selective enhancement in All-
mediated contraction (Malik et al., 1999). In Type 2 diabetes, NA-mediated
contraction of resistance arteries was enhanced as a result of an impairment in the
ability of the endothelium to modulate the contractile response (Cipolla et al. , 1996).
Intriguingly, ACh-mediated relaxation was not impaired in these vessels, suggesting
a selective impairment in either basal or adrenoceptor-mediated NO release.
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1.5.3. Animal studies
The difficulties encountered when studying vascular function in diabetic patients has
prompted the development, and widespread use, of a number of animal models for
research purpose. Diabetes can occur spontaneously in some animal species or can be
induced by treating animals with chemicals or viruses. The most commonly used
animal models are the alloxan-induced diabetic rabbit, the streptozotocin (STZ)-
induced diabetic rat and the genetically susceptible bio-breeding (BB) rat (Bell &
Hye, 1983). Both alloxan and STZ cause selective ablation of the pancreatic p-cells,
although sufficient P-cell activity remains which obviates the need for exogenous
insulin. These animals exhibit hyperglycaemia and other characteristics of diabetes
such as polydipsia, polyphagia and polyuria (Tomlinson et al., 1992). The BB rat is a
model of spontaneous diabetes that exhibits a total lack of insulin secretion from
pancreatic (3-cells. BB rats are hyperglycaemic, hypoinsulinaemic, have significant
polyuria and glycosuria, and need insulin administration to survive (Nakhooda et al.,
1977).
Most studies of vascular function in diabetic animals have focused upon
determination of endothelium-dependent relaxation. In isolated arteries prepared for
isometric force measurement, endothelium-dependent relaxation is assessed by pre-
contraction of the artery with a suitable agonist (usually NA) and by the subsequent
determination of relaxation to an endothelium-dependent vasodilator (usually ACh).
As described earlier, (Chapter 1.2 & 1.3), ACh-induced vasodilatation is mediated by
release of NO (Moncada et al., 1991), PGI2 (Woolfson & Poston, 1990), or EDHF
(Garland & McPherson, 1992). The relative contribution of these dilating factors
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varies in arteries from different territories. It is unlikely that diabetes would produce
the same pathophysiological changes in conduit and resistance arteries, as it is well
established that these vessels are functionally distinct. Receptor populations vary in
arteries of different anatomical origin (Cambridge et al., 1995) and, perhaps more
significantly, the factors that contribute to endothelium-dependent relaxation differ in
large compared with small vessels. Endothelium-dependent relaxation is mediated
almost exclusively by NO in conduit arteries (Vanhoutte, 1989), whereas the
contribution of EDHF becomes increasingly significant as the diameter of the vessel
diminishes (Shimokawa et al., 1996). Most studies in conduit arteries from diabetic
animals have shown an attenuation of the normal vasodilatory response to ACh
(Poston & Taylor, 1995). The defect appears to lie at the level of the receptor rather
than an inability of the endothelial cells to release, or of the vascular smooth muscle
cells to relax to NO, as responses to Ca2+ ionophores and NO donors remain normal.
As with human in vitro studies, investigation of resistance artery function using
vessels from animal models has failed to determine the exact nature of vascular
dysfunction in diabetes. In resistance arteries from diabetic rats, endothelium-
dependent relaxation has been found to be impaired, normal or even enhanced (Chan
et al., 2000). This disparity may be due to differences in disease duration, the
vascular bed studied and the methods of study (perfusion versus isolated tissue
preparation). The importance of disease duration has been highlighted in a recent
study that demonstrated a triphasic response in relation to disease duration in the
STZ-induced diabetic rat (Pieper, 1999). ACh-induced endothelium-dependent
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relaxation was increased 24 hours following disease induction, normal after 1-2
weeks and impaired after 8 weeks of the disease.
1.6. Development of diabetic microvascular complications: the role of
hyperglycaemia.
The profound association of elevated blood glucose with the development of micro-
and macrovascular complications of diabetes suggests strongly that hyperglycaemia
may directly alter vascular physiology. Multiple mechanisms have been suggested
for the possible pathway(s) by which hyperglycaemia could cause vascular
dysfunction. These include a role for aldose reductase and the polyol pathway, free
radicals, protein kinase C and advanced glycosylation end products. Each of these
pathways implicated in hyperglycaemia-induced endothelial dysfunction will now be
discussed.
1.6.1. Aldose reductase and thepolyolpathway
Hyperglycaemia leads to an increase in glucose metabolism through the polyol
pathway (Hawthorne et al., 1989), which increase sorbitol flux and fructose synthesis
through enhanced aldose reductase activity.
NADPH NADP NAD NADH
Glucose ► Sorbitol ► Fructose
Aldose reductase Sorbitol dehydrogenase
Aldose reductase, the rate-limiting enzyme in the conversion of glucose to sorbitol, is
present in high amounts in endothelial cells (Kern & Engerman, 1982). The activity
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of aldose reductase requires and may deplete NADPH, which is an essential co-factor
for the generation of NO from arginine by the enzyme NOS. Hence, NADPH
depletion as a result of chronic hyperglycaemia could lead to a reduction in NO
production. The importance of increased polyol formation in diabetic endothelial
dysfunction is further supported by the observation that aldose reductase inhibitors
restore endothelium-dependent relaxations in diabetic animals and reverse the effect
of hyperglycamia-induced endothelial cell dysfunction (Cameron & Cotter, 1992;
Williamson et al., 1990; Tesfamariam et al., 1993).
1.6.2. Vasoconstrictor Prostanoids
In aortae from diabetic rabbits and normal rabbits exposed to elevated glucose in
vitro, impaired relaxations to acetylcholine are restored by treatment with various
cycloxygenase inhibitors (Tesfamariam et al., 1989; Tesfamariam et al., 1990),
indicating that contractile prostanoids could counteract NO-mediated relaxations.
The potent vasoconstrictor prostanoid, thromboxane A2, is unlikely to account for the
impaired relaxation as a TxA2 synthase inhibitor failed to prevent the abnormal
relaxations of aortae exposed to elevated glucose (Tesfamariam et al., 1990). This
leaves open the possibility that other prostanoids are important. PGH2/TxA2-receptor
blockade also prevents the abnormal endothelium-dependent relaxations of diabetic
aortae and aortae exposed to elevated glucose, suggesting that PGH2, the precursor
prostaglandin, or other prostaglandins could account for the impairment.
35
1.6.3. Free radicals
The formation of oxidation products that are potentially damaging to the endothelium
depends upon the balance between pro- and antioxidant status. There is abundant
evidence in diabetes for an increase in oxidative stress, where pro-oxidants outweigh
antioxidants (reviewed Wolff, 1993). This increased stress may be due to elevated
free radical generation, decreased levels of antioxidants and/or impaired regeneration
of reduced forms of antioxidants. An increase in free radical synthesis may occur
through the autoxidation of glucose (Wolff, 1993) or through a glucose-induced
increase in activity of the cyclooxygenase pathway (Tesfamariam & Cohen, 1992).
There is substantial evidence to indicate that hyperglycaemia-induced endothelial
cell dysfunction is mediated by free radicals produced through increased arachidonic
acid metabolism (Tesfamariam & Cohen, 1992; Tesfamariam, 1994; Giugliano et al.,
1996). In addition it has been demonstrated that in human aortic endothelial cells
glucose-induced increases in eNOS expression and NO release is associated with a
concomitant increase in superoxide anion generation (Cosentino et al., 1997).
Superoxide anions inactivate NO and furthermore, interact with NO to produce
peroxynitrite (Squadrito & Pryor, 1995), which results in endothelial dysfunction
through increased cyclooxygenase catalysis, lipid peroxidation and increased
prostanoid production (Tate et al., 1984; Jackson et al., 1986). A role for superoxide
anions in glucose-induced endothelial-dysfunction is further demonstrated by the fact
that superoxide dismutase, a superoxide anion scavenger, normalises glucose-
impaired NO-induced relaxation (Hattori et al., 1991; Diederich et al., 1994).
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1.6.4. Protein kinase C
Activation of PKC by increases in DAG induced by hyperglycaemia has been
suggested as a mechanism for endothelial dysfunction and vascular complications in
diabetes (Wolf et al., 1991). Normal blood vessels treated for just a few minutes with
phorbol esters, which activate PKC, develop endothelium-dependent relaxations that
are impaired like those of diabetic blood vessels, and the abnormal relaxation can be
attributed in part to the increased production of vasoconstrictor prostanoids
(Tesfamariam et al., 1991). Furthermore, the abnormal endothelium-dependent
relaxation was restored with sphingosine, a PKC inhibitor. The PKC inhibitor also
prevented the glucose-induced increase in prostanoid production, suggesting that
glucose impairs endothelium-dependent relaxation by a PKC-mediated production of
prostanoids.
1.6.5. Advanced glycosylation endproducts
When plasma and cell membrane proteins are exposed to high concentrations of
glucose for prolonged periods, they undergo nonenzymatic glycosylation, cross-
linking, and formation of advanced glycosylation end products (AGEs, Brownlee et
al., 1988). The resulting altered proteins may cause cellular dysfunction and have
been implicated in the complications of diabetes. AGEs have been shown to
inactivate NO in vitro and aminoguanidine, an inhibitor ofAGEs formation, has been
shown to partially restore endothelium-dependent relaxations of diabetic rat aortae
(Bucala et al., 1991), suggesting that advanced glycosylation end products may be
responsible for endothelial dysfunction in chronic diabetes. AGEs form slowly over
days to weeks in vitro (Brownlee et al., 1988), and are therefore unlikely to play a
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role in the effect of elevated glucose applied to blood vessels in vitro. It should also
be noted that aminoguanidine is a structural analogue of arginine that actually
inhibits NOS (Corbet et ai, 1992) and therefore could have a direct effect on NO
generation.
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1.7. Hypothesis and Aims
The work carried out in this thesis studied the hypothesis that the vascular
abnormalities present in the microvasculature in Type 1 and Type 2 diabetes are the
consequence of exposure to elevated blood glucose concentrations.
To date few investigators have examined vascular function in vitro in human arteries
isolated from patients with Type 1 and Type 2 diabetes. Therefore the aims of this
thesis were threefold:
(1) to refine a protocol that could be used for isolating and identifying resistance
arteries isolated from patients with diabetes
(2) to determine whether endothelial and/or vascular smooth muscle function are
altered in diabetes and






2.1 SMALL VESSEL MYOGRAPHY
2.1.1. Introduction.
Prior to the mid 1970s, investigations into the structure and function of isolated
vessels had been confined to the aorta and arteries with lumen diameters greater than
500pm. However, it was recognised that it is the smaller arterial vessels (100-
500pm) which present the greatest resistance, and which are most involved in
regulating blood flow and capillary pressure (Furness & Marshall, 1974). Until the
1970's, characteristics of resistance vessels could only be inferred, primarily from
haemodynamic studies, or by extrapolation from characteristics of elastic and
conduit arteries.
A major technical breakthrough (Bevan & Osher, 1972) made possible the study of
isolated resistance arteries in vitro. This technique, small vessel myography, allowed
direct mechanical measurements on intact segments from small (less than 500pm)
vessels by mounting them as ring preparations horizontally on two fine wires, with
the wires clamped at each end to ensure that the responses were isometric. In
addition, this technique allowed measurement of media: lumen ratio under standard
conditions and enabled analysis of function and structure in the same vessel
(Mulvany & Halpern, 1976). Further refinement allowed investigation of vessels
with internal diameters as small as ~100pm (Mulvany & Halpern, 1976, 1977;
Mulvany et al., 1978), a dual myograph for simultaneous testing of two vessels was
introduced by Mulvany & Nyborg (1980), and isobaric (pressure) myographs have
also been developed (Duling et al., 1981).
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Myography is relatively atraumatic, with the measured responses exceeding the
estimated in vivo responses and corresponding to the force-generating capacity
known from other smooth muscle preparations (Mulvany & Halpern, 1977). The
presence of intraluminal wires does cause some damage to the endothelial cell layer,
but does not impair endothelium-dependent relaxation (Falloon et al., 1995). The
main criticism of wire myography is that it is not physiological: the vessel rings are
flat, rather than cylindrical and are not exposed to shear forces. This is reflected in
the demonstration that vessel sections in a wire myograph are less depolarised than
those in perfusion systems and, as a consequence, develop less myogenic tone and
are less sensitive to vasoconstrictors (Buus et al., 1994; Dunn et al., 1994). Despite
these imperfections, wire myography provides a valuable tool for investigations of
vascular physiology and pathophysiology. It allows the determination of the
following parameters for vessels with diameters in the range 100-1000pm:
(a) normalised internal diameter (the lumen diameter under a known stretch).
(b) Thickness of the adventitial, medial and intimal layers of the vascular wall.
(c) isometric response to agonists.
(d) simultaneous measurements of isometric response and membrane potential.
(e) simultaneous measurements of isometric response and cytoplasmic ion
concentration.
(f) fixation of vessels under clearly defined conditions for histometric analysis.
The small vessel myograph used in the experimental procedures during this thesis
was the dual myograph model 41 OA, manufactured by J.P. Trading, Science Park
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Aarhus, Aarhus C, Denmark. Functional analyses were developed on the basis of
information supplied in the course on Basic Myography run by Professor Mulvany at
the University of Aarhus.
2.1.2. Isolation ofsmall resistance arteries
2.1.2.1. Rat mesenteric vessels.
Male Cob-Wistar rats, maintained on standard chow and tap water ad libitum, were
obtained from the Animal Unit, Department of Pharmacology, University of
Edinburgh. The animals (150-250g) were killed by stunning followed by cervical
dislocation and a ventral mid-line incision was made. The mesenteric bed was
removed and immediately placed in physiological salt solution (PSS) of the
following composition (mM): - NaCl 119, KC1 4.7, CaCh 2.5, MgSC>4 1.17,
NaHCCE 25, KH2PO4 1.18, K2EDTA 0.026 and D-glucose 5.5. The mesenteric bed
was then pinned out in a silicone coated (Sylgard, Dow-Corning, UK) petri dish
containing PSS and dissection was performed at room temperature.
For resistance arteries, approximately 200-300pm in diameter, third order branches
of the superior mesenteric artery, were excised under a dissection microscope (x20
magnification) (Zeiss, UK) using No. 5 watchmaker forceps (Merck, Poole, Dorset,
UK) and fine trabecular dissection scissors (Geuder G-19745, Altomed Ltd, Tyne &
Wear, UK). To avoid direct contact with the section of vessel to be studied,
surrounding connective tissue was gently pulled away from the artery to expose the
thin membrane connecting the connective tissue to the artery. This membrane was
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cut, thus isolating the artery from the fat cells. The artery, along with the feeder
artery, was then excised.
2.1.2.2. Human vessels: tissues from gluteal fat biopsies.
Skin biopsies, approximately 2cm long, 0.75cm wide and 0.75cm deep, were taken
from the gluteal region under local anaesthesia (2% Lignocaine hydrochloride, Astra
Pharmaceuticals Ltd, UK) (Aalkjaer et al., 1986). The biopsies were immediately
immersed in cold PSS and brought to the laboratory. Arteries (usually 1-3) were
dissected out from each biopsy using light microscopy. In order to distinguish
arteries from veins the following guidelines were followed:
1. the artery is stiffer than the vein, and sometimes sticks out of the
biopsy.
2. the walls of arteries are thicker and more distinct than walls of veins.
3. if you pull the connected tissue the vein will flatten out, while the
artery tends to keep its shape.
4. the artery is often smaller than the vein and when dissected from the
biopsy the artery retains its shape whilst the vein tends to curl up.
2.1.3. Mounting and normalisation of vessels in the myograph
2.1.3.1. Mounting of the vessel in the myograph.
Once dissected, the arteries were carefully transferred to the myograph chamber,
which contained 12.5ml of PSS, for mounting on 40pm wires. The first wire was
positioned in the centre between the jaws and the jaws were then screwed together so
that the wire was clamped. The far end of the wire was bent towards the movable jaw
and wrapped around under the fixing screw in a clockwise direction so that
tightening the screw also tightened the wire. This resulted in the wire being clamped
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between the jaws with the near end pointing towards the operator. Using the feeder
artery, the vessel was slid onto the end of the wire (if the lumen was not patent, the
wire tip was used to gently open the end of the vessel). Once the vessel was on the
wire the jaws were opened to free the wire. The proximal end of the vessel was then
gently pulled along the wire with care being taken not to stretch the vessel if the end
of the wire caught on the vessel wall. The vessel was pulled along the wire until the
segment to be investigated was situated between the mounting jaws. Once in
position, the jaws were screwed together to clamp the wire, ensuring that the bottom
end of the vessel was inside the jaw gap, such that it was not touched by the jaws.
The near end of the wire was then secured under the near fixing screw on the
movable jaw, again in a clockwise direction, so that tightening the screw also
tightened the wire. The 'feeder' segment of the artery on the far side of the jaw was
gently rubbed with forceps and after about half a minute this severed the vessel so
that the portion of the 'feeder' artery on the far side of the jaw could be discarded.
The jaws were then separated to allow insertion of the second wire through the vessel
lumen. The wire was then gently fed through the lumen, with care taken to ensure
that the end of the wire did not catch on the vessel wall. When the second wire was
fully passed through the vessel it was positioned with the vessel at the centre and the
jaws were screwed back together, ensuring that it moved under the first. The second
wire was then secured around the fixing screws of the fixed jaw. With both wires
secured, the jaws were separated so that the vessel was slightly stretched and final
adjustments were made to ensure that the wires were level (Figure 2.1).
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Figure 2.1. Schematic diagram of the wire myograph, where vessel segments are
threaded on two 40gm stainless steel wires that are fastened to a micrometer and
a force transducer, for measurement of isometric tension. (Figure taken from
Mulvany & Aalkjaer, 1990).
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In order to measure the vessel length, a travelling micrometer eyepiece was attached
to the microscope and the microscope was set to the magnification at which the
eyepiece was calibrated (x40). Measurement of the vessel length was achieved using
the travelling micrometer. Once the arteries were mounted, the PSS in the myograph
was replaced, perfused with 95% Oa and 5% CO2 and equilibrated at 37°C.
2.1.3.2. Determination of normalised lumen using small vessel myograph
Following a 30min equilibration period, to allow the PSS in the myograph chamber
to reach 37°C, the vessel was then normalised. This procedure determines for a
vessel mounted on the myograph the internal circumference, denoted IC100, which
the vessel would have if relaxed and under a transmural pressure of lOOmmHg. This
procedure is necessary as the sensitivity of preparations to agonists is dependent on
the degree of stretch (Nilsson & Sjoblom, 1985; Mulvany 1983).
Normalisation was performed by stretching the vessel in steps and recording
micrometer and force (measured on a dual channel flat bed pen recorder (Sekonic
SS-250F)) readings for each stretch. Each pair of readings was keyed into a computer
program ("Normalisation" program, gift from Dr. N. Stevens, Manchester
University; adapted to Windows format by Mr. D. Christie, Dept. Medicine,
University ofEdinburgh) and, having entered the transducer calibration, the effective
pressure corresponding to each stretch was calculated. This procedure was completed
once the effective pressure exceeded lOOmmHg (13.3kPa). The program fits an
exponential curve to the data and, using LaPlace's equation, the point on the curve
corresponding to lOOmmHg is determined and denoted ICioo- Having found this, the
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stretch on the vessel was adjusted to give an internal circumference of 0.9ICioo,
which has been shown to be the optimum resting setting for these vessels (Mulvany
& Halpern, 1977).
2.1.4. Assessment ofvessel viability
In order to confirm the viablility of each vessel section and the reproducibilty of
contraction, vessels were subjected to a standard start procedure (Aalkjaer et al.,
1987).
The standard start was performed after the vessel had been equilibrated at its
normalised setting at 37°C. It consisted of a series of five stimulations of 3 minutes
each followed by washout periods of 5 minutes in PSS to allow full relaxation. The
first, second and fifth contractions were produced using NA-K, a high potassium
solution (125mM KPSS, made by the equimolar substitution of KC1 for NaCl in
PSS) containing lOpM noradrenaline (NA). The third contraction was produced by
KPSS alone and the fourth by NA (lOpM). This procedure confirms the
reproducibility of contraction and demonstrates which component is due to K+ and
which is due to NA (important e.g. in mouse aorta). According to convention (based
upon the active force produced by smooth muscle cells (Mulvany & Halpern, 1976))
a viable resistance artery should produce an effective pressure in excess of 13.3kPa
in response to the final exposure to NA-K.
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2.1.5. De-endothelialisation.
The purpose of de-endothelialisation is to eliminate endothelial effects on the rest of
the vessel (e.g. to examine smooth muscle function in the absence of endothelium-
derived factors). The endothelium removal can be used either to rule out the
influence of the endothelium on a certain mechanism, or to confirm the role of the
endothelium in the mechanism (this can only be done if endothelium intact vessels
are compared with denuded vessels). In large arteries the most common approach for
removing the endothelium is by mechanical means, usually by rubbing the inner
surface of a vessel segment with a small stick or wire (Osol et al., 1989). This
technique is difficult to apply to small resistance arteries because of their fragility
and therefore a wide range of alternative non-mechanical methods have been tried;
for example, perfusion with a dilute detergent (DeMay & Gray, 1985), dissolving the
intracellular matrix with enzymes such as collagenase or elastase (Harder, 1987), or
rupturing endothelial cells osmotically with distilled water (Bolton et al., 1984).
Unfortunately, these chemical and enzymatic methods are difficult to control
precisely (e.g. exposure time, shear rate) and carry the risk of damaging adjacent
smooth muscle cells. It then becomes difficult to know with certainty whether an
observed difference in the vessel response is due specifically to endothelial cell
removal. Alternative ways of denuding resistance arteries mechanically are the
introduction of a single human hair into the vessel lumen (Osol et al., 1989) and
perfusion of the lumen with an air bubble (Falloon et al., 1993). The use of a human
hair provides a simple and effective tool for mechanical denudation of small arteries
as the surface of the hair is uneven and consists of repeating ridges or scales with
jagged edges which provides a reasonable degree of cellular abrasion. Both
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functional and morphological evidence have demonstrated that this technique for
denudation is effective, and that smooth muscle cell damage can be either absent, or
very minimal (Osol et al., 1989; Gustafsson & Nilsson, 1990), although this is
obviously operator dependent.
2.1.5.1. Removal of endothelium using a human hair.
Removal of the endothelium was achieved by passing a human hair through the
lumen of the mounted artery, according to the method described by Gustafsson &
Nilsson, (1990). Following normalisation and the standard start procedure to ensure
that the vessel was viable, the functional integrity of the endothelium was checked by
adding acetylcholine (ACh; 10pM) to vessels submaximally contracted with NA
(3pM). Following this, the vessel was set to a small tension (0.5mN) and under a
microscope magnification of x40 the tip of the hair was inserted into the vessel
lumen. The hair was then worked down through the whole inner surface of the vessel
rubbing carefully and cautiously forwards and backwards. Care was taken to avoid
pushing the tip into the vessel wall and thereby damaging the muscle layer. It was
also necessary to avoid stretching/compressing the vessel in its longitudinal direction
when the hair was moved forward/backwards, as this damages the vessel and causes
a significant impairment in contraction. After the procedure, the solution in the
chamber was changed and the vessel was allowed to equilibrate for 5-10min.
Following equilibration, the vessel was slowly stretched back to its normalised
micrometer setting and was allowed to relax for 5min before repeating the test for
endothelium-dependent relaxation. A successful endothelium-removal was classed as
abolition of ACh-mediated relaxation but with minimal reduction of active tension.
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In general, it was not possible to perform this procedure without some reduction in




The use of vasoconstrictors acting via different mechanisms should indicate whether
changes in contraction are due to a loss of receptor function or a general inability of
the smooth muscle cells to contract. For this reason three vasoconstrictors were
chosen, KC1, NA and endothelin-1 (ET-1). KC1 was selected as it causes smooth
muscle contraction by direct depolarization, whereas NA and ET-1 were selected as
examples of agonists which produce receptor-mediated constriction. A further use of
the concentration-responses curve to NA was that it determined which concentration
produced a suitable contraction for investigation of vasodilator compounds.
2.1.6.2. Vasodilatation
It would appear that the most important mechanism of vasodilatation altered by
diabetes is the endothelium-dependent nitric oxide (EDNO) system. Therefore, it
would be necessary to determine whether any alteration in relaxation was due to an
impaired release of endothelium-derived relaxing factors or a general inability of the
vascular smooth muscle cells to relax. For this reason four vasodilators were chosen:
ACh, bradykinin (BK), A23187 and 3'-morpholinosydnonimine (SIN-1). Both ACh
and BK are receptor-dependent, endothelium-dependent vasodilators, but act on
9-4-
different receptors. The Ca ionophore A23187 is a receptor-independent,
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endothelium-dependent agonist. The employment of SIN-1, an endothelium-
independent vasodilator, is necessary to ensure that the vessel retains the ability to
relax.
2.1.7. Statistics
The influence of manipulations in vitro, or the presence of diabetes in vivo, on
functional responses were determined using summary statistics. Maximum response
(Emax) and sensitivity (EC50) values were obtained from concentration-response
curves using Fig P (Biosoft, UK). Data were analysed using Graph Pad (USA)
software (Statmate, Instat) to assess statistical power, normal distribution and
equality of variance. Comparisons were made using a variety of statistical tests:
Student's paired/ unpaired t-test, Mann-Whitney test, one-way analysis of variance
(ANOVA) followed by Dunnet's or Tukey post-hoc tests or Kruskall-Wallis followed
by Dunn's post hoc test, as appropriate.
2.1.8. Drugs.
Stock solutions were prepared for each drug and these were stored in 1ml aliquots at
-20°C. Drugs were thawed as required, subsequent dilutions were made in distilled
water and any residual solution was discarded at the end of the experiment. A list of
the drugs used throughout the course of this thesis is shown in Table 2.1. All salts
were supplied by BDH (Poole, Dorset, U.K) and Insulin (human Velosulin 100U/
ml) was obtained from NovoNordisk (Crawley, West Sussex, U.K.).
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Table 2.1. A list of the drugs used throughout the course of this thesis.
DRUG STOCK SUPPLIER
Vasoconstrictors
Noradrenaline 10"3M in dH20 Sigma
endothelin-1 10"5M in 50% MeOH Alexis
potassium chloride 125mM * BDH-Merck
Vasodilators
acetylcholine 10"3M in dH20 Sigma
bradykinin 10"4M in dH20 Sigma
A23187 10"4M in 10% EtOH Sigma
SIN-1* 10"3M in dH20 Alexis
dH20, distilled water; EtOH, ethanol; MeOH, methanol; SIN-1, 3'-
morpholinosydnonimine.
*SIN-1 was also obtained as a gift from Dr. K. Schonafinger, Cassella, Germany.
125mM KC1 made by the equimolar substitution of KC1 for NaCl in PSS.
ALEXIS CORPORATION (UK) LTD, 3 Moorbridge Court, Moorbridge Road East,
Bingham, Nottingham, England, UK.
BDH LABORATORY SUPPLIES, Poole, Dorset, England, UK.
SIGMA-ALDRICH COMPANY LTD, Fancy Road, Poole, Dorset, England, UK.
53
2.2. MORPHOLOGICAL ANALYSIS.
Since limited information is available regarding the structure of human subcutaneous
resistance arteries, histological staining was used to complement the results obtained
from the functional investigations.
Immunohistochemistry has become an established routine histological technique for
the identification of tissue constituents (antigens). The basis of this methodology
relies on antigen-antibody interactions, with the site of antibody binding being
identified either by direct labelling of the Ab, or by use of a secondary labelling
method. Hence, this means that this technique can be used to detect anything which
is antigenic in nature, producing highly specific results.
2.2.1. Fixation ofvessels.
Human subcutaneous resistance arteries were isolated as previously described, and
immediately fixed in 10% neutral buffered formalin solution for 24hrs at room
temperature. In addition to freshly isolated vessels, those which had previously been
used for functional investigations were carefully removed from the wires at the end
of the experiment and also fixed. Following fixation, the tissues underwent a routine
processing schedule (Pathology Department, University of Edinburgh) and were
embedded in paraffin wax (60°C melting point). Due to the inherent fragility and size
of the microvessels, embedding in paraffin wax using normal procedures proved
difficult as the vessel was difficult to locate in the wax and proper orientation of the
vessel was not always achieved. In order to overcome these obstacles the tissues
were wrapped in paper before being embedded in the wax. In this way the vessels
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could be manipulated using the paper, thus avoiding any damage to the vessel, and
embedding in the wax in the proper orientation was easily achieved. In order to
identify the very small pieces of tissue at the embedding stage a few drops of eosin
was added before transferring the tissue to the cassette. The pink coloration of the
tissues remains during processing but is washed out during section staining.
Once embedded in the wax, serial 3 pm sections were cut using a rotary microtome
(Leitz 1515), mounted from water at 50°C onto poly-L-lysine coated glass slides
(BDH-Merck, Poole, Dorset, U.K.), to avoid the sections floating off during staining,
and dried overnight in an oven at 37°C.
2.2.2. Haematoxylin and eosin
General morphology was established using the classical histochemical combination
of haematoxylin and eosin. Haematoxylin is a basic dye which stains cell nuclei
blue/black, whilst eosin is a red anionic dye which stains cell cytoplasm and most
connective tissue fibres in various shades of red.
The tissue sections were deparaffmised in xylene for 5 minutes twice and rehydrated
through a descending alcohol series (100%-90%-70% ethanol) for 3 minutes each,
followed by thorough washing in tap water for 5 minutes. Harris haematoxylin was
added for 30 seconds followed by washing in tap water for 3min. The sections were
then treated with eosin (1% in tap water) for 2-3 minutes after which the nuclear
staining was checked microscopically. The sections were then rinsed in water,
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rapidly dehydrated through an ascending alcohol series, cleared in xylene and
coverslipped using DPx mountant (BDH-Merck).
2.2.3. Immunohistochemistry.
Immunohistochemistry is a technique used for identifying cellular or tissue
constituents (antigens) by means of antigen-antibody interactions.
Immunohistological staining was performed using a three-step indirect avidin-biotin-
peroxidase complex (ABC) method. In this technique the unconjugated primary
antibody (1° Ab) is applied, followed by a biotinylated labelled secondary antibody
(2° Ab) directed against the 1° Ab. This is then followed by the ABC conjugated to
peroxidase which, in combination with the chromagen 3,3'-diaminobenzidine
tetrahydrochloride (DAB), yields an insoluble, stable, dark brown reaction end
product (Figure 2.2).
2.2.3.1. Immunohistochemical Protocol
Tissue sections were dewaxed in xylene for 5 minutes (twice) and rehydrated
through a descending alcohol series (100%-90%-70% ethanol) for 3 minutes each
followed by a thorough washing in tap water. Endogenous peroxidase activity was
inhibited by treating the sections with freshly prepared methanolic H2O2 (1 part 3%
H2O2 in 4 parts absolute methanol) for 30 minutes, followed by washing in distilled
water (Streefkerk, 1972).
In order to unblock any antigenic sites that may have been masked during fixation
the sections were treated with the proteolytic enzyme trypsin. All sections were
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DAB
Figure 2.2. Schematic diagram showing the three-step indirect avidin biotinylated
enzyme complex (ABC) immunohistochemical technique. The primary antibody
(1° Ab), directed against the antigen (Ag), is incubated overnight at 4°C. A
secondary biotinylated antibody (2° Ab) is added, followed by addition of the
preformed ABC conjugated to peroxidase (A). To visualise the sites of positive
binding, the chromagen 3,3-diaminobenzidine tetrahydrochloride (DAB), which
is the substrate for peroxidase, is added, producing an insoluble brown
precipitate.
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preheated to 37°C in a coplin jar filled with distilled water before transferring to a
coplin jar containing prewarmed 0.05M Tris buffered solution (TBS) at 37°C for 10
minutes. The sections were then washed for 30 minutes in freshly prepared TBS
containing 0.1% trypsin and 0.1% CaCh (pH 7.8), preheated to 37°C. After washing
in phosphate buffer solution (PBS) for 20 minutes, the sections were ringed and
isolated on the slide by drawing round the tissues with a paraffin-wax pen (Dako Ltd,
Buckinghamshire). In order to eliminate non-specific background staining, which
may occur as a result of non-immunological binding of the 1° Ab by hydrophobic
interactions to certain sites within the tissues sections, a solution of 1% normal goat
serum was applied for 30 minutes at room temperature.
Following blocking, the primary antibodies, optimally diluted in 1% normal goat
serum in PBS, were applied to sections and left overnight at 4°C (a list of the
antibodies used is shown in Table 2.2). In order to test the specificity of the
antibodies involved it is necessary to include controls. In this study, a negative
control, which involves omission of the 1° Ab from the staining schedule, was
included in the protocol.
Following overnight incubation with the primary antibody, the sections were brought
to room temperature (30min) and washed in PBS for 20 minutes. The appropriate
biotinylated secondary antibody (goat anti-mouse IgG, Dako Ltd, UK), diluted 1/200
in BSA/PBS, was applied for 30min at room temperature, where necessary.
Following washing in PBS for 20 minutes, the ABC complex (freshly prepared 30
minutes before use) was applied to the sections for 30min at room temperature. After
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Table 2.2. A list of the antibodies used for immunohistochemical staining of the
endothelium, vascular smooth muscle and localisation of ET-1.
Primary Antibody Working Dilution Supplier
mouse anti ET-1 IgG 1/500 Ams Biotechnology
mouse anti smooth 1/50 Novacastra Labs
muscle actin, IgG Ltd
biotinylated ulex 1/100 Vector Labs
europaeus agglutinin*
All antibodies were optimally diluted in 1% BSA in PBS. *This antibody was
already biotinylated and therefore did not require addition of the secondary antibody.
Ams Biotechnology, 5 Thorney Leys Park, Witney, Oxon.
Novacastra Labs Ltd, 24 Claremont Place, Newcastle Upon Tyne, NE2 4AA.
Vector Laboratories Ltd, 16 Wulfic Square, Bretton, Peterborough, PE3 8RF.
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washing in PBS for 20 minutes, the DAB substrate was applied for 5 min in order to
visualise sites of positive reactivity. The slides were rinsed in PBS and washed in
running tap water for 5min before counterstaining the nuclei with haematoxylin,
dehydrating through alcohols (70%-90%-100%), clearing in xylene and mounting in
DPx.
2.2.4. Solutions.
2.2.4.1. Haematoxylin and eosin
Harris haematoxylin (Acidified) and eosin Y were obtained ready to use from
Themoshandon (Runcorn, Cheshire, UK).
2.2.4.2. Immunohistochemistry.
(1) Phosphate Buffer Solution (PBS) usedfor washing
(a) 12.7g disodium hydrogen orthophosphate was dissolved in
100ml distilled water by microwaving on full power for 5
minutes
(b) 1.7g sodium dihydrogen orthophosphate was dissolved in
100ml distilled water
(c) The two solutions were mixed and the volume made up to 1
litre with distilled water
(d) The pH was adjusted to 7.6 using 4N HC1
(2) 0.05M Tris bufferfor trypsinisation
(a) 6.04g Trisma base dissolved in 80ml distilled water
(b) 2.77ml 4N HC1 was added to Tris solution
(c) 8.1 g NaCl was dissolved in 900ml distilled water
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(d) the 2 solutions were mixed, pH adjusted to 7.8 with 4N HC1,
and the volume made up to 1 litre
(3) Vector ABC complex kit
(a) to 5mls PBS, 2 drops of solution A and 2 drops of solution B
were added
(b) the solution was left to stand for 30min before use
(4) DAB substrate
to 1 aliquot (0.5ml) ofDAB the following were added:-
(a) 1,5ml Tris buffer with thymol
(b) 60)0.1 imidazole solution (0.045g imidazole in 1ml distilled
water)
(c) 30pl 1% H202
(d) the solution was freshly prepared immediately before use
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CHAPTER 3
EFFECT OF PROLONGED COLD STORAGE




Isolated blood vessel segments are used extensively to investigate in vitro the
physiological and pharmacological control of the vasculature and the mechanisms
responsible for deranged vascular function in disease states. One of the major
limitations of this type of investigation is the perceived need to use freshly isolated
blood vessels. This is mainly due to the well-documented fragility of the vascular
endothelium, which may be damaged both during isolation and storage (Kristek et
al., 1993; Torok et al., 1993), in contrast to smooth muscle which can remain viable
for up to eight days when stored at 2-6°C (Kristek et al., 1993). The requirement that
blood vessels must be freshly isolated restricts the number of investigations which
can be performed on vessel segments from a single animal and is even more
problematic when studying human blood vessels, since the availability of such
vessels can be both irregular and unpredictable. Consequently, a straightforward and
reliable method for storing vessels prior to experimentation is desirable and this idea
has stimulated investigations into both refrigeration (2-6°C; Shibata, 1969; Carrier et
al., 1973; Kristek et al., 1993; Torok et al., 1993) and low temperature (-70 or -
190°C) cryopreservation of blood vessel samples (Muller-Schwienitzer et al., 1986;
Ku et al., 1990).
Most studies carried out to date on the effects of storage of blood vessels on vascular
reactivity have been performed using large conduit vessels (Shibata, 1969; Carrier et
al., 1973; Kristek et al., 1993; Torok et al., 1993) rather than small vessels.
Following the introduction of small vessel myography (Mulvany & Halpern, 1977),
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however, it has become desirable to preserve vascular function in small resistance
arteries for a prolonged time period.
3.2. Aim
The aim of the experiments described in this study was, therefore, to determine
whether vascular smooth muscle and endothelial cell function could be preserved in
resistance arteries by storing them in physiological salt solution (PSS) at 4°C.
3.3. Methods
3.3.1. Experimental set-up
Male Cob-Wistar rats (150-250g) were killed by stunning followed by cervical
dislocation. The mesenteric bed was removed and placed in cold (4°C) PSS of the
following composition (mM) NaCl, 119; KC1, 4.7; CaCh, 2.5; MgSC>4, 1.17;
NaHCCb, 25; KH2PO4, 1.18; ethylenediamine-tetra-acetic acid di-potassium salt
(K2EDTA), 0.026; and D-glucose 5.5. Third order branches of the mesenteric artery
(mean internal diameter; 237±6pm, 107 vessels from 32 rats) were dissected from
the mesenteric bed and cleaned of connective tissues under a light microscope. One
was used immediately after dissection (day 0) whilst the others were stored
separately (at 4°C, in vials containing 1ml PSS) for up to four days (day 1-day 4).
The mesenteric arterial vessel segments were mounted in a small vessel, dual
chamber, myograph (chamber volume 12.5ml) for measurement of isometric tension.
Following equilibration, the vessels were normalised and the viability was assessed
using a standard start procedure (Chapter 2).
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3.3.2. Experimental Protocol
Following normalisation and assessment of vessel viability the ability of the vessel to
respond to contractile and dilator agonists was investigated by producing cumulative
concentration response curves (CCRCs). In order to assess the effects of prolonged
cold storage on vascular smooth muscle cell contractility CCRCs were obtained for
the receptor-dependent vasoconstrictors noradrenaline (NA; 1x10"9-3x10~5M),
phenylephrine (PHE; 1x10"9-3x10"5M) and endothelin-1 (ET-1; lxlO"n-3xlO~7M) and
for the receptor-independent vasoconstrictor potassium (K+; 2.5-140mM). The use of
these constrictors, which act via different mechanisms, would determine whether any
alteration in contractile function following cold storage was due to altered receptor
function or a general inability of the vascular smooth muscle cells to contract.
Endothelium-dependent and -independent vasodilator responses were assessed by
producing CCRCs to acetylcholine (ACh; 1x10"9-3x10"5M) and 3-
morpholinosydnonimine (SIN-1; 1x10"9-1x10"4M), respectively, in vessels
submaximally precontracted with 3pM NA (which induced approximately 80%
maximum contraction). The use of these endothelium-dependent and -independent
vasodilators should determine whether prolonged cold storage altered the ability of
endothelial cells to release, and/or vascular smooth muscle cells to relax in response
to, endothelium-derived relaxing factors. After each CCRC the vessel was washed
four times with PSS and allowed a 15 min equilibration period in PSS before
exposure to the next agonist.
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3.3.3. Drugs
All salts were obtained from BDH Laboratory Supplies (Poole, Dorset, U.K.)
Acetylcholine chloride, noradrenaline bitartrate, phenylephrine hydrochloride were
from Sigma (Poole, Dorset, U.K.) SIN-1 was a gift from Dr.K.Schonafinger,
Cassella, Germany and endothelin-1 was obtained from Calbiochem-Novabiochem
(U.K.) Ltd (Beeston, Nottingham, U.K.).
All drugs were dissolved in distilled water and stored as stock solutions at -20°C,
with the exception of ET-1. Endothelin stock was dissolved in 50% ethanol. Further
dilutions were made in 50% methanol/ 50% distilled water, divided into aliquots and
stored as 10"5 M stock solutions at -20°C. On the day of use, stock solutions were
thawed and subsequent dilutions were made in distilled water. These solutions were
added directly to the PSS in the myograph chamber to give the final dilutions. All
concentrations are expressed as final bath concentration.
3.3.4. Statistics
All values presented are mean ± standard error mean (s.e.mean) for n experiments.
NA, PE1E, K+ and ET-1 -induced tension is expressed as a percentage of the
maximum contractile response to that agonist. The relaxation to ACh and SIN-1 is
expressed as a percentage relaxation of the initial NA-induced precontraction.
Sensitivity to the agonists is expressed as the negative log of the effective
concentration (M) of the drug required to produce 50% of the maximum effect (pD2
for vasoconstrictors and -loglCso for vasodilators). The sensitivity was calculated
66
from each concentration-response curve by fitting the Hill equation using curve
fitting software (Fig.P; Biosoft, Cambridge, U.K.).
The effect of storage on maximum response and sensitivity (pD2, -loglCso) was
determined by comparing responses in vessels stored for 1 to 4 days with the
response produced by freshly isolated vessels using one-way analysis of variance
(ANOVA) followed by Dunnett's post hoc test. Significance was assumed if P<0.05.
3.4. Results
3.4.1. Vasoconstrictor Responses.
The standard start procedure demonstrated that the vessels analysed immediately
following dissection were viable (i.e. produced contractions in response to a
combination of NA (10~5M) and KPSS that exceeded 13.3kPa - see Chapter 2.1.4)
and that this viability was unaffected by storage over a four day period (Table 3.1.).
Indeed, all the arteries used in this investigation were shown to be viable. The
arteries produced strong, concentration-dependent, contractions in response to each
of the vasoconstrictors, NA, PHE, KC1 and ET-1. The magnitude and sensitivity of
these responses were unaffected by storage (Table 3.2.).
The concentration of noradrenaline required to produce approximately 80% of the
maximum contractile response in freshly isolated vessels was 3pM. This
concentration was used to precontract the tissues in order to assess the relaxant
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Table 3.1. The effect of prolonged cold storage on the viability of rat mesenteric
resistance arteries. Values are mean ± s.e.mean, n numbers in parentheses.
VIABILITY (kPa)
Day 0 26.33±1.78 (24)
Day 1 29.14+2.56 (22)
Day 2 27.87±2.08 (24)
Day 3 29.66+2.76 (20)
Day 4 31.42+2.55 (17)
The viability value is an indication of the effective pressure developed by the artery
in response to a solution containing high concentrations of potassium (125mM) and
NA (10~5M), which produces a maximal contraction. It is calculated using the
LaPlace relation (Effective pressure = Wall tension/ (internal circumference/ (2n))
and is used routinely to determine whether a vessel has been damaged during
isolation. In the current investigation measurement of viability also provided an
indication of whether prolonged storage had caused a loss of viability. Rat
mesenteric arteries usually produce an effective pressure >20kPa and are considered
unviable if the effective active pressure developed in response to NA-KPSS is less
than 13.3kPa (lOOmmHg). All the vessels mounted in the organ bath for the current
study were shown to be viable.
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Table 3.2. The effects of cold storage on the (a) maximum contraction (mN/mm) and
(b) sensitivity (PD2) of rat 3rd order mesenteric arteries to vasoconstrictors.
Results are shown as mean ± s.e.mean, n=10.
(a)
Maximum Contraction (mN/mm)
Day 0 Day 1 Day 2 Day 3 Day 4
NA 2.79+0.28 2.52+0.31 3.06+0.32 2.26+0.18 2.09+0.28
PHE 2.91+0.16 3.39+0.25 3.59+0.41 2.73+0.34 2.76+0.45
K+ 1.35+0.07 1.44+0.18 1.79+0.31 1.50+0.21 1.83+0.27
ET-1 2.90+0.33 3.23+0.25 2.64+0.42 2.91+0.35 2.57+0.29
b)
Sensitivity (pD2)
Day 0 Day 1 Day 2 Day 3 Day 4
NA 5.76+0.08 5.85+0.06 5.85+0.05 5.89+0.09 5.97+0.10
PHE 5.60+0.09 5.55+0.04 5.60+0.10 5.47+0.06 5.74+0.17
K+ 1.58+0.04 1.64+0.01 1.62+0.04 1.61+0.04 1.54+0.04
ET-1 8.45+0.18 8.38+0.09 8.50+0.09 8.66+0.11 8.59+0.13
Comparison of stored (days 1 to 4), with freshly isolated (day 0), vessels using
oneway ANOVA and Dunnett's post hoc test, demonstrated that contractile function
was not significantly altered during storage.
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properties of the vasodilator agents. The contraction produced by this concentration
ofNA was unchanged by storage for two days; an apparent reduction on days 3 and
4 (Table 3.3.) did not achieve significance.
3.4.2. Responses to vasodilator agonists.
Following precontraction with 3pM NA, ACh and SIN-1 both induced
concentration-dependent relaxations which were still evident after four days of
storage. Storage of the vessels for up to three days resulted in no change in the
responses induced by these agonists (Table 3.4.). The magnitude and sensitivity of
the relaxations to these agonists was unchanged until the fourth day of storage, when
the arteries demonstrated a significant increase in the maximum response to ACh and
a significant increase in sensitivity to both ACh and SIN-1 (Table 3.4.; Figures 3.1.).
A trend towards increased maximum response to SIN-1 was also observed but this
did not achieve significance.
3.5. Discussion
The results of this study indicate that rat mesenteric resistance arteries remain viable
if stored in PSS at 4°C for up to four days. The sensitivity of the arteries to the
vasodilators, ACh and SIN-1, remained stable following the first three days of cold
storage and thereafter increased on day 4, whereas responses to the vasoconstrictors
were unaltered.
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Table 3.3. The effect of prolonged cold storage on the magnitude of noradrenaline
(3pM)-induced contraction obtained prior to the construction of CCRC's to the
vasodilators ACh and SIN-1 in rat mesenteric resistance artery.
Contraction (mN/mm)
Pre-ACh Pre-SIN-1
Day 0 1.91±0.15 2.2410.19
Day 1 2.4710.23 2.4710.17
Day 2 2.0710.20 2.3110.16
Day 3 1.4510.15 1.6310.21
Day 4 1.9210.42 1.7210.45
Values are mean ± s.e.mean, n=10. Comparison of stored (days 1 to 4), with freshly
isolated (day 0), vessels using oneway ANOVA and Dunnett's post hoc test,
demonstrated that pre-contraction was not significantly altered during storage.
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Table 3.4. The effect of prolonged cold storage on (a) maximum relaxation (%) and
(b) sensitivity (-loglCso) of rat 3rd order mesenteric arteries to vasodilators.
(a)
Maximum Relaxation (%)
Day 0 Day 1 Day 2 Day 3 Day 4
ACh 92.65±2.84 94.28+1.96 96.06+2.79 90.97+4.82 100.36+0.36*
SIN-1 84.84±6.56 90.72+3.48 94.33+2.82 96.21+1.62 96.12+2.08
(b)
-loglCso
Day 0 Day 1 Day 2 Day 3 Day 4
ACh 7.46+0.13 7.26+0.06 7.27+0.16 7.41+0.12 7.97+0.11*
SIN-1 4.87±0.10 5.13+0.18 4.88+0.10 5.07+0.10 5.52±0.08f
Values are mean ± s.e.mean, n=10. *P<0.05 when compared with maximum
response and -loglCsofor day 0 (ACh) and 'P<0.01 when compared with -loglCso





Figure 3.1. The effect of cold storage on the cumulative concentration response
curves to (a) acetylcholine (ACh; 10"9-3xl0"5M) and (b) 3-
morpholinosydnonimine (SIN-1; 10"9-10"4M) in rat mesenteric resistance
arteries. Each point represents mean±s.e.mean, n=10. ■ Day 0, O Day 4.
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3.5.1. Vasodilator Function.
Previous investigations have shown that cells in the vascular wall undergo time-
dependent alterations when stored at 4°C. The severity and speed of these changes
vary between different cell types with the earliest alterations occurring in nerve
fibres and endothelial cells (Kristek et al., 1993). These morphological alterations are
accompanied by functional abnormalities, with endothelium-dependent relaxation
reduced after as little as 24h storage (Flanders et al., 1996). Similarly,
cryopreservation, which involves storing the tissues in DMSO at either -70 or -
190°C, produces endothelial cell dysfunction (Ku et al. 1990). In addition to the
problems this poses for pharmacological investigation, such endothelial cell
dysfunction is a cause for concern for bypass grafting and organ transplantation.
Consequently the preservative effects of a variety of solutions have been
investigated. Whilst this has produced evidence that some preservation solutions
(University of Wisconsin, St Thomas' Hospital) are better for preserving endothelial
function in rabbit aorta (Eberl et al., 1993) and porcine hepatic artery (Flanders et al.,
1996), the reasons for these differences are unclear. Indications into the protective
action of these solutions are not provided by comparison of their contents. University
of Wisconsin (Flanders et al., 1996) solution is a calcium-free, high potassium
solution which contains agents which inhibit free radical generation (adenosine,
allopurinol, glutathione) and platelet aggregation (adenosine). In contrast, St.
Thomas' solution is a simple salt solution containing moderately high concentrations
of potassium and magnesium but no glucose (Eberl et al., 1993).
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In contrast to investigations using large conduit arteries, these results demonstrated
that the rat mesenteric resistance artery retains endothelium-dependent vasodilator
function throughout the period of preservation. This suggests that the endothelium in
these vessels does not become damaged as rapidly as the endothelium of rabbit
aortae. Indeed, the sensitivity to both endothelium-dependent and -independent
dilators was increased significantly after storage for four days.
In rat mesenteric resistance arteries ACh causes relaxation by stimulating the release
ofNO (following activation of constitutive NO synthase (eNOS; Forstermann et al.,
1991)) and a hyperpolarizing factor (EDHF) from the endothelium (Furchgott et al.,
1987, Feelisch & Noack, 1987). NO elicits vasodilatation by stimulation of soluble
guanylate cyclase, resulting in elevation of cyclic guanosine 3',5' monophosphate
(cGMP; Waldman & Murad, 1987) which lowers intracellular Ca2+ concentrations in
the smooth muscle cells. In some vessels NO can also cause relaxation by smooth
muscle hyperpolarisation, achieved by stimulating ATP-sensitive and/ or
charybdotoxin-sensitive potassium channels (Plane et al., 1996; Plane et al., 1998).
Hence, alterations in the production, release or action of either or both of these
mediators may account for the increase in sensitivity to ACh on day 4. One possible
explanation for the observed increase in sensitivity to ACh is that guanylate cyclase-
mediated relaxation has been upregulated in stored arteries (Moncada et al., 1991).
It has been demonstrated that the basal release of NO from the endothelium in vivo
reduces the sensitivity of the vascular wall to agonist-induced dilatation, probably at
a site distal to soluble guanylate cyclase (Busse et al., 1989). This basal release is
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stimulated by shear stress (Nishida et al., 1992) and, therefore, is unlikely to occur in
the stored arteries. Consequently, it is possible that a reduced basal release of
endothelium-derived NO results in an upregulation of guanylate cyclase-mediated
relaxation. It should be noted, however, that endothelial cell dysfunction in stored
rabbit aorta was not accompanied by an increased sensitivity to sodium nitroprusside
(Torok et al., 1993). Alternatively, the increased sensitivity observed to ACh could
be due to an increase in permeability of the vascular smooth muscle cells. The
hydrophobic property of NO is central to its physiological function, permitting it to
pass freely across cell membranes by passive diffusion (Mann et al., 2003). Previous
investigations have demonstrated that increases in membrane permeability can occur
as a consequence of destabilization of the membrane bilayers (Ehringer et al., 2002)
and it has been suggested that increased smooth muscle cell permeability may
develop as a consequence of storage (Torok et al., 1993). Such changes may allow
more efficient access of NO to soluble guanylate cyclase in the vascular smooth
muscle cells.
A large component of ACh-mediated relaxation in rat mesenteric resistance arteries
is mediated by EDHF (Plane et a\., 1997) and, therefore, the increased sensitivity to
ACh observed on day 4 may be due to an increased activity of EDHF. The
mechanisms of such an increase can only be speculated upon since the identity of
EDHF still remains elusive, although several possibilities can be considered. Some
studies have indicated that, in the presence of insult (e.g. hypertension), EDHF-
mediated relaxation is augmented to compensate for the reduced response to NO
(Kagota et al., 1999; Katusic, 2002), suggesting that NO activity may regulate EDHF
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activity. In addition, previous studies have suggested that EDHF acts through gap
junctions (Chaytoe et al., 1998) and therefore it is feasible that changes in membrane
properties may alter the function of gap junctions.
SIN-1, an endothelium-independent vasodilator, was included in the study to ensure
that the vessels retained the ability to relax. At the time it was thought that SIN-1, the
active metabolite if molsidomine, was an NO donor, spontaneously releasing NO by
a free radical process following base-catalysed hydrolysis to produce endothelium-
independent relaxation (Feelisch, 1991). However, during the conversion of SIN-1
superoxide anions are formed, in addition to NO, which react together to form
peroxynitrite (OONO"; Singh et al., 1999). Therefore, rather than being an NO donor,
SIN-1 is now thought of as an OONO" donor. The observed biological effects of
OONO" have been shown to be mediated by direct reaction with tissue thiols causing
thiol-dependent relaxations of vascular smooth muscle (Wu et a\., 1994) and
stimulation of platelets (Moro et al., 1994). In addition cultured endothelial cells
treated with OONO" demonstrated a thiol-dependent stimulation of sGC, which
subsequently increased cGMP production to levels comparable to cells treated with a
NO donor (Mayer et al., 1995). The observed increase in sensitivity to SIN-1 on day
4, therefore, may be due to upregulation of sGC and this may account for the
observed increase in sensitivity to both ACh and SIN-1.
It is unclear why endothelial cell function is preserved in the rat mesenteric arteries
but not in larger vessels stored at a similar temperature (Kristek et al., 1993; Torok et
al., 1993; Flanders et al., 1996). The size and origin of the vessels may be important
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as endothelial cell function appears to vary according to the diameter of the vessel
(Haefliger et al., 1993), and upon its anatomical origin (Vanhoutte & Miller, 1985).
Alternatively, the different storage conditions may be significant as some
preservative solutions appear to be more effective than others in maintaining the
function of the endothelium (Eberl et al., 1993; Vohra et al., 1997). Further work is
required to clarify the cause of these variations.
3.5.2. Vasoconstrictor Function.
The measurement of vessel viabilty is usually performed to ensure that vessel
preparation does not damage the vessel wall. As an experienced myographer will
rarely cause such damage, the inclusion of this measurement in the present study
further demonstrated that prolonged storage did not impair viability. Indeed, the
effective pressure (viability) measurements were remarkably consistent throughout
the study (Table 3.1.).
It has been suggested that the changes in contractile function detected in stored
vessels represent a balance between the effects of endothelial cell and smooth muscle
cell dysfunction (Kristek et al., 1993). Consequently, the observed increase in
sensitivity of the rabbit aorta to NA after preservation for three to four days (Shibata,
1969; Carrier et al., 1973; Vohra et al., 1997) may be the result of early endothelial
cell dysfunction, as the vascular endothelium can modulate the constrictor response
to many agonists. This would be similar to the increased reactivity to NA (Dohi et
al., 1990) documented following removal of the endothelium in mesenteric
resistance arteries from normal rats. Alternatively, Kristek et al., (1993) suggested
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that storage leads to altered calcium homeostasis, as a result of increased
permeability and membrane depolarisation. As the time of preservation lengthens the
increased response to NA is probably balanced by an attenuation resulting from
gradual impairment of contractile function.
This investigation demonstrated that NA and PHE-induced contractions in the rat
mesenteric artery were unaffected by storage. It is possible that the conservation of
endothelium-dependent relaxation prevented the increased responsiveness to these
agonists reported by other investigators (Shibata, 1969; Carrier et al., 1973; Kristek
et al., 1993). Furthermore, the maintenance of these responses indicated that a-
adrenoceptor-mediated vasoconstriction was not altered by storage.
In order to assess the responses to vasodilators it is necessary to pre-contract the
vessels using a submaximal concentration in order to prevent over estimation of the
sensitivity of the tissue to these agents. In the present study, the submaximal
concentration of NA (3xlO"6M) used to pre-contract the vessels often produced a
biphasic response with a slight loss of tone after the initial contraction, after which
the contraction stabilised. This loss of tone appeared to be more marked on days 3
and 4, and this may account for the apparent reduction in pre-contraction to NA on
these days. The lack of significance, however, may be due to the variability of this
biphasic response. Therefore, this demonstrates that responses to NA are maintained
throughout storage, with no loss of response to the dilators.
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In contrast to NA, it has previously been reported that KCl-mediated
vasoconstriction is significantly reduced following preservation for four days but this
reduction could be partially attenuated if preservation was performed in a high
potassium Ringer solution (Shibata, 1969). This may be due to storage-induced
alterations in the smooth muscle cell polarisation state as preservation has been
shown to significantly reduce intracellular potassium but increase intracellular
sodium and calcium (Carrier et al., 1973). Our results demonstrated that such
changes were not significant in the rat mesenteric artery, as responses to K+ were
unaltered.
Contractile responses to ET-1 following prolonged storage of the vessels have not
been investigated previously. However, various insults, including hypoxia, can lead
to the release of this potent vasoconstrictor by endothelial cells (reviewed in Haynes
& Webb, 1993), resulting in receptor down-regulation and reduced sensitivity to this
agonist (Clozel et al., 1993). Consequently, it is possible that the endothelial cell
damage reported in larger vessels following storage (Kristek et al., 1993; Torok et
al., 1993; Flanders et al., 1996), would have caused reduced sensitivity to ET-1. The
unaltered response in the rat mesenteric artery to ET-1 in the present study suggests
that prolonged storage of this tissue does not lead to significant release of ET-1 from
the vascular endothelium. This supports the argument that there is no significant
endothelial cell damage in these vessels after storage which is consistent with the
results obtained using ACh.
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Finally, the maintenance of the responsiveness to the vasoconstrictors studied
suggests that the contractile activity of the smooth muscle was not attenuated during
preservation. This is consistent with previous investigations carried out in rabbit
conduit arteries in which contractile function to exogenously applied vasoconstrictors
was not reduced after preservation for up to eight days (Shibata, 1969; Kristek et al.,
1993). Indeed, Shibata (1969) demonstrated that contractile responses to NA in those
vessels were only reduced significantly after 10-12 days preservation and detectable
contractions were still present after twenty days storage in Ringer's solution.
In summary, this study has clearly demonstrated that rat mesenteric artery segments
maintain stable responsiveness to vasoconstrictors and to endothelium-dependent and
endothelium-independent vasodilators for up to three days when stored in a simple
PSS at 4°C. The increase in sensitivity observed with both ACh (endothelium-
dependent) and SIN-1 (endothelium-independent) on day four suggests an increase in
smooth muscle sensitivity to vasodilators after this storage period. Preservation of
the contractile responses implies that receptor function and smooth muscle cell
polarisation state are not adversely affected by preservation. Consequently, rat
resistance artery segments can be stored for subsequent investigation and do not
develop the significant endothelial cell damage previously observed in larger arteries,
thereby allowing more efficient use of animal tissues in the future.
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CHAPTER 4
THE EFFECT OF ELEVATED GLUCOSE




Diabetic microangiopathy and macroangiopathy are the principal causes ofmorbidity
and mortality in patients with diabetes mellitus (Head & Fuller, 1990) but the
mechanisms underlying abnormal microvascular function remain controversial.
Patients with strict glycaemic control have a lower incidence of vascular
complications (Diabetes Control and Complications Trial Group, 1993), implicating
hyperglycaemia as an independent risk factor for the development of cardiovascular
disease. The mechanism by which elevated glucose contributes to the pathogenesis
of vascular dysfunction is not completely understood but there is much evidence to
suggest that the action of both glucose and insulin can directly alter the function of
cells in the vascular wall.
The majority of studies of vascular function in diabetic animal models have reported
impaired endothelium-dependent relaxation in both resistance (Taylor et al., 1992)
and conduit (Durante et al., 1988; Abiru et al., 1990; Cameron & Cotter, 1992)
arteries. This may be the result of hyperglycaemia as several groups have reported
attenuated endothelium-dependent relaxation in arteries from non-diabetic animals
following exposure to elevated concentrations of glucose (Tesfamariam et al., 1990;
Taylor & Poston, 1994). Furthermore, endothelial dysfunction does not develop in
arteries from rats with streptozotocin (STZ)-induced diabetes if they are treated with
insulin to control hyperglycaemia (Taylor et al., 1994). It is also possible, however,
that direct effects of insulin on the arterial wall affect vasodilator function as insulin
causes an endothelium-dependent relaxation in isolated arteries (Han et al., 1995)
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and stimulates enhanced nitric oxide release by vascular endothelial cells (Walker et
al., 1997).
Contractile function is also altered in patients and animals with diabetes. The nature
of the alteration remains controversial, however, as responses to noradrenaline (NA)
have variously been reported to be reduced (Cameron & Cotter, 1992), increased
(Abebe et al., 1990; Harris & MacLeod, 1988), or unaltered (Fulton et al., 1991) in
isolated arteries. Recently, interest has been increasing in the role of the
endothelium-derived vasoconstrictor endothelin-1 (ET-1) in the vascular
complications of diabetes (reviewed Hopfner & Gopalakrishnan, 1999). Reports of
elevated plasma (Takahashi et al., 1990) and tissue (Properzi et al., 1995)
concentrations of ET-1 have been followed by demonstrations of impaired ET-1-
mediated constriction in both the forearm of patients with type 2 diabetes (Nugent et
al., 1996) and in isolated aortic rings from rats with STZ-induced diabetes (Fulton et
al., 1991; Hodgson & King, 1992). It remains unclear, however, whether exposure to
high concentrations of glucose or insulin contributes to the impaired contractile
response to ET-1.
4.2. Aim
The aim of this study was to determine the effects of acute elevations of glucose or
insulin in vitro on resistance artery function.
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4.3. Methods
4.3.1. Measurement ofvascular reactivity
Male Cob-Wistar rats (150-250g) were killed by stunning followed by cervical
dislocation and the mesentery was removed and placed in PSS. Third order
mesenteric arteries (mean internal diameter 218±6pm, n=56) were dissected free
from connective tissue and mounted as ring preparations on two 40pm intraluminal
wires in a small vessel myograph for measurement of isometric tension. Arteries
were bathed in PSS, maintained at 37°C and perfused with 95% O2; 5% CO2.
Following normalisation, vessel viability was assessed using a standard start
procedure and the functional integrity of the endothelium was confirmed by adding
acetylcholine (ACh; lOpM) to vessels submaximally contracted with 3pM NA (see
Chapter 2 for details).
4.3.2. Experimental Protocol
Two mesenteric arteries were isolated from each rat and exposed to one of the
following protocols:-
(i) Incubation in 5.5mM glucose or 20mM glucose for 1 hour.
(ii) Incubation in 5.5mM glucose or 14.5mM mannitol and 5.5mM
glucose for 1 hour.
(iii) Incubation in 15mM glucose or 44mM glucose for 1 hour.
(iv) Incubation in 20mM glucose or 14.5mM mannitol and 5.5mM glucose
for 4 hours.
The incubation medium was changed every 30min and, before continuation of the
protocol, the arteries were contracted for 3min with NA-K to confirm viability.
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Cumulative concentration-response curves (CCRCs) were then obtained for the
receptor-dependent agonists NA (1x10~9-3x10"5M), and ET-1 (lxlO"n-3xlO"7M) and
for the receptor-independent vasoconstrictor potassium (K+; 2.5-140mM).
Endothelium-dependent and -independent vasodilatation was assessed using the
vasodilators ACh (1x10~9-3x10"5M), the Ca2+ ionophore A23187 (1x10"9-1x10"5M)
and 3-morpholinosydnonimine (SIN-1; lxlO"9-lxl(T4M), respectively. Vasodilator
responses were obtained in arteries following submaximal contraction with NA
(3pM). The glucose/mannitol remained in the bath for the duration of both the
contraction and relaxation phases. After each CCRC, the contents of the bath were
replaced four times with fresh PSS, containing the appropriate concentrations of
glucose/mannitol, and a 20min washout period was allowed between each CCRC.
In order to investigate the role of the endothelium, some experiments were
performed in arteries denuded of endothelium. The endothelium was removed by
rubbing the lumen with a human hair (see Chapter 2 for details), and complete
denudation was confirmed by the lack of relaxation in response to ACh (10pM) in
vessels submaximally precontracted with NA (3pM).
The influence of insulin on vascular function was assessed separately. Two vessels
were taken from each rat and incubated for 1 hour in either normal PSS (5.5mM
glucose) or in PSS containing insulin (lOOOmU/1). These vessels were then exposed




Reagents for the preparation of PSS were obtained from BDH Laboratory Supplies,
Poole, Dorset, UK. Acetylcholine chloride, A23187 free acid and noradrenaline
bitartrate were purchased from Sigma, Poole, Dorset, UK. SIN-1 and ET-1 were
obtained from Alexis Corporation (UK) Ltd, Bingham, Nottingham. Insulin (human
Velosulin 100U/ ml) was obtained from NovoNordisk, Crawley, West Sussex, U.K.
All drugs were dissolved in distilled water with the exceptions of A23187 and ET-1.
A23187 was dissolved in 100% ethanol and further dilutions were made in 10%
ethanol, divided into aliquots and stored as l(f4M stock solution at -20°C. ET-1 was
dissolved in 50% methanol and stored as 10"5M stock solution at -20°C. In both cases
final bath concentrations of ethanol were less than 1%. Stock solutions were thawed
as required, subsequent dilutions were made in distilled water and any residual
solution was discarded at the end of the experiment. All concentrations are expressed
as the final molar concentration in the organ bath.
4.3.4. Statistics
All values presented are mean ± standard error mean (s.e.mean) for n experiments.
NA, K+ and ET-1-induced contractions are expressed as a percentage of the
maximum contractile response to that agonist. The relaxation to ACh, A23187 and
SIN-1 is expressed as a percentage relaxation of the initial NA-induced
precontraction.
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Sensitivity to the agonists is expressed as the negative log of the effective
concentration (M) of the drug required to produce 50% of the maximum effect (pD2
for vasoconstrictors and -loglCso for vasodilators). The sensitivity was calculated
from each concentration-response curve by fitting the data to the Hill equation using
curve fitting software (Fig.P, Biosoft, Cambridge, UK). The effect of increased
concentrations of glucose or mannitol on vascular function was assessed by
comparison with normal glucose (5.5mM) controls using one-way ANOVA followed
by Dunnett's post-hoc test or Kruskal-Wallis test followed by Dunn's multiple
comparison test, as appropriate. The influence of 4 hour exposure to 20mM glucose
was assessed by comparison with concomitant controls exposed to 14.5mM mannitol
and 5.5mM glucose using Student's unpaired t-test. The influence of insulin was
determined by comparison with concomitant controls using Student's unpaired t-test.
In all tests, significance was assumed ifP<0.05.
4.4. Results
4.4.1. Effect ofelevated concentrations ofglucose or mannitol
There was no significant change in the contractile responses of vessels following 1
hour incubation in an elevated concentration of mannitol compared to 5.5mM
glucose (Table 4.1a).
Incubation in 15 or 44mM glucose for 1 hour resulted in reduced sensitivity to ET-1,
causing a shift to the right of the ET-1 concentration-response curve (Figure 4.1a.).
This decrease in responsiveness was not evident in intact (Table 4.1) or denuded
88
Table 4.1. Maximum contraction (Emax., mN/mm) and sensitivity (pD2) to
vasoconstrictor agonists in rat mesenteric resistance arteries following (a) 1 hr or (b)












































































Values are expressed as mean ± s.e.mean (n values shown in parentheses). *P<0.05,
**P<0.01 when compared with 5.5mM glucose using one-way ANOVA followed by
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Figure 4.1. Concentration-response curves to (a) endothelin-l, (b) noradrenaline and
(c) potassium in rat mesenteric resistance arteries following lhr incubation in
normal PSS (5.5mM (A), n=ll-13) or PSS containing elevated concentrations
of glucose (15mM (□), n=10; 20mM (O), n=9-10; 44mM (A), n=10) or
mannitol (20mM (O), n=6-9). Each point represents mean ± s.e.mean.
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(pD2 8.66+0.08 (n=l 1) vs 8.86+0.09 (n=8), P=0.12; Emax 2.63+0.31 (n=ll) vs
2.98+0.30 (n=8), P=0.45) arteries exposed to 20mM glucose.
The sensitivity of the arteries to NA was significantly reduced following lhr
incubation in 44mM glucose. Despite an apparent rightward shift in the
concentration response curve to NA in the presence of 15 or 20mM glucose, the
alteration in sensitivity did not achieve significance (Figure 4.1b.).
Sensitivity to K+ was unaffected following exposure to raised glucose concentrations
(Figure 4.1c.). The magnitude of the responses to all constrictor agonists were not
altered following 1 hour incubation in elevated concentrations of glucose compared
with controls (Table 4.1a.).
All the arteries studied relaxed in a concentration-dependent manner in response to
each of the vasodilators: ACh, A23187 and SIN-1 (Figure 4.2.). The magnitude and
sensitivity of these responses were not altered following exposure to elevated
concentrations of glucose compared with controls (Table 4.2.).
4.4.2. Effect ofIncubation Time
There was no significant difference in either the magnitude or sensitivity of
contractile or relaxant responses of vessels following 4 hours incubation in 20mM









Figure 4.2. Concentration-response curves to (a) acetylcholine, (b) A23187 and (c)
3'-morpholinosydnonimine (SIN-1) in rat mesenteric resistance arteries following
lhr incubation in normal PSS (5.5mM (A), n= 11-13) or PSS containing elevated
concentrations of glucose (15mM (□), n=10; 20mM (O), n=6-10; 44mM (A), n=8-
10) or mannitol (20mM (O), n=5-9). Each point represents mean ± s.e.mean and is
expressed as % relaxation of 3pM NA-induced tone.
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Table 4.2. Maximum relaxation (Emax., % reversal of 3pM NA-induced
precontraction) and sensitivity (-loglCso) to vasodilator agonists in rat
mesenteric resistance arteries following (a) lhr or (b) 4hr incubation in normal
PSS or PSS containing elevated concentrations of glucose or mannitol.
(a) 1 hr
Incubation ACh A23187 SIN-1
Media Emax -loglCso Emax -loglCso Emax -loglCso
5.5mM glucose 88.61±3.66 7.02+0.24 85.62±2.24 5.41+0.05 95.62+1.22 5.28+0.12
(11-13)
15mM glucose 88.41+5.64 7.07+0.05 70.88+7.50 5.66+0.15 88.19+3.27 5.08+0.06
(10)
20mM glucose 93.38+2.99 7.07+0.18 81.90+6.25 5.29+0.12 93.90+1.89 5.24+0.08
(6-10)
44mM glucose 91.32+2.27 6.94+0.20 80.14+4.66 5.74+0.15 90.36+3.39 4.95+0.14
(8-10)
20mM mannitol 98.59+0.96 7.56+0.17 87.57+7.45 5.38+0.10 93.96+3.36 5.32+0.44
(5-9)
(b) 4 hr
Incubation ACh A23187 SIN-1
Media Emax -loglCso Emax -loglCso Emax -loglCso
20mM glucose 83.11+10.1 7.49+0.30 76.26+5.64 5.33+0.06 89.20+3.73 5.00+0.15
(4)
20mM mannitol98.47+3.61 7.48+0.09 87.12+4.43 5.49+0.19 96.36+1.94 5.48+0.12
(4-6)
Values are expressed as mean ± s.e.mean (n). ACh, acetylcholine; SIN-1, 3'-
morpholinosydnonimine. NS difference between Emax or -loglCso obtained in
5.5mM glucose compared with elevated glucose (15, 20, 44mM) or mannitol
(20mM).
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4.4.3. Effect ofElevated Concentrations ofInsulin
Exposure to an elevated concentration of insulin for lhr did not alter either the size
or sensitivity of vasoconstrictor responses to ET-1 NA or K+ (Figure 4.3. and Table
4.3.).
Likewise, the magnitude and sensitivity of vasodilator responses to ACh, A23187
and SIN-1 were not altered following exposure to elevated concentrations of insulin
compared with controls (Figure 4.4 and Table 4.4).
4.5. Discussion
This study assessed the time- and concentration-dependent effects of exposure to
elevated concentrations of glucose or insulin on vascular contraction and relaxation.
Exposure to elevated concentrations of glucose or insulin had no effect on
endothelium-dependent or -independent dilatation. However, 1 hour exposure to 15
and 44mM glucose altered the sensitivity to ET-1 and NA-mediated contraction.
Increasing the duration of exposure to 4 hours incubation with 20mM glucose had no
further effect on contractile function. The contractile responses were unaltered
following incubation with insulin.
4.5.1. Effect ofelevated glucose concentrations.
This study demonstrated that incubation of rat mesenteric resistance arteries in 15 or
44mM glucose for lhr reduced their sensitivity to the vasoconstrictor peptide ET-1.









Figure 4.3. Concentration-response curves to the vasoconstrictors (a) endothelin-1,
(b) noradrenaline and (c) K+ in rat mesenteric resistance arteries following lhr
incubation in normal PSS (A, n=10-12) or PSS containing an elevated
concentration (1000mU/l) of insulin (□, n=10-12) Each point represents mean ±
s.e.mean.
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Table 4.3. Maximum contraction (Emax., mN/mm) and sensitivity (PD2) to
vasoconstrictor agonists in rat mesenteric resistance arteries following





Emax. pD2 Emax. pD2 Emax. pD2
PSS (10-12) 2.4210.25 6.1010.13 1.8410.21 1.6710.05 2.2110.28 8.8010.09
Insulin (10-12) 2.9310.20 5.9710.09 00 00 1+p ON -J1+© © 2.8210.26 8.6810.10









Figure 4.4. Concentration-response curves to the vasodilators (a) acetylcholine, (b)
A23187 and (c) 3'-morpholinosydnonimine (SIN-1) in rat mesenteric resistance
arteries following lhr incubation in normal PSS (A, n=10-12) or PSS containing
1000mU/l of insulin (□, n=10-12) Each point represents mean ± s.e.mean.
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Table 4.4. Maximum relaxation (Emax., % reversal of 3pM NA-induced
precontraction) and sensitivity (-loglCso) to vasodilator agonists in rat
mesenteric resistance arteries following lhr incubation in normal PSS or PSS
containing an elevated concentration of insulin (1000mU/l).
ACh A23187 SIN-1
Emax. -loglCso Emax. -loglCso Emax. -loglCso
Normal (10-12) 96.43±2.73 7.23±0.13 83.36±2.74 5.66±0.17 94.95+2.03 5.37±0.17
Insulin (10-12) 90.86±2.90 7.11±0.16 89.63±1.88 5.55±0.11 96.12+1.32 5.30+0.10
Values are expressed as mean ± s.e.mean (n). ACh, acetylcholine; SIN-1, 3'-
morpholinisydnonimine. NS difference between the Emax or -loglCso obtained in
normal medium or that containing insulin for any agonist.
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no effect. A non-specific impairment of vascular smooth muscle cell contractility is
also unlikely since responses to K+ (direct depolarising agent) were unaltered.
The impaired sensitivity to ET-1 following incubation in 15 or 44mM glucose is
consistent with reports of attenuated ET-1-mediated contraction in the forearm of
patients with Type 2 diabetes (Nugent et al., 1996) and in aortic rings isolated from
rats with STZ-induced diabetes (Fulton et al., 1991; Hodgson & King, 1992). It is
not clear why 20mM glucose had no effect. High glucose concentrations can trigger
the release of ET-1 by endothelial cells (Yamauchi et al., 1990), which may account
for the raised plasma concentrations of this peptide in diabetic patients (Takahsahi et
al., 1990) and for its increased release from mesenteric arteries of diabetic rats
(Takeda et al., 1991). Although increased glucose concentrations could impair
contractile responses to ET-1 by increasing production of endothelium-derived
vasodilators such as nitric oxide (NO) and prostacyclin (PGE; Wanner et al., 1989;
DeNucci et al., 1988), this hypothesis is not suppoited by investigations using aoilae
from diabetic rats (Hodgson & King, 1992) and retinal pericytes cultured in the
presence of elevated glucose (Chakravarthy et al., 1994), which demonstrated that
the impaired response to ET-1 was endothelium-independent. In the present study,
however, an impaired contractile response to ET-1 was not observed in endothelium-
denuded vessels. However, as investigations with denuded vessels were only
performed in 20mM glucose the influence of the endothelium on the reduced
response to ET-1 in the presence of 15 or 44mM glucose is not clear.
Alternatively, the impaired response to ET-1 could result from ETA receptor down-
regulation (Awazu et al., 1991; Miasiro & Paiva, 1990), due to raised concentrations
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of ET-1 (Clozel et al., 1993), a mechanism which has been implicated in the reduced
response to ET-1 in aortae from STZ-induced diabetic rats (Hodgson & King, 1992).
However, the ability of glucose to stimulate ET-1 production from endothelial cells
in vitro is only evident after 3hrs (Yamauchi et al., 1990) and therefore the time
course used currently (lhr) may be insufficient to induce down-regulation of ET-1
receptors.
Vasodilatation in response to ACh, which induces relaxation by a receptor-dependent
release ofNO and endothelium-derived relaxing factor (EDHF) from the endothelial
cells, has been reported to be impaired both in patients (McNally et al., 1994) and in
animals with diabetes (Taylor et al., 1992; Durante et al., 1988; Abiru et al., 1990;
Cameron & Cotter, 1992). Exposing arteries from non-diabetic animals to raised
glucose concentrations in vitro (Tesfamariam et al., 1990; Taylor & Poston, 1994)
can induce a similar attenuation. The glucose-mediated alteration appears to be the
result of alterations to the muscarinic receptor as responses to a receptor-
independent, endothelium-dependent vasodilator (the calcium ionophore, A23187)
and to a NO donor (sodium nitroprusside) were unaffected (Tesfamariam et al.,
1990). In the present investigation, however, ACh-induced relaxation, as well as
responses to A23187 and SIN-1, was unaffected by incubation in the presence of
high glucose concentrations.
4.5.2. Effect ofIncubation Time
The results of this study demonstrate that increasing glucose exposure time from 1
hour to 4 hours had no effect on either the contractile or relaxant responses. It is
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possible, however, that this is a type 2 error as the groups used for this comparison
were small. The effect of time was not pursued in these experiments as the decision
had been taken to use a 1 hour incubation with the human vessels. This contrasts
with those reported previously (Tesfamariam et al., 1990) which have demonstrated
that glucose-mediated attenuation of endothelium-dependent relaxation is a time-
dependent phenomenon; the abnormality produced in isolated rabbit aortae is less
pronounced after a 2-3 hour incubation than after a 6 hour exposure to elevated
glucose (Tesfamariam et al., 1990). Therefore, the maintained endothelial cell
function in our investigation may be due to the shorter (1 and 4 hr) incubation
periods used. This conclusion is supported by the studies of Heygate et al (1993)
who demonstrated that endothelium-dependent vasodilatation of rat mesenteric
resistance arteries was only reduced after 6hrs incubation in 40mM glucose.
4.5.3. Effect ofelevated concentrations of insulin
In contrast to the effect of elevated glucose, incubation of rat mesenteric resistance
arteries in PSS containing an elevated concentration of insulin (1000mU/l) had no
effect on the contractions induced by ET-1, NA or K+. This was unexpected as
insulin has direct vasoactive properties and, in previous studies, caused
vasodilatation in the human forearm in vivo (Anderson et al., 1991; Creager et al.,
1985; Sakai et al., 1993) and inhibited vasoconstriction by a number of agonists in
isolated arteries in vitro (Alexander & Oake, 1977; Wu et al., 1994; Yagi et al.,
1988; McNally et al., 1995). Previous investigations with isolated rat mesenteric
arteries have reported attenuation of NA-induced vasoconstriction in the presence of
insulin (Walker et al., 1997; Wambach & Liu, 1991), although one of these studies
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only observed a significant effect at insulin concentrations greater than 100U/1
(Wambach & Liu, 1991). The use of different incubation periods is unlikely to
account for the different results obtained in the current investigation since the action
of insulin, whilst known to be concentration-dependent, is not time-dependent
(McNally et al., 1995).
Exposure to high concentrations of insulin were expected to alter ET-1-mediated
contraction as insulin can augment both acute and chronic ET-1 secretion (Hu et al.,
1993; Hattori et al., 1991; Oliver et al., 1991) and stimulate the production of ET-1
(Hu et al., 1993; Oliver et al., 1991) in vitro. However, the fact that insulin-mediated
release of ET-1 from cultured endothelial cells only occurs at supraphysiological
concentrations (25,000mU/l) may explain the absence of a significant effect in the
current investigation which used a significantly lower concentration (1000mU/l) of
insulin.
The unaltered responses to endothelium-dependent vasodilators following incubation
with insulin is consistent with previous investigations using isolated resistance
arteries incubated in vitro in a similar fashion (Walker et al., 1997; McNally et al.,
1995). As insulin treatment in vivo prevents the development of a defect in
endothelium-dependent relaxation in diabetic rats (Taylor et al., 1994), these results
suggest that insulin may act by reducing the circulating glucose concentrations rather
than by directly altering the cells of the arterial wall. This appears to be confirmed by
the recent demonstration that endothelium-dependent relaxation in aortic rings from
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STZ-induced diabetic rats is improved by insulin when administered in vivo but not
when administered in vitro (Pieper, 1997).
In summary, these results demonstrate that acute elevation of glucose to a
pathophysiologically relevant concentration (15mM), but not insulin, reduces the
vascular sensitivity to ET-1 in the rat mesenteric resistance artery in vitro. This
suggests that elevated glucose concentrations may be a primary factor for the
impaired contractile response to ET-1 in diabetic patients and this may contribute to
the development of the vascular complications of diabetes. The mechanisms
underlying the impaired response to ET-1 are unclear and future studies using
endothelin receptor antagonists and NO synthase inhibitors may be beneficial in
determining the relative contributions of receptor down-regulation and increased









Isolated vessel techniques are used extensively to investigate mechanisms associated
with the development of a variety of different disease processes. The majority of studies
use vessels isolated from experimental animals but the results from such studies are
sometimes difficult to extrapolate to humans due to the heterogeneity of conditions
used: for example, species differences, disease duration, variations between different
vessel types or the method of study. In order to overcome these problems a technique
(small vessel myography) was developed to obtain small arteries from subcutaneous fat
for investigation of vascular function (Aalkjaer et al., 1986). This technique enables the
intrinsic properties of isolated human resistance arteries, which contribute significantly
to the maintenance of blood pressure, to be studied from patients and matched control
subjects.
The vascular endothelium can modulate vascular tone by releasing various factors,
including nitric oxide (NO), prostacyclin (PGI2) and endothelium-derived
hyperpolarising factor (EDHF) (Vanhoutte, 1989). It is recognised that functional
responses differ between arteries from a variety of anatomical locations, as a result of
heterogeneity in receptor populations and endothelium-derived relaxing factors
(Vanhoutte & Miller, 1985). Receptor populations may vary in proximal and distal
sections of the same artery (Ohkubo & Chiba, 1988) and there is preliminary evidence
to suggest that acetylcholine (ACh)-induced endothelium-dependent relaxation may
differ in small and large resistance arteries taken from human subcutaneous fat (Angus
et al., 1992).
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The relative contributions ofNO, PGI2 and EDHF to endothelium-dependent relaxation
also appear to depend both upon the origin and the size of a particular vessel
(Shimokawa et al., 1996; Urakami-Harasawa et al., 1997). In a variety of arteries,
particularly those with a small diameter, a component of the endothelium-dependent
relaxation is insensitive to NO synthase and cyclooxygenase inhibition. This NO- and
prostanoid-independent relaxation is accompanied by an endothelium-dependent
hyperpolarisation of the vascular smooth muscle cell membrane potential suggesting the
existence of an EDHF (Cohen & Vanhoutte, 1995), the identity of which remains
elusive. The contribution of EDHF has been investigated by increasing extracellular
potassium concentrations or by using a variety of potassium channel antagonists.
EDHF-mediated relaxation is attenuated by either apamin (a specific inhibitor of small
conductance (SKca) calcium-activated potassium channels) alone or in combination
with charybdotoxin (ChTx; a non-specific inhibitor of calcium-activated potassium
channels) (Murphy & Brayden, 1995; Corriu et al., 1996; Zygmunt & Hogestatt, 1996).
To date, however, there have been relatively few investigations of heterogeneity of
vessel type and endothelium-dependent relaxation in human arteries. Likewise, few
studies have investigated the contributions of PGI2, NO and EDHF(s) to endothelium-
dependent relaxation in human resistance arteries (Deng et al., 1995; Hillier et al., 1998;
Ohlmann et al., 1997; Petersson et al., 1995; Urakami-Harasawa et al., 1997;
Wallerstedt & Bodelsson, 1997). These studies have suggested that all three factors may
contribute to relaxation of human resistance arteries but comparisons are difficult as
they have used arteries from a variety of anatomical locations (omental, gluteal, pial,
gastroepiploic). In addition, experimental protocols have varied with the choice of
106
different vasodilators (ACh, bradykinin (BK), A23187, substance P) and the use of
several different vasoconstrictors (noradrenaline (NA), prostaglandin F2a (PGF2a),
U46619) to pre-contract the vessels.
5.2. Aims
Therefore, the aims of this study were (1) to determine criteria for identifying
differences between vessels isolated from biopsies of subcutaneous fat resistance using
gross morphological, histological and functional procedures and (2) to identify the
mediators of ACh-induced endothelium-dependent relaxation of NA-contracted human
subcutaneous resistance arteries. NA was chosen as the vasoconstrictor since it is the
best characterised physiological agent both in vitro and in vivo.
5.3. Methods
5.3.1. Subjects
Gluteal biopsies of skin and subcutaneous fat (approximately 2cm x 1cm x 1cm) were
obtained under local anaesthesia (2% lignocaine hydrochloride; Astra, Hertfordshire,
U.K.) from 10 normotensive, non-smoking, male volunteers (age 56±3 yrs) and
immediately placed in physiological salt solution (PSS). All subjects gave written
informed consent and the protocol was approved by the Lothian Research Ethics
Committee. Vessels were dissected from these biopsies using light microscopy and
were identified as either small or large resistance arteries or veins by differences in their
physical characteristics. The wall of the vein is very thin relative to the diameter of the
vessel and, when dissected from the biopsy, the vein collapses in on itself. In contrast,
the thickness of the artery wall is similar to the diameter of the vessel and the artery
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maintains its shape when dissected free from surrounding connective tissue. The third
type of vessel, appears larger than resistance-sized arteries, and combines physical
characteristics of arteries and veins. From the 10 biopsies taken, 2 contained all three
types of vessels. Resistance and large arteries were isolated from 5 of the biopsies,
whilst the remaining 3 biopsies contained only veins.
5.3.2. Morphological Investigations
Human subcutaneous vessels were dissected free of fat and fixed in 10% neutral
buffered formalin for 24hrs at room temperature. The tissues were dehydrated in ethanol
and chloroform and embedded in paraffin wax for subsequent histological analysis. This
procedure was performed both in freshly isolated vessels and in some that had been
used for functional investigation. Serial 3pm transverse sections were cut using a rotary
microtome and mounted onto poly-L-lysine coated glass slides. Sections were oven
dried overnight at 37°C. General morphology was established using a combination of
the stains haematoxylin and eosin, which show nuclei and cellular tissue components,
respectively. Smooth muscle and endothelial cells were detected using mouse anti a-
smooth muscle actin IgG (1:50 dilution) and biotinylated ulex europaeus agglutinin
(1:100 dilution), respectively, a-sma IgG (but not ulex which was already biotinylated)
was incubated with a goat anti-mouse biotinylated secondary antibody. Roth smooth
muscle and endothelium were detected using a strepavidin-biotin-peroxidase kit,
followed by incubation with diaminobenzidine. Positive signals appeared brown.
Negative controls were obtained by omitting the primary antibody (for detailed
methodology refer to Chapter 2).
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5.3.3. Functional Investigations
Human subcutaneous resistance vessels, approximately 2mm long, were mounted as
ring preparations on two 40pm intraluminal wires in an isometric small vessel
myograph, containing PSS, maintained at 37°C and equilibrated with 95% 02/5% CO2,
for measurement of isometric force. Following a 30min equilibration period, the vessels
were subject to a standard normalisation procedure (detailed in Chapter 2) and set to
their optimum resting level (0.9L100, where L/oo is the internal circumference the vessels
would have when relaxed and subjected to a pressure of 13.3kPa). After a further 30min
equilibration, the vessels were then subjected to a standard start procedure, which
consisted of five consecutive stimulations of 3min each, followed by a 5min washout
period. The first, second and fifth contractions were produced using high (125mM)
potassium solution (KPSS; made by equimolar substitution of KC1 for NaCl in PSS)
containing lOpM noradrenaline (NA). The third was obtained with NA (lOpM) alone
and the forth with KPSS alone. The functional integrity of the endothelium was
assessed by adding ACh (O.l-lOpM) to vessels submaximally contracted with NA
(3pM). In some vessels, the endothelium was removed by rubbing the lumen with a
human hair (Chapter 2).
5.3.3.1. Functional Characteristics of Small and Large Resistance Arteries and
Veins.
Cumulative concentration-response curves were obtained in all three vessel types using
the receptor-dependent agonists NA (10"9-3xl0"5M) and ET-1 (10"n-3xl0"7M) and the
receptor-independent vasoconstrictor K+ (10-125mM). Cumulative concentration-
response curves were obtained for the receptor-dependent, endothelium-dependent
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vasodilators ACh (10~9-3xl0"5M) and BK (10"'°-3xl0"6M), the receptor-independent,
endothelium-dependent dilator A23187 (10"9-3xl0"6M) and the endothelium-
independent vasodilator, SIN-1 (10~9-3xl0~5M). Responses to vasodilators were
obtained following precontraction of the vessel with a submaximal concentration (3pM)
ofNA.
5.3.3.2. Functional Identification of Mediators of Endothelium-Dependent
Relaxation in Small Resistance Arteries
Each artery was precontracted with a submaximal concentration of NA (3pM) and a
cumulative concentration-response curve was obtained in response to ACh (10~9-3xl0~
5M). On completion of the curve the contents of the bath were changed and the arteries
were bathed in fresh PSS. In order to determine the relative contributions of PGE, NO
and EDHF as mediators of endothelium-dependent relaxation, the procedure was
repeated following incubation with either:- (a) indomethacin (lOpM for 45min), (b) N -
nitro-L-arginine (L-NOARG; lOOpM for 45min) or (c) L-NOARG (lOOpM for 45min)
plus charybdotoxin (ChTx; 50nM for lOmin) and apamin (30nM for lOmin). Most
arteries were exposed to only one antagonist but, in order to obtain three groups of six
vessels, two of those initially incubated with indomethacin were subsequently incubated
with L-NOARG (in the absence of indomethacin) before production of a further
concentration-response curve to ACh. The effect of L-NOARG on ACh-mediated
relaxation in these two arteries was not different from the effect on arteries exposed
only to L-NOARG.
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Three of the arteries incubated with the combination of L-NOARG, ChTx and apamin,
were exposed to a single concentration (lOOpM) of the endothelium-independent
vasodilator 3-morpholinosydnonimine (SIN-1) once the cumulative concentration-
response curve to ACh had been completed.
5.3.4. Drugs
Reagents for the preparation of PSS were obtained form BDH Laboratory Supplies,
Poole, Dorset, UK. All drugs were purchased from Sigma, Poole, Dorset, UK.
Acetylcholine chloride and noradrenaline bitartrate were dissolved in distilled water (10"
3M stock); indomethacin (10"3M stock) in 1.5xl0"3M Na2C03 (final bath concentration
of Na2CC>3 did not exceed 0.015mM) and apamin (10"5M stock) in 0.05M acetic acid
(final bath concentration of acetic acid did not exceed 0.15mM). L-NOARG (10"2M
stock) was dissolved in 0.1N hydrochloric acid. Charybdotoxin (10"6M stock) was
dissolved in a Tris buffer (lOmM, pH 7.5) containing 0.1% BSA, lOOmM NaCl and
ImM EDTA (final bath concentrations of NaCl and EDTA did not exceed 5mM and
0.05mM, respectively). 0.01% BSA was added to the myograph chamber before
applying the toxins. All drugs were stored as stock solutions at -20°C and thawed as
required; subsequent dilutions were made in distilled water and any residual solution
was discarded at the end of the experiment. The concentration given is the final molar
concentration in the bath.
5.3.5. Statistics
All values are presented as mean ± standard error mean (s.e.mean) from n experiments
(where n represents the number of subjects). Contractions are given as mN/ mm and the
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relaxation to ACh is expressed as a percentage reversal of the initial NA-induced
precontraction. Sensitivities to vasoconstrictors and to ACh are expressed as the
negative log of the effective concentration (M) of the drug required to produce 50% of
the maximum effect (pD2 and -loglCso, respectively). The sensitivities were calculated
from each concentration-response curve by fitting the data to the Hill equation using
curve fitting software (Fig. P, Biosoft, Cambridge). Comparison of maximum response
and sensitivities between small and large resistance arteries and veins were made using
Student's unpaired t-test. Student's paired t-test was used in the comparison of
maximum response and sensitivity before and after incubation with the inhibitors.
Significance was assumed ifP<0.05.
5.4. Results
Large and small resistance arteries, and small veins, isolated from the biopsies of
subcutaneous fat were distinguished using physical differences as described in the
methods section.
5.4.1. Morphology
Haematoxylin and eosin staining demonstrated that small resistance arteries had a
clearly defined media and adventitia (Figure 5.1A(ii)). Immunohistochemistry showed
that the media contained mainly smooth muscle cells (Figure 5.1A(iii)) with a
monolayer of endothelial cells lining the internal elastic lamina (Figure 5.1A(iv)). In
contrast, veins failed to hold their shape and distinction between media and adventitia
was less obvious following staining with haematoxylin and eosin (Figure 5.lB(ii)).
However, immunohistochemistry demonstrated that the media stained strongly for a-
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(A) (B) (C)
Figure 5.1. Physical and morphological differences between small resistance arteries (A),
veins (B) and large resistance arteries (C) isolated from human subcutaneous fat
biopsies, (i) light microscopy showing differences in physical characteristics between
the three vessel types, (ii) haematoxylin and eosin staining showing media (M),
lumen (L) and adventitia (A), (iii) and (iv) immunohistochemical localisation of
smooth muscle (SM) and endothelium (E) using monoclonal antibodies against a-
smooth muscle actin and ulex europaeus agglutinin, respectively. Magnification
x200.
113
sma (Figure 5.lB(iii)) and the ulex antibody identified a clear endothelium lining the
lumen (Figure 5.1B(iv)). The large resistance arteries had a clearly defined media and
adventitia when stained with haematoxylin and eosin (Figure 5.1C(ii)). Like the small
resistance arteries and veins, the media comprised mainly of smooth muscle cells
(Figure 5.1C(iii)) and an endothelial layer was evident on the luminal surface (Figure
5.1C(iv)).
5.4.2. Normalisation
Normalisation, a procedure which determines the internal circumference which the
vessel would have if relaxed and under a transmural pressure of lOOmHg (13.3kPa), is
performed by distending the vessel stepwise until the effective transmural pressure
exceeds lOOmmFIg (see Chapter 2 for details). Normalisation of small resistance arteries
was uncomplicated with the effective transmural pressure exceeding 13.3kPa after three
to four stretches. In contrast, large resistance arteries and veins did not maintain stretch
as well as the small resistance arteries and typically required in excess of 6 stretches to
fully complete the normalisation procedure. The internal diameter of large resistance
arteries (519±72pm; n=7) was significantly greater (P<0.005) than that of the small
resistance arteries (168±18pm; n=7) when stretched to an effective pressure of 13.3kPa.
Although veins were chosen which appeared similar in size to the small resistance
arteries, they were found to have an internal diameter (410±93pm; n=5) similar




5.4.3.1. Functional Characteristics of Large and Small Resistance Arteries and
Veins
All three types of vessel produced concentration-dependent contractions in response to
the vasoconstrictors NA, ET-1 and KPSS (Figure 5.2). The maximum contractile
response to NA tended (P=0.07) to be greater in the large than in the small resistance
arteries and veins, although this difference only reached significance (P=0.03) when
compared with veins. Furthermore, this difference was still apparent when the
contractions were expressed as a percentage of the maximum response to NA-K to
control for variations in vessel size (Table 5.1.). Sensitivity to NA was significantly
(P=0.01) greater in large (pD2; 7.34+0.18; n=7), compared with small (pD2; 6.74±0.11;
n=7) resistance arteries, but was similar (P=0.80) to the sensitivity exhibited by veins
(pD2: 7.40±0.14; n=5).
The contraction produced by ET-1 (Figure 5.2b) was greater (,P=0.02) in large
compared with small resistance arteries and tended (P=0.10) to be stronger than the
response produced in veins (Table 5.1). However, these differences were lost when the
results were expressed as a percentage of the maximum response to NA-K, to control
for variations in vessel size (Table 5.1). Large vessels also tended (P=0.09) to be more
sensitive (pD2, 9.05±0.16, n=7) to ET-1 than small resistance arteries (pD2, 8.61+0.17,
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Figure 5.2. Concentration-response curves to (a) noradrenaline, (b) endothelin-1 and (c)
K+ in small resistance arteries (#, n=7), veins (A, n=5) and large resistance arteries
(■, n=7) isolated from human subcutaneous fat biopsies. Each point represents
mean ± s.e.mean.
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Table 5.1. Maximum contraction (Emax) of small and large resistance arteries and
veins to noradrenaline (NA), endothelin-1 (ET-1) and KPSS.
Emax (mN/mm) Emax (%NA-K)
NA ET-1 KPSS NA ET-1 KPSS
SRA (n=7) 1.8310.49 1.57±0.30* 1.39±0.49
LRA (n=7) 3.21±0.49 3.35±0.60 2.99±0.72




Results are shown as mean ± s.e.mean and are expressed as force per unit length of
tissue (mN/mm) and as a percentage of the maximum response to NA-K, to control for
variations in vessel size. *P<0.05 when compared with large resistance artery. SRA,
small resistance artery; LRA, large resistance artery; V, vein.
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As with NA and ET-1, the Emax to KPSS (Figure 5.2c) produced by large resistance
arteries tended to be greater than that produced by small resistance arteries (P=0.09) and
veins (P=0.19; Table 5.1). However, the sensitivity (pD2) to this constrictor in large
resistance arteries (1.53±0.04, n=7) was similar to that in small resistance arteries
(1.51±0.04, n=7; P=0.65) and veins (1.58+0.06, n=5; P=0.50).
Small resistance arteries relaxed in a concentration-dependent manner in response to
ACh (Figure 5.3a) (Emax, 96.72+2.68%, -loglCso, 7.34+0.11, n=7). However, exposure
to this agonist failed to elicit an active relaxation in large resistance arteries (Emax,
17.43+7.95%; n=7) or veins (Emax, 18.20+7.28%; n=5) (Figure 5.3a). BK-mediated
relaxation was similar in small (Emax, 86.92+5.31%; -loglCso, 7.63+0.14; n=7) and
large (Emax, 78.13+5.93%, P=0.29; -loglCso, 7.96+0.27, P=0.31, n=7) resistance
arteries. In contrast, veins failed to relax in response to BK (Emax, 20.56+6.68%, n=5)
(Figure 5.3b). Relaxation to A23187 (Figure 5.3c) was similar in large (Emax,
67.04+8.36%; -logIC50, 6.63+0.20; n=7) and small (Emax, 76.00+11.52%, P=0.54; -
loglCso, 6.76+0.23, P=0.66; n=7) resistance arteries, but only produced relaxation in
two out of five veins (Emax 52.89% and 91.18%). All three vessel types relaxed in
response to SIN-1 (Figure 5.3d). The magnitude (Emax, 99.19+3.86%, n=7) and
sensitivity (-loglCso, 5.92+0.21, n=7) of this response in large resistance arteries were
similar to that produced by small resistance arteries (Emax, 98.33+3.44, P=0.87; -
loglCso, 6.21+0.14, P=0.27) and veins (Emax, 106.22+18.65, P=0.67; -loglCso,
5.52+0.11,P=0.17).
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Figure 5.3. Concentration-response curves to the vasodilators (a) acetylcholine, (b)
bradykinin, (c) A23187 and (d) 3'-morpholinosydnonimine (SIN-1) in small
resistance arteries (#, n=7), veins (A, n=5) and large resistance arteries (■, n=7)
isolated from human subcutaneous fat biopsies. Each point represents mean ±
s.e.mean.
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Based on the criteria for distinguishing the different vessels isolated from the biopsies,
vessels identified as large resistance arteries or veins were discarded and subsequent
experiments with the inhibitors were only performed in vessels identified as small
resistance arteries.
5.4.3.2. Functional Identification of Mediators of Endothelium-Dependent
Relaxation ofHuman Small Resistance Arteries
Human subcutaneous small resistance arteries pre-contracted with a submaximal
concentration of NA (3pM), relaxed in a concentration-dependent manner when
exposed to the endothelium-dependent vasodilator ACh (10~9-3xl0~5M). In each of the
three groups of arteries, this produced approximately 90% relaxation in the absence of
the inhibitors (see below) and was abolished by removal of the endothelium (Figure
5.4.). Addition of, and incubation with, the inhibitors did not increase the resting tone of
any of the arteries. Furthermore, the amplitude of the response to the pre-contracting
concentration (3pM) of NA was not increased following incubation with any of the
inhibitors (Table 5.2.). Indeed, the trend was for the second pre-contraction to be
smaller than the first, probably as a result of tachyphylaxis. This was most apparent
with the arteries incubated with the combination of L-NOARG, ChTx and apamin, but
did not reach significance.
5.4.3.2.1. Effect ofcyclooxygenase inhibition
Following incubation with indomethacin (lOpM for 45min), the magnitude of ACh-
induced endothelium-dependent relaxation was not significantly different from the
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Figure 5.4. Trace demonstraing the effect of acetylcholine (ACh) in a human small
resistance artery submaximally precontracted with noradrenaline (NA) before (a)
and after (b) removal of the endothelium. W-washout.
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Table 5.2. Magnitude of precontraction to NA (3pM), in human small resistance
arteries, before and after incubation with either indomethacin (lOpM for 45min), L-
NOARG (lOOpM for 45min) or L-NOARG plus ChTx (50nM for lOmin) and
apamin (30nM for lOmin).
NA Precontraction (mN/mm)
Before After
Indomethacin 2.16±0.40 2.02±0.40 0.12
L-NOARG 2.58±0.32 2.53±0.33 0.52
L-NOARG + ChTx + 1.91+0.44 1.61+0.38 0.053
Apamin
Values are expressed as force per unit length of tissues (mN/mm) and are shown as
mean ± s.e.mean, n=6 for each group.
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control (maximum relaxation (%) 90.80+4.69 vs 97.56±1.83, P=0.18, for control vs
indomethacin, n=6). The sensitivity of the response to ACh following exposure to
indomethacin was not altered compared with controls (-loglCso values 7.23±0.25 vs
7.24±0.20, P=0.96, for control vs indomethacin, n=6. Figure 5.5a.).
5.4.3.2.2. Effect ofNOS inhibition.
Following exposure to L-NOARG, ACh-evoked relaxation was significantly reduced,
but not completely abolished (maximum relaxation (%) 91.55+3.95 vs 61.68±3.38,
PO.OOOl), with a corresponding rightward shift of the ACh concentration-response
curve (-loglCso values 7.19±0.13 vs 6.41±0.10, ,P<0.005, for control vs L-NOARG,
n=6. Figure 5.5b.).
5.4.3.2.3. Effect ofpotassium channel blockade
Incubation of arteries with a combination of L-NOARG plus the potassium channel
blockers ChTx (50nM for lOmin) and apamin (30nM for lOmin) virtually abolished the
L-NOARG resistant component of ACh-induced relaxation (maximum relaxation (%)
92.59±3.65 vs 15.2±10.5, P<0.002, for control vs ChTx & apamin, n=6. Figure 5.5c.).
The sensitivity could not be calculated following incubation with the K+ channel
blockers.
Addition of the endothelium-independent dilator, SIN-1 (lOOpM) caused complete
relaxation (127.6+13.0%; n=3) of vessels incubated with the combination of L-
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Figure 5.5. Concentration-response curves to acetylcholine in isolated human resistance
arteries before (■) and after (O) incubation with either (a) indomethacin (lOpM for
45min), (b) L-NOARG (lOOpM for 45min) or (c) L-NOARG plus ChTx (50nM for




This study has demonstrated the existence of three functionally distinct vessels obtained
from biopsies of human subcutaneous fat and secondly that ACh-induced endothelium-
dependent relaxation of noradrenaline contracted human subcutaneous resistance
arteries is mediated by both NO-dependent and independent pathways.
5.5.1. Vessel Identification
Gluteal subcutaneous fat biopsies provide a convenient source of resistance arteries for
investigating the vascular consequences of a variety of conditions, including
hypertension (Deng et al., 1995) and pre-eclampsia (Aalkjaer et al., 1984). However,
this investigation has demonstrated the existence of three functionally distinct vessels
isolated from biopsies of human subcutaneous fat: small and large resistance arteries
and veins. The most apparent difference was the inability of large resistance arteries to
relax in response to the endothelium-dependent vasodilator ACh.
ACh-induced vasodilatation results from the release of relaxing factors following
stimulation of muscarinic receptors on the endothelium. The failure of ACh to relax
large resistance arteries has been reported previously (Angus et al., 1992) and could be
due to (i) damage to the endothelium, (ii) reduced smooth muscle responsiveness to
relaxant factors or (iii) lack of endothelial muscarinic receptors. Endothelial damage as
a result of vessel isolation is unlikely to account for the lack of response of large
resistance arteries to ACh as immunohistochemistry clearly demonstrated an intact
endothelial cell layer, and responses to other endothelium-dependent vasodilators (BK
and A23187) were similar to those responses obtained in small resistance arteries.
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Likewise, the lack of response to ACh in large resistance arteries is unlikely to be due to
reduced responsiveness of vascular smooth muscle cells to relaxing factors, as
endothelium-independent responses to SIN-1 were comparable with those in small
resistance arteries, indicating that the smooth muscle was able to relax in response to
NO. Therefore, the lack of response to ACh in large resistance arteries is most likely
due to an absence of muscarinic receptors on the endothelial cells. This observation
reinforces the demonstration of receptor heterogeneity in the endothelium (Vanhoutte,
1989) and is consistent with those reported by Angus et al (1992) who demonstrated
that large subcutaneous resistance arteries which failed to relax to ACh relaxed when
exposed to substance P.
In order to allow comparison with small and large resistance arteries, the functional
responses of subcutaneous veins were also investigated. The lack of responsiveness to
endothelium-dependent vasodilators (ACh and BK) is consistent with previous
observations in large systemic veins (Vanhoutte & Miller, 1985; DeMey & Vanhoutte,
1982; Luscher et al., 1988). Immunohistochemistry indicated that the veins had an
intact endothelium, suggesting that the lack of responses to these vasodilators may be
due to the lack of necessary receptors on the endothelial cells. However, the variable
response to A23187 contrasts with some systemic veins which, despite responding
poorly to ACh, relax significantly in response to A23187 (Luscher et al., 1988). There
is evidence that this may be due to anatomical variation in this response and this may
account for the heterogeneity of the response to A23187 in the veins used in the present
study. The failure to relax to endothelium-dependent vasodilators, however, was not due
to reduced vascular smooth muscle sensitivity as exposure to SIN-1 caused complete
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relaxation of human subcutaneous veins, comparable with that of small resistance
arteries.
The three vessel types all contracted in a concentration-dependent maimer in response to
NA, ET-1 and KPSS. The increased maximum response to these agonists in large
resistance arteries compared with small resistance arteries and veins is most likely the
result of size differences, as responses were similar if the results were expressed as a
percentage of the response to NA-K, to control for variations in vessel size. The
observed increase in sensitivity to NA and ET-1, but not to KPSS, in large resistance
arteries and veins compared with small resistance arteries may suggest heterogeneity in
NA/ET receptor populations. Alternatively, it is possible that the inhibitory role of the
endothelium on contractile response that has been reported in small resistance arteries,
is absent from large resistance arteries and veins.
5.5.2. Role of the L-arginine/NOpathway in ACh relaxation
Since the discovery of NO as a major endothelium-derived relaxing factor (Palmer et
al., 1987), structural analogues of its precursor, L-arginine (Palmer et al., 1988), have
been used to abolish endothelium dependent relaxation in a variety of arteries (Rees et
al., 1989; Rees et al., 1990; Mulsch & Busse, 1990). In some vessels, particularly
resistance arteries, endothelium-dependent relaxation may remain partially or wholly
insensitive to NOS inhibition (Shimokawa et al., 1996; Urakami- Harasawa et al.,
1997). Our finding that ACh-evoked endothelium-dependent relaxation is only partially
inhibited following NOS inhibition is in accordance with previous in vitro data on
human small arteries (Woolfson & Poston, 1990; Deng et al., 1995; Hillier et al., 1998).
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Similar results have heeri obtained with other endothelium-dependent agonists such as
BK and substance P in human arteries from various anatomical (omental, pial,
gastroepiploic) locations (Petersson et al., 1995; Ohlmann et al., 1997; Urakami-
Harasawa et al., 1997). The failure of L-NOARG to completely block ACh-mediated
relaxation is unlikely to be related to incomplete inhibition of NO synthase as a lower
concentration (3xlO"5M) abolished endothelium-dependent relaxation in the rat aorta,
pulmonary and iliac arteries (Nagao et al., 1992). Furthermore, the incomplete
inhibition of ACh-mediated relaxation in the rabbit renal artery was not overcome by
increasing the concentration of L-NOARG (100-300pM; Brandes et al., 1997) or by the
combined application of two different L-arginine analogues (Plane & Garland, 1996;
Plane et al., 1997). These results suggest, therefore, that a NO-independent mechanism
is responsible for the relaxation that persists in the presence of L-NOARG.
5.5.3. Role for prostanoids in ACIt relaxation
Cyclo-oxygenase activity has been demonstrated in both the endothelium and vascular
smooth muscle (Moncada, 1982), implicating endothelium-derived prostaglandins as
mediators of endothelium-dependent relaxation. Indeed, PGI2 contributes to
endothelium-dependent relaxation in the rabbit mesenteric, coeliac and coronary artery
beds (Forstermann et al., 1986; Lamantagne et al., 1992), with PGE2 assuming greater
significance in the rabbit extra-pulmonary artery (Forstermann et al., 1986). Bradykinin
(BK)-mediated relaxation of human omental resistance arteries may also be partially
mediated by prostaglandins (Ohlmann et al., 1997). In the present study, the inability of
the cyclooxygenase inhibitor indomethacin to inhibit ACh-mediated relaxation suggests
that vasodilator prostanoids do not contribute to this response in human subcutaneous
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resistance arteries. This is consistent with results obtained in similar vessels (Deng et
al., 1995; Hillier et al., 1998) as well as in human gastroepiploic resistance arteries
(Urakami-Harasawa et al., 1997), and also reflects the inability of indomethacin to
inhibit substance P-mediated relaxation of human omental vessels (Wallerstedt &
Bodelsson, 1997). It is possible, however, that the effects of cyclooxygenase inhibition
only become apparent when production of NO is also blocked. In human subcutaneous
(Woolfson & Poston, 1990) and omental (Ohlmann et al., 1997) resistance arteries a
small, indomethacin-sensitive component of relaxation (to ACh and BK, respectively)
was evident only in the presence of L-arginine analogues (L-Nitroarginine methyl ester
(L-NAME); L-N°-monomethyl arginine (L-NMMA)). In contrast, however,
indomethacin had no effect on BK-mediated relaxation either in the absence or presence
of L-NAME in human subcutaneous resistance arteries (Hillier et al., 1998).
Interestingly, in the present study the ACh-mediated relaxation tended to be greater in
vessels incubated with indomethacin, although this difference did not reach statistical
significance. This result is similar to that reported recently by Hillier et al. (1998) and
may suggest that indomethacin inhibits the action of contractile prostanoids, thus
enabling ACh to have a greater relaxant effect.
5.5.4. Rotefor EDHF in ACh relaxation
Previous investigations have demonstrated that an NO/PG-independent component of
ACh-induced relaxation is mediated by EDHF (Nakashima et al., 1993; Urakami-
Harasawa et al., 1997; Wallerstedt & Bodelsson, 1997). In the current investigation, the
role of EDHF in human subcutaneous resistance arteries was assessed using a
combination of the inhibitors previously applied to a variety of vessels including rat
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hepatic (Zygmunt & Hogestatt, 1996), guinea pig basilar and human pial (Petersson et
al., 1997) arteries. This combines the large (BKca) and small (SKca) calcium-dependent
K+ channel inhibitors, ChTx and apamin, in the continuing presence of a NO synthase
inhibitor (Zygmunt & Hogestatt, 1996).
The results from this study demonstrate that the combination of ChTx and apamin
virtually abolished the NO-independent component of ACh-induced relaxation. This
was not due to a toxic effect on the vascular wall for, as in a previous study (Deng et al.,
1995), the arteries retained the ability to relax in response to an endothelium-
independent dilator. These results correspond with those obtained in a variety of
isolated vessels, including guinea pig basilar (Petersson et al., 1997), and rat mesenteric
(Plane et al., 1997) and hepatic, arteries (Zygmunt & Hogestatt, 1996), which indicate
that the ChTx/apamin-sensitive, NO-independent component of ACh-evoked relaxation
is mediated by EDHF. In rat mesenteric arteries, the NO-independent component of
ACh-mediated relaxation is accompanied by smooth muscle cell hyperpolarization
(Plane & Garland, 1996). This response is abolished by the combination of ChTx and
apamin (Zygmunt & Hogestatt, 1996), probably by inhibition of BKca and SKca on the
endothelium (Doughty et al., 1999).
Several studies have investigated the relative contribution of relaxing factors to the
endothelium-dependent relaxation produced by bradykinin (Nakashima et al., 1993;
Ohlmann et al., 1997; Urakami-Harasawa et al., 1997; Pascoal & Umans, 1996) and
substance P (Petersson et al., 1995; Wallerstedt & Bodelsson, 1997) in human arteries.
Exposure of human omental microvessels and gastroepiploic arteries to ChTx and/or
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apamin had little or no effect on NO-independent relaxation to bradykinin (Pascoal &
Umans, 1996; Ohlmann et al., 1997; Urakami-Harasawa et al., 1997). These results
contrast with our findings in which NO-resistant relaxation to ACh was almost
abolished by ChTx and apamin. There are several possible explanations for these
differences, (i) the relative contribution of voltage-dependent and -independent
mechanisms to endothelium-dependent relaxation may be influenced both by the
contractile and relaxant agonists used (Plane et al., 1992; Plane & Garland, 1996).
Many previous studies which investigated the role of EDHF in human arteries have
used different contractile agonists from that used in the present study (including
arginine vasopressin (AVP; Pascoal & Umans, 1996), the thromboxane A2 mimetic
U46619 (Urakami-Harasawa et al., 1997) and prostaglandin F2a (PGF2a; Ohlmann et
al., 1997). This may be significant as ACh-induced relaxation of rat mesenteric arteries
is associated with hyperpolarisation following contraction with NA, but not following
contraction with U46619 (Plane & Garland, 1996). Furthermore, human omental vessels
pre-contracted with AVP relaxed in response to ACh (Pascoal & Umans, 1996) whereas
those pre-contracted with U46619 did not (Wallerstedt & Bodelsson, 1997). (ii) The
choice of dilator may be important as NO and EDHF alone were implicated in
substance P-mediated relaxation of these arteries (Wallerstedt & Bodelsson, 1997)
whilst prostanoids also contributed to BK-mediated relaxation (Ohlmann et al., 1997).
(iii) The effector mechanisms for EDHF may vary between vessels as a result of
heterogeneous distribution of K+ channel subtypes as demonstrated in large and small
vessels of the rat pulmonary tree (Albarwani et al., 1995) and rabbit ear (Berman &
Griffith, 1997).
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The identity of EDHF remains elusive and it is possible that several different factors
account for its activity: cytochrome P450 epoxyeicosatrienoic acids (Hecker et al.,
1994), endocannabinoids (Randall et al., 1996) and myoendothelial gap junctions
(Chaytor et al., 1998). It has recently been proposed that EDHF is potassium released
fioin CliTx and apaiuin sensitive potassium channels on the vasculax endothelium which
then acts on inwardly rectifying potassium channels and Na+/K+-ATPases on the
smooth muscle cells to induce hyperpolarization (Edwards et al., 1998). However,
subsequent studies have challenged the identification of K+ as EDHF by demonstrating
differences in the characteristics of EDHF and K+-mediated in rat mesenteric (Doughty
et al., 2000; Lacy et al., 2000), porcine coronary and guinea pig carotid arteries
(Quignard et al., 1999). Furthermore, continuing work in our laboratory (Hadoke et al.,
1999) has indicated an obligatory role for the endothelium in K+-mediated relaxation in
human small resistance arteries. This suggests that K+ is not an EDHF in these arteries
but may be mediated by a further endothelium-dependent factor or is dependent on
myoendothelial gap junctions (Doughty et al., 2000).
In conclusion, this investigation demonstrated heterogeneity of ACh-mediated,
endothelium-dependent relaxation in human subcutaneous resistance arteries of
different sizes. This suggests variation in endothelial cell receptor populations as
resistance artery diameter increases and indicates the importance of confirming that
arteries isolated from subcutaneous fat have similar internal diameters and are
responsive to both ACh and BK. Furthermore, this study demonstrated an NO/PG-
independent response to ACh in human subcutaneous small resistance arteries, which
had characteristics consistent with EDHF-mediated relaxation, suggesting that EDHF
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Diabetes mellitus is associated with accelerated atherosclerosis and increased
prevalence of cardiovascular disease. Both macrovascular disease (resulting in
myocardial infarction, stroke and atheroma) and microvascular disease (resulting in
diabetic retinopathy, nephropathy and neuropathy) are more prevalent in the diabetic,
than in the non-diabetic, populations and contribute significantly to the increased
morbidity and mortality associated with this disease (Watkins et al., 1987; Eurodiab
IDDM Complications Study Group, 1994).
There is substantial evidence to indicate that the ability of the endothelium to
mediate vascular relaxation is impaired in large conduit arteries from animal models
of diabetes (Poston & Taylor, 1995) and in patients with both type 1 (Zenere et al.,
1995; Lakakis et al., 1997; Clarkson et al., 1996) and type 2 (Morris et al., 1995;
Enderle et al., 1998) diabetes mellitus. Similarly, contractile function may also be
altered in these vessels, although the nature of this alteration remains controversial.
These abnormalities have serious consequences as impaired function of conduit
arteries has been implicated in the increased risk of atheroma in patients with
diabetes.
Although it has been suggested that the microvascular complications associated with
increased morbidity and mortality in diabetes are also the result of vascular
dysfunction (Jaap & Tooke, 1995; Tooke, 1996), in vivo studies of microvascular
function in patients with diabetes are contradictory. Endothelium-dependent
relaxation has been reported as either unaltered (Calver et al., 1992; Smits et al.,
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1993; Avogaro et al., 1997; Cockcroft et al., 1998) or attenuated (Johnstone et al.,
1993; O'Driscoll et al., 1997; Ting et al., 1996; Gazis et al., 1998) in patients with
diabetes. Consequently, the development, nature and causes of functional alterations
remain unclear. It would appear unlikely that diabetes would produce the same
pathophysiological changes in conduit and resistance arteries, as these are
functionally distinct. Receptor populations vary in arteries of different anatomical
origin (Cambridge et al., 1995) and the factors that contribute to endothelium-
dependent relaxation differ in large compared with small vessels. Endothelium-
dependent relaxation is mediated almost exclusively by NO in conduit arteries
(Vanhoutte, 1989), whereas the contribution of an endothelium-derived
hyperpolarizing factor becomes increasingly significant as vessel size decreases
(Shimokawa et al., 1996).
The few studies of vascular function using resistance arteries isolated from either
patients with type 1 or type 2 diabetes have produced conflicting results.
Endothelium-dependent relaxation induced by acetylcholine has been reported to be
reduced (McNally et al, 1994) or unaltered (Malik et al, 1999, Lawrence et al, 1994)
in human resistance arteries. The impact of diabetes on contractile function is also
controversial, with contraction of human resistance arteries reported as being
unchanged (Lawrence et al, 1994) or attenuated (McNally, et al 1994).
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6.2. Aims
The aim of the present investigation was to assess the impact of type 1 and type 2
diabetes on resistance artery function by studying both contractile and relaxant
responses in resistance arteries taken from patients with these conditions.
6.3. Methods
6.3.1. Subjects
Two different groups of patients were studied. All patients were recruited from the
diabetic outpatient clinic at the Western General Hospital, Edinburgh. Healthy, age
and sex-matched, non-diabetic controls were selected for comparison with each of
the diabetic groups. All subjects provided informed written consent and the study
protocol was approved by the Lothian Research Ethics Committee.
6.3.1.1. Type 1 Diabetes
Twelve patients (seven male, five female) with type 1 diabetes and twelve age- and
sex-matched controls were recruited. Patients with type 1 diabetes were selected on
the basis that they had no history of cardiovascular disease and were taking no major
drugs other than insulin. Controls were recruited from the general population and had
no history of cardiovascular disease or diabetes. Six patients and four controls were
smokers, and three patients were also taking oral contraceptives. Biopsies from eight
patients and six controls provided sufficient vessels to allow investigation of the
influence of elevated glucose concentrations on contractile and relaxant function.
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6.3.1.2. Type 2 Diabetes
Eight male patients with type 2 diabetes and 10 age and sex matched controls were
recruited. Patients with type 2 diabetes were being treated by diet alone arrd had no
history of cardiovascular complications. Controls were recruited from the general
population and had no history of cardiovascular disease or diabetes. Two patients and
four controls were smokers.
6.3.1.3. Patient Assessment
Each individual enrolled in the study was subjected to a physical examination and a
variety of tests, performed by clinical staff in the Metabolic Unit (Western General
Hospital, Edinburgh). Blood pressure was measured three times (sitting, left arm;
sitting, right arm and standing, left arm) to obtain mean values for systolic and
diastolic pressure. The presence of retinopathy was assessed using dilated pupil
opthalmoscopy, whilst neuropathy was tested by measuring vibration in the toe. The
presence of microalbuminuria was assessed in patients by calculation of the
albumin/creatinine ratio (ACR). The determination of blood glucose, HbAic, serum
total cholesterol and triglycerides was done using routine laboratory methods.
6.3.2. Analysis ofResistance Artery Function
Sub-cutaneous gluteal resistance arteries were obtained from both groups of patients
and their controls. A biopsy of skin and subcutaneous fat (approximately 2cm long x
lcm x 1cm) was taken from the gluteal region under local anaesthesia (5ml of 2%
lignocaine hydrochloride; Astra, Hertfordshire, UK). Resistance arteries were
dissected from the biopsy and mounted as ring preparations on two 40pm stainless
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steel wires in a small vessel myograph, containing physiological salt solution
maintained at 37°C and perfused continuously with 95% O2; 5% CO2, for
measurement of isometric tension. The vessels were set to their optimum resting
force and, following a 30min equilibration at their optimum resting setting, vessel
viability was assessed using a standard start procedure (see Chapter 2 for details).
6.3.3. Protocol
Resistance arteries from the studies of type 1 and type 2 diabetes were subjected to
the same protocol in order to assess the influence of disease on vascular function.
Cumulative concentration-response curves were obtained using the receptor-
dependent agonists noradrenaline (NA; KT9-3xlO~5M) and endothelin-1 (ET-1; 10"' '-
3x10~7M) and the receptor-independent vasoconstrictor, potassium (K+; 10-125mM).
Responses to vasodilators were obtained following contraction of the artery with a
sub-maximal concentration of NA (3pM). Using this approach, cumulative
concentration-response curves were obtained for the receptor-dependent,
endothelium-dependent agonists acetylcholine (ACh; 10"9-3xl0"5M) and bradykinin
(BK; 10"10-3x10~6M), the receptor-independent, endothelium-dependent calcium
ionophore, A23187 (10"9-3xl0"6M) and the endothelium-independent vasodilator 3'-
morpholinosydnonimine (SIN-1; 10"9-3xl0"5M). These concentration-response
curves were always obtained in the same order (NA, ACh, BK, A23187, SIN-1, K+
and ET-1) with a washout period of 15-30min between each curve.
The influence of exposure to elevated glucose concentrations on resistance artery
function was assessed using a protocol based on experience gained using rat
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mesenteric arteries (Chapter 4). Arteries from patients with Type 1 diabetes and
matched controls were selected arbitrarily for incubation for lhr in PSS containing
either normal (5.5mM) or elevated (20mM) concentrations of glucose. The
incubation medium was changed every 30min and, before continuation of the
protocol, the arteries were contracted for 3min with NA-K to confirm viability. The
vessels were then exposed to vasoconstrictors and vasodilators using the protocol
described above. Appropriate glucose concentrations were maintained for the
duration of the experiment. After each CCRC, the contents of the bath were replaced
four times with fresh PSS, containing the appropriate concentrations of glucose, and
a 20min washout period was allowed between each CCRC.
6.3.4. Statistics
All values are mean ± s.e.mean for n experiments, where n represents the number of
subjects. Contractile responses are expressed as force per unit length of tissues
(mN/mm) and as a percentage of the maximum response to the final stimulation with
NA-K (% NA-K). Relaxation is expressed as a percentage relaxation of the initial
precontraction with NA. Sensitivity values were obtained by fitting the Hill equation
to the data using curve fitting software (Fig P, Biosoft, Cambridge, UK). Sensitivities
are expressed as the negative logarithm of the concentration of the agonist required
to produce 50% of the maximum effect (pD2 for vasoconstrictors, -loglCso for
vasodilators). Comparison of maximum responses and sensitivities was analysed




All salts were obtained from BDH (Poole, Dorset, U.K.). Noradrenaline
hydrochloride, acetylcholine chloride, bradykinin acetate salt and A23187 free acid
were obtained from Sigma (Poole, Dorset, U.K.). Endothelin-1 and 3'-
morpholinosydnonimine were obtained from Alexis (Nottingham, U.K.). Stock
"3
solutions (10" M) were prepared by dilution with distilled water for all drugs except
endothelin-1 which was initially dissolved in 50% methanol to give a 10"5M stock
solution and A23187 which was initially dissolved in ethanol to give 10"4M stock
solution. Subsequent dilutions were made in distilled water and final bath
concentrations of methanol and ethanol did not exceed 1.5% and 3% v/v,
respectively. Stock solutions were frozen as 1ml aliquots at -20°C and thawed as
required. Any residual solution was discarded at the end of the experiment.
6.4. Results
6.4.1 Type 1 Diabetes
Type 1 diabetic patients were evenly matched for age, sex, blood pressure, serum
cholesterol and serum triglycerides (Table 6.1). As expected, HbAlc and glucose
were significantly higher in type 1 diabetic patients compared with controls (Table
6.1). With one exception, the patients with type 1 diabetes had no history of
macrovascular or microvascular complications, nor any evidence of retinopathy or
neuropathy. One patient had evidence ofproliferative retinopathy, but no elevation of
albumin/creatinine ratio. Urinary albumin/creatinine ratios for the type 1 diabetic
patients (1.1 l±0.26mg/mmol, n=12) were within the normal range (0.0-
3.5mg/mmol), indicating normal renal function. The gluteal resistance arteries
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Table 6.1. Baseline characteristics of control subjects and patients with type 1
diabetes.
CONTROL Type 1 P
Age (yrs) 31.5±2.2 32.3+1.9 0.78
Duration type 1 Diabetes (yrs) - 13.9+2.5 -
Blood Pressure (mmHg) Systolic 122.6+2.7(10) 121.3+3.3 0.78
Diastolic 79.2±2.4 (10) 77.1+2.1 0.51
Glucose (mmol/1) 4.85+0.07 (11) 13.84+1.84(10) <0.0001
Glycosylated Hb (%) 5.48+0.11 9.38+0.35 <0.000001
Serum Cholesterol (mmol/1) 4.55+0.36 (11) 5.25+0.28 0.13
Serum Triacylgycerol (mmol/1) 1.17+0.19 (11) 1.72+0.38 0.22
Serum Creatinine (pmol/1) 75.6+3.6 (11) 68.8+2.4 0.12
Serum Albumin (g/1) 42.08±0.63 38.42+3.34 0.38
Urea (mmol/1) 3.98±0.34 4.23+0.19 0.52
Values are mean ± s.e.mean. All values are for 12 observations except when
indicated otherwise by n values quoted in parentheses, (n). Hb, haemoglobin;
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isolated from patients (mean internal diameter 224±22pm) and controls (195±9pm)
were similar in size (P=0.24).
6.4.1.1. Responses to Vasodilators
The four vasodilators used in this study all evoked concentration-dependent
relaxation in arteries from both patients and controls following contraction with a
sub-maximal concentration of NA. ACh, BK and SIN-1 all produced approximately
100% relaxation in arteries isolated from patients and controls. A23187 produced a
smaller (60-70%) relaxation than the other three vasodilators and did not achieve a
definite maximum in the concentration range used (Figure 6.1.). The presence of type
1 diabetes had no apparent influence on vasodilator responsiveness as the size and
sensitivity of the relaxations to ACh, BK, SIN-1 and A23187 were not different in
arteries from patients compared with controls (Table 6.2). Responses to vasodilators
in the three type 1 diabetic patients taking oral contraceptives were not different from
those obtained with the rest of the group.
6.4.1.2. Responses to Vasoconstrictors
All the arteries produced concentration-dependent contractions in response to the
vasoconstrictors ET-1, NA and K+. Arteries isolated from patients with type 1
diabetes demonstrated a significantly increased sensitivity to ET-1 compared with
controls, but no alteration in the maximum contraction (Figure 6.2b, Table 6.3)). In
contrast, size and sensitivity of contractile responses to NA and KPSS were similar
in arteries isolated from patients with type 1 diabetes and control subjects (Figures
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Figure 6.1. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh; n=12), (b) bradykinin (BK; n=8), (c) A23187 (n=8-10) and
(d) SIN-1 (n=l 1-12) in human resistance arteries isolated from patients with type
1 diabetes (O) and from non-diabetic controls (■). Results as expressed as %
relaxation of vessels initially precontracted with 3pM NA and shown as mean ±
s.e.mean.
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Table 6.2. Maximum relaxation (% reversal of 3pM NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to the
vasodilator agonists in arteries from patients with type 1 diabetes and controls.
Maximum Relaxation (%) Sensitivity (-logIC5o)
Control Type 1 P Control Type 1 P
ACh 97.2±1.0 95.8±1.8 0.50 7.30±0.09 7.23+0.12 0.63
BK 94.3±2.2 (8) 91.7±1.9 (8) 0.38 7.6910.15 (8) 7.93+0.15 (8) 0.29
A23187 73.3±3.2 (10) 61.2±12.3 (8) 0.12 5.3710.17(10) 6.1010.16(8) 0.61
SIN-1 93.8±4.4 95.5±3.2 0.76 5.8710.21 6.2210.22 0.26
All values are mean ± s.e.mean, n=8-12, unless indicated otherwise by values in
parentheses. Sensitivity values for A23187 are an approximate as the response to this
agonist did not reach a maximum in the concentration range used. ACh,
acetylcholine, BK, bradykinin, SIN-1, 3'morpholinosydnonimine.
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Figure 6.2. Cumulative concentration-response curves to vasoconstrictor agonists (a)
endothelin-1 (ET-1), (b) noradrenaline (NA) and (c) potassium (K+) in human
resistance arteries isolated from patients with type 1 diabetes (□) and non-
diabetic controls (■). Each point represents mean ± s.e.mean, n=12.
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Table 6.3. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated from
patients with type 1 diabetes and non-diabetic controls.
(a)
Maximum Contraction (niN/mm) Maximum Contraction (%NA-K)
Control Type 1 P Control Type 1 P
NA 3.97±0.54 4.05±0.71 0.93 115.4±3.2 108.3±2.4 0.09
K+ 2.67±0.47 3.26±0.61 0.46 71.9±6.7 85.0±7.7 0.21
ET-1 3.39±0.39 3.84±0.65 0.56 103.7±5.9 104.5±6.0 0.92
All values are mean ± s.e.mean, n=12.
(b)
Sensitivity (pD2)
Control Type 1 P
NA 6.98+0.14 6.73+0.11 0.19
K+ 1.47+0.03 1.50+0.04 0.55
ET-1 8.35+0.13 8.87+0.12 0.008
All values are mean ± s.e.mean, n=12.
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6.4.2. Influence ofElevated Glucose Concentrations
The details of the control subjects and patients with Type 1 diabetes who provided
arteries for exposure to elevated glucose are given in Table 6.4). As with the larger
group, non-diabetic controls and diabetic patients were well matched but glucose and
glycosylated haemoglobin concentrations were elevated in the latter. Urinary
albumin/creatinine ratios for the type 1 diabetic patients (1.76±0.36mg/mmol) were
within the normal range (0.0-3.5mg/mmol), indicating normal renal function. The
gluteal resistance arteries isolated from patients (mean internal diameter control
incubation, 284±28pm; glucose incubation, 268+22pm) were larger than those
obtained from controls (control incubation, 187±17pm, P=0.016; glucose incubation,
190±29pm, P=0.05).
6.4.2.1. Responses to Vasodilators
Incubation with 20mM glucose for 1 hour did not alter the ability of resistance
arteries from control subjects to respond to either the endothelium-dependent (ACh,
BK) or -independent (SIN-1) vasodilators (Figure 6.3; Table 6.5a). Endothelium-
dependent relaxation was also unaffected in arteries from patients with type 1
diabetes following exposure to elevated glucose, whereas the sensitivity of these
vessels to SIN-1 was enhanced (Figure 6.4; Table 6.5b).
6.4.2.2. Responses to Vasoconstrictors
Incubation with 20mM glucose had no effect on the contractile responses of arteries
from non-diabetic controls (Figure 6.5; Table 6.6) and patients with type 1 diabetes
(Figure 6.6; Table 6.7).
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Table 6.4. Characteristics of non-diabetic control subjects (n=6) and patients with
type 1 diabetes (n=8) who provided vessels for incubation with control (5.5mM)
and elevated (20mM) glucose.
CONTROL Type 1 P
Age (yrs) 28.5±2.6 30.5+1.5 0.49
Duration type 1 Diabetes (yrs) - 9.8+2.3 -
Blood Pressure (mmHg) Systolic 120.0±4.09 120.2+4.7 0.97
Diastolic 74.8±2.8 74.9+0.99 0.99
Glucose (mmol/1) 4.82±0.10 14.31+1.71 <0.0005
Glycosylated Hb (%) 5.02±0.20 9.45+0.46 <0.000005
Serum Cholesterol (mmol/1) 4.47+0.70 5.24+0.31 0.29
Serum Triacylgycerol (mmol/1) 1.12+0.31 1.89+0.54 0.29
Serum Creatinine (pmol/1) 74.5+2.7 66.9+3.4 0.12
Serum Albumin (g/1) 43.67+1.43 36.71+5.81 0.30
Urea (mmol/1) 4.58+0.26 4.63+0.37 0.93
Values are shown as mean ± s.e.mean.
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Figure 6.3. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh), (b) bradykinin (BK) and (c) SIN-1, in resistance arteries
isolated from healthy volunteers and incubated in the presence of 5.5.mM
(Control, ■ n=6) or 20mM (□, n=6) glucose. Results as expressed as %
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Figure 6.4. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine (ACh), (b) bradykinin (BK) and (c) SIN-1 in resistance arteries
isolated from patients with type 1 diabetes incubated in the presence of 5.5mM
(•; control) and 20mM (O; elevated) glucose. Results are expressed as %
relaxation of vessels initially precontracted with 3pM NA and shown as mean ±
s.e.mean, n=8.
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Table 6.5. Maximum relaxation (% reversal of 3pM NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to the
vasodilator agonists in arteries from (a) non-diabetic control subjects (n=6) and
(b) patients with type 1 diabetes (n=8) after incubation with either normal (5mM)
or elevated (20mM) glucose.
(a) Non-Diabetic Controls
Maximum Relaxation (%) Sensitivity (-logIC5o)
Normal Glucose High Glucose P Normal Glucose High Glucose P
ACh 98.6±1.0 94.6+1.9 0.09 7.45+0.22 7.43+0.20 0.94
BK 93.2±3.3 92.9+1.5 0.94 8.06+0.12 8.10+0.16 0.86
SIN-1 97.7±1.0 95.0+2.1 0.26 6.46+0.18 6.28+0.14 0.46
(b) Type 1 Diabetics
Maximum Relaxation (%) Sensitivity (-logIC50)
Normal Glucose High Glucose P Normal Glucose High Glucose P
ACh 98.6+2.1 95.2+1.8 0.25 7.35+0.20 7.36+0.16 0.94
BK 94.0+1.7 93.4+2.0 0.36 8.04+0.19 7.89+0.13 0.52
SIN-1 99.2+1.0 95.1+3.1 0.24 6.81+0.17 6.32+0.11 0.03












Figure 6.5. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-l and (c) high potassium, in resistance arteries
isolated from healthy volunteers and incubated in the presence of 5.5.mM
(Control, ■ n=6) or 20mM (□, n=6) glucose for 1 hour. Results are expressed as
force per unit length of tissues (mN/mm) and shown as mean ± s.e.mean.
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Table 6.6. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated from
non-diabetic controls incubated with either normal (5mM) or high (20mM)
glucose for 1 hour.
(a)
Maximum Contraction (mN/mm) Maximum Contraction (%NA-K)
Normal High P Normal High P
NA 4.75+0.93 3.34+1.01 0.33 108.3±5.5 112.6±19.1 0.84
K+ 3.72±0.73 3.16+0.88 0.63 84.5±6.0 116.6±30.0 0.31
ET-1 4.09±0.84 3.41+0.92 0.60 94.1±6.8 135.3±41.3 0.34
All values are mean ± s.e.mean, n=6.
(b)
Sensitivity (pD2)
Normal Glucose High Glucose P
NA 6.81+0.18 6.55+0.16 0.32
K+ 1.47+0.04 1.48+0.02 0.69
ET-1 8.31+0.20 8.49+0.19 0.52












Figure 6.6. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-1 and (c) high potassium, in resistance arteries
isolated from patients with type 1 diabetes and incubated in the presence of
5.5.mM (Control, O n=8) or 20mM (#, n=8) glucose. Results are expressed as
force per unit length of tissues (mN/mm) and shown as mean ± s.e.mean.
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Table 6.7. Maximum contraction (a) and sensitivity (b) values from concentration-
response curves obtained to the vasoconstrictor agonists in arteries isolated from
patients with type 1 diabetes incubated with either normal (5mM) or high
(20mM) glucose for 1 hour.
(a)
Maximum Contraction (mN/mm) Maximum Contraction (%NA-K)
Normal High P Normal High P
NA 4.80±0.69 5.00±0.47 0.81 104.9±2.3 113.0±6.0 0.23
K+ 4.33±0.66 4.10±0.57 0.79 95.4+5.7 87.8±3.6 0.28
ET-1 4.70±0.63 4.87±0.70 0.86 105.9±6.5 106.4+4.25 0.95
All values are mean ± s.e.mean, n=8.
(b)
Sensitivity (pD2)
Normal Glucose High Glucose P
NA 6.67+0.15 6.87+0.12 0.32
K+ 1.48+0.02 1.49+0.02 0.87
ET-1 8.77+0.21 8.57+0.21 0.51
All values are mean ± s.e.mean, n=8.
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6.4.3. Type 2 Diabetes
Type 2 diabetic patients were well matched with their controls in all respects, with
the single exception that HbAlc levels were slightly, but significantly, elevated in
the diabetic group (Table 6.8). The resistance arteries isolated from gluteal biopsies
taken from patients (mean internal diameter, 161+1Opm) were similar in size
(P=0.13) to those isolated from controls (190+14pm).
6.4.3.1. Responses to Vasodilators
In accordance with the study of type 1 diabetes, there was no evidence of endothelial
cell dysfunction in resistance arteries from patients with type 2 diabetes. The
responses produced by ACh, BK, and A23187 were similar in arteries from patients
with type 2 diabetes and controls (Figure 6.7; Table 6.9). There was a tendency
towards a reduced response (maximum relaxation and sensitivity) to SIN-1 in arteries
from diabetic patients but this did not achieve significance (Figure 6.7; Table 6.9).
6.4.3.2. Responses to Vasoconstrictors
The magnitude of contraction (Emax) produced in arteries from patients with type 2
diabetes tended to be smaller than those produced in control arteries for all three
vasoconstrictors (Figure 6.8). This difference, however, only achieved significance in
the case of potassium. The presence of type 2 diabetes had no effect on sensitivity to
vasoconstrictors, with no evidence of an increase in sensitivity to ET-1 similar to that
seen in patients with type 1 diabetes.
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Table 6.8. Baseline characteristics of 8 male patients with type 2 diabetes and 10 age
and sex-matched non-diabetic control subjects.
CONTROL Type 2 P
Age (yrs) 62.1±2.3 58.9+2.4 0.36
Sex (M:F) 10:0 8:0
Smoker (Y:N) 2:8 4:4
Blood Pressure (mmHg) 135.30+4.18 138.75+4.09 0.93
78.70±2.57 77.50+2.47 0.50
BMI 28.03±0.61 26.78+1.09 0.31
Glucose (mmol/1) 5.41+0.25 6.31+0.76 0.29
HbAlc (%) 6.11+0.15 6.63+0.19 0.046
Triglycerides (mmol/1) 2.11 ±0.42 2.84+0.41 0.23
Cholesterol (mmol/1) 5.19+0.14 4.91+0.24 0.31
Values are shown as mean ± s.e.mean. BMI, body mass index;
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Figure 6.7. Cumulative concentration-response curves to the vasodilator agonists (a)
acetylcholine, (b) bradykinin, (c) A23187 and (d) SIN-1 in human resistance
arteries isolated from patients with type 2 diabetes (O, n=8) and non-diabetic
controls (■, n=10). Results as expressed as % relaxation of vessels initially
precontracted with 3pM NA and shown as mean ± s.e.mean.
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Table 6.9. Maximum relaxation (% reversal of 3pM NA-induced tone) and
sensitivity (-LoglCso values) from concentration-response curves obtained to the
vasodilator agonists in the arteries from patients with type 2 diabetes and
controls.
Maximum Relaxation (%) Sensitivity (-loglCso)
Control Type 2 P Control Type 2 P
ACh 95.9±2.0 99.4+1.4 0.19 7.28+0.10 7.37+0.06 0.48
BK 90.7±3.2 93.0+4.1 0.67 7.64+0.16 7.54+0.16 0.67
A23187 78.4±6.7 79.6+10.5 0.92 6.22+0.07 6.52+0.16 0.10
SIN-1 99.5±1.1 94.7+2.3 0.06 6.43+0.13 6.05+0.14 0.07
All values are mean ± s.e.mean, n=8-12, unless indicated otherwise by values in
parentheses. Sensitivity values for A23187 are an approximate as the response to this
agonist did not reach a maximum in the concentration range used. ACh,
acetylcholine, BK, bradykinin, SIN-1, 3'morpholinosydnonimine.
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Figure 6.8. Cumulative concentration-response curves to vasoconstrictor agonists (a)
noradrenaline (b) endothelin-1 and (c) high potassium, in resistance arteries
isolated from patients with type 2 diabetes (O, n=8) and non-diabetic controls
(■, n=10). Results are expressed as force per unit length of tissues (mN/mm)
and shown as mean ± s.e.mean.
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Table 6.10. Maximum contraction (a) and sensitivity (b) to vasoconstrictor agonists
in isolated resistance arteries from patients with type 2 diabetes (n=8) and non-
diabetic control subjects (n=10).
(a)
Maximum Contraction (mN/mm)
Control Type 2 P
NA 2.76±0.50 2.20±0.45 0.43
ET-1 2.61±0.39 1.79+0.33 0.14
K+ 2.43±0.42 1.04±0.17 0.01
(b)
Sensitivity (pD2)
Control Type 2 p
NA 6.66±0.09 6.71+0.18 0.80
ET-1 8.18±0.16 8.37+0.09 0.36
K+ 1.56±0.04 1.59+0.06 0.69
Values are expressed as mean ± s.e.mean. NA, noradrenaline, ET-1, endothelin-1.
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6.5. Discussion
This investigation has made two striking observations in resistance arteries isolated
from patients with diabetes: (1) there is a selective alteration of contractile function,
dependent on the type of diabetes and (2) endothelium-dependent (and endothelium-
independent) relaxation is unaffected by either type 1 or type 2 diabetes.
6.5.1. Type 2 diabetes
Endothelium-dependent and independent vasodilatation was assessed in resistance
arteries isolated from patients with type 2 diabetes and control subjects. In this
selected group of well-controlled type 2 patients, responses to receptor-dependent
(ACh, BK) and receptor-independent (A23187), endothelium-dependent dilators
were unaltered in the present study. These results contrast with previous findings
demonstrating reduced endothelium-dependent and independent responses in type 2
diabetic patients (McVeigh et al., 1992; Morris et al., 1995; Watts et al., 1996). This
discrepancy may be due to the inclusion of patients with more severe
hyperglycaemia and dyslipidaemia in previous studies, whereas this study included
only well-controlled type 2 patients. On the other hand, these findings are well in
agreement with previous studies demonstrating unaltered endothelium-dependent
relaxation in patients with uncomplicated type 2 diabetes (Avogaro et al., 1997;
Cockcroft et al., 1998). These results indicate, therefore, that overall, altered blood
insulin and glucose levels during the development and progression of type 2 diabetes
do not result in impaired function ofmicrovascular endothelium.
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The tendency towards a reduced response to the endothelium-independent
vasodilator, SIN-1, did not achieve significance; a factor which may be due to type 2
error, despite good group numbers (n=8 and 10), as the power to detect a difference
was 40-50%. Reduced responses to endothelium-independent dilators have been
reported in the forearm of patients with type 2 diabetes (McVeigh et al., 1992;
Morris et al., 1995). These results, however, contrast with the majority of studies in
which endothelium-independent relaxation is unaltered (Cockcroft et al., 1998;
Avogaro et al., 1997; Cipolla et al., 1996) or even enhanced (Lawrence et al., 1994).
Only the contractile responses to the receptor-independent vasoconstrictor K+ were
diminished significantly in resistance arteries from patients with Type 2 diabetes.
This was not due to a general inability of the smooth muscle cells to contract as
responses to the receptor-dependent vasoconstrictors, NA and ET-1, were not altered.
This observation is in agreement with previous studies in which contractile responses
evoked by K+ depolarization have been found to be reduced in diabetic vessels
(Fulton et al., 1991; Hattori et al., 1996). The diminished contractile response of
diabetic rat aorta to high K appears to be associated with reduced Ca influx
9+
through voltage-dependent Ca channels. Therefore, it is possible that activation of
Ca2+ channels by membrane depolarisation may be specifically impaired in diabetes.
6.5.2. Type 1 diabetes
A selective enhancement of the response to the endothelium-derived contracting
factor, ET-1, was detected in resistance arteries from patients with Type 1 diabetes.
Whilst altered receptor activity in the endothelium may contribute to this
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abnormality, it was strikingly evident that endothelium-dependent relaxation was
unaltered in these arteries. These results indicate that endothelial cell function is
largely maintained in sub-cutaneous resistance arteries from patients with Type 1
diabetes and no detectable microvascular complications.
Damage to the endothelium often results in increased release of ET-1. Consequently,
the elevated plasma (Takahashi et al., 1990) and tissue (Properzi et al., 1995)
concentrations of this peptide in patients suggest that damage to the endothelium is a
feature of Type 1 diabetes. Similarly, urinary concentrations of ET-1 are elevated
(Morabito et al., 1995), and its release from resistance arteries is enhanced (Takeda
et al., 1991), in diabetic rats whilst increased release of ET-1 possibly contributes to
the down-regulation of glomerular ET receptors (Awazu et al., 1991). The precise
role of ET-1 in the development of vascular complications, however, remains
unclear. Functional data obtained using arteries from diabetic rats are contradictory,
and there is evidence that the duration of diabetes has a significant impact on both
ET-1-mediated contraction and endothelial cell function (Hopfner & Gopalakrishnan,
1999).
The selective enhancement of ET-1-mediated contraction in arteries from patients
with Type 1 diabetes suggests altered function of the ET receptors in the endothelium
and /or smooth muscle cells. This contrasts with studies using diabetic animals in
which increased ET-1-mediated contraction was just one component of a non¬
specific enhancement of contractile function, possibly mediated by altered second
messenger activity (White & Carrier, 1990; Hopfner et al., 1999). Unaltered
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responses to NA and KPSS in the present study indicated that vascular remodelling,
or a general abnormality in second messenger systems, were not responsible for the
increased response to ET-1. Endothelium-derived relaxing factors have a modulatory
effect on ET-1-mediated contraction of human sub-cutaneous resistance arteries
(Buckley et al., 2002). The current investigation suggests that this function of the
endothelium has been lost in arteries from patients with Type 1 diabetes. As the
ability of the endothelium to mediate relaxation was not impaired, this may suggest
down-regulation of endothelial ETB receptors. This is strikingly similar to results
obtained using resistance arteries from patients with hypertension (Angus et al.,
1992) and normal pressure glaucoma (Buckley et al., 2002). Alternatively, the
enhanced ET-l-mediated contraction may be a consequence of up-regulation of ETA
and/ or ETB receptors on the vascular smooth muscle cells. Further studies would be
required to identify the exact mechanism(s) responsible for the enhanced response to
ET-1.
The demonstration of unaltered responses to NA is consistent with data obtained in
the isolated fore-arm (Calver et al., 1992; Johnstone et al., 1993) and in resistance
arteries from patients with Type 1 diabetes (Malik et al., 1999). Increased All-
mediated contraction in the latter supports the contention that contractile
abnormalities detected in these arteries are the result of specific alterations in
receptor function. Furthermore, although a non-specific reduction in contractile
function (using NA, All and KPSS) has also been reported in resistance arteries this
may have been due to a slightly (but not significantly) lower media-lumen ratio in
arteries from the diabetic group (McNally et al., 1994).
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Endothelial cell dysfunction in animal models of diabetes has been indicated by
impaired endothelium-dependent relaxation in conduit and resistance arteries (Chan
et al., 2000). Similar abnormalities have also been reported in the fore-arm
(Johnstone et al., 1993) and brachial arteries (Zenere et al., 1995) of patients with
Type 1 diabetes. These results are challenged, however, by similar investigations
which have found responses to endothelium-dependent relaxants to be unchanged
(Smits et al., 1993; Lambert et al., 1996) or even enhanced (Makimattila et al.,
1997). The unaltered responses to receptor-dependent (ACh, BK) and receptor-
independent (A23187), endothelium-dependent dilators in the present study
demonstrated that endothelium-dependent relaxation was not impaired. Furthermore,
the maintained response to SIN-1 indicated that the ability of the vascular smooth
muscle to relax was similarly unaffected. These results are consistent with studies in
which endothelium-dependent relaxation in the human fore-arm is only impaired in
diabetes if patients also exhibit microalbuminuria (Calver et al., 1992; Smits et al.,
1993; Elliot et al., 1993). Furthermore, relaxation in response to NO donors (usually
sodium nitroprusside) has been shown repeatedly (although not exclusively (Malik et
al., 1999; Calver et al., 1992)) to be unaltered in patients with this condition
(Johnstone et al., 1993; Smits et al., 1993; Lambert et al., 1996; Elliot et al., 193).
Therefore, it is probable that impaired endothelium-derived nitric oxide activity in
the microvasculature is restricted to patients with evidence of nephropathy. This
would correspond with the demonstration that microvascular permeability is only
increased in patients with long-standing Type 1 diabetes if they also have severe
microvascular complications (Jaap et al., 1996).
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These results challenge a previous demonstration that ACh-mediated relaxation is
selectively impaired in resistance arteries isolated from patients with Type 1 diabetes
(McNally et al., 1994). The difference between these studies is unlikely to be due to
differences in disease duration in diabetic groups. The duration of diabetes in the
group with impaired ACh-mediated relaxation (18yrs) was shorter than in patients
who demonstrated normal responses to this agonist (24 yrs). In contrast to the present
study, the patient group used by McNally et al. (1994) had evidence ofmicrovascular
complications (retinopathy), possibly indicating that endothelium-dependent
relaxation is only altered in patients with both diabetes and microvascular disease.
Methodological variations are, however, a more likely reason for these discrepant
results. In particular, the functional difference detected between large and small
resistance arteries obtained from sub-cutaneous biopsies (Chapter 5) may be
important. The inadvertent inclusion of a small number of these arteries in the
diabetic group could explain both the specific reduction in ACh-mediated relaxation
and the variable size and sensitivity of this response reported in the study by
McNally et al. (1994).
6.5.2.1. Influence of Elevated Glucose Concentrations
Incubation of human sub-cutaneous resistance arteries with elevated glucose
demonstrated that arteries from non-diabetic controls and patients with type 1
diabetes responded differently to glucose exposure.
Incubation with elevated glucose had no effect on either contractile or relaxation of
arteries from non-diabetic controls. The inability of glucose exposure to impair
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endothelium-dependent relaxation contrasts with studies using rat mesenteric artery
(Taylor & Poston, 1994) and rabbit aorta (Tefamariam et al., 1990). As discussed
previously, this lack of effect may be a result of the short incubation time (lhr), the
relatively low concentration of glucose (20mM rather than the 40mM concentrations
used in some studies; Heygate et al., 1993), or the contribution of EDHF to
relaxation of resistance arteries (see Chapter 5). It should also be noted that 20mM
glucose failed to cause a significant change in reactivity of rat mesenteric arteries;
therefore, it would be interesting to assess the influence of 15mM or 44mM glucose
but there were not enough vessels available. The presence of type 1 diabetes had no
effect on the influence of elevated glucose on contraction or endothelium-dependent
relaxation of resistance arteries. This indicated, therefore, that the sensitivity of
contractile function and endothelium-dependent relaxation to glucose exposure was
not altered in resistance arteries from patients with diabetes.
The demonstration that resistance arteries from patients with type 1 diabetes were
more sensitive than controls to ET-1 was striking given the reduction in sensitivity to
this agonist following incubation of rat mesenteric arteries with elevated glucose
(Chapter 4). One possibility is that the inhibitory effect of hyperglycaemia in vivo
causes a compensatory enhancement of the response to ET-1 which becomes
apparent in isolated vessels in vitro. It was hypothesised, therefore, that the
combination of the inhibitory effect of glucose with the enhanced contractility in
diabetic arteries would return the sensitivity of resistance arteries from patients with
type 1 diabetes towards control values. In fact, however, glucose did not alter ET-1
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mediated contraction of human resistance arteries and had no ameliorating effect on
the enhanced sensitivity to this agonist in arteries from the diabetic group.
The only difference in the response of resistance arteries from diabetic patients and
controls to elevated glucose was observed with the endothelium-independent
relaxation induced by SIN-1. The enhanced sensitivity to SIN-1 in the presence of
glucose suggests an increased sensitivity of the vascular smooth muscle. The
mechanisms through which exposure to glucose would enhance peroxynitrite-
mediated relaxation are not clear and would require further investigation.
6.5.3. Conclusions
The work reported in this chapter has shown that the presence of diabetes is
associated with altered contractile function in subcutaneous resistance arteries. The
nature of this alteration is vasoconstrictor-selective and depends upon whether the
patient has type 1 or type 2 diabetes. The enhanced response to ET-1 in the type 1
study may be caused by an impairment of the ability of the endothelium to modulate
the response to this agonist. It was striking that a short-term elevation of glucose
concentration had no effect on ET-1-mediated contraction (in cither diabetic or
control subjects) suggesting that the altered response to this agonist is not the result
of acute hyperglycaemia. In contrast, the reduction in potassium-mediated
contraction in the type 2 diabetic group suggests an alteration in contractile
regulation within the smooth muscle cells. Arguably the most striking result is the
demonstration that endothelium-dependent relaxation is not impaired in either form
of diabetes. This contrasts with large vessel studies which generally report impaired
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NO activity. It is possible, therefore, that the EDHF-mediated component of
relaxation in small arteries protects against the endothelial cell dysfunction caused by
diabetes in conduit arteries. The possibility that the balance of endothelium-derived
relaxing factors has altered in patients with type 1 diabetes is supported by the
demonstration that SIN-1-mediated relaxation was sensitive to elevated glucose in
resistance arteries fromO these patients. It remains possible that endothelial cell
function is altered in resistance arteries in other vascular territories and also in sub¬





Type 1 and Type 2 diabetes mellitus are associated with abnormal vascular function,
but few studies have documented their effects on human resistance arteries. The
primary aim of the research described in this thesis was to determine whether
endothelial cell and vascular smooth muscle cell function were altered in resistance
arteries isolated from patients with these conditions. The results from this
investigation clearly demonstrated normal endothelium-dependent and endothelium-
independent relaxation in resistance arteries from both Type 1 and Type 2 diabetic
subjects. In contrast, however, there was a selective alteration of contractile function,
which was dependent on the type of diabetes. Arteries isolated from Type 1 diabetic
patients demonstrated a selective enhancement of ET-1 -induced contraction, whilst a
selective attenuation of contractile responses to K+ was demonstrated in arteries
isolated from patients with Type 2 diabetes. The variable results between the two
groups could be attributed not only to the different type of diabetes but also to
variations in a number of factors, and may be partially explained by differences in
the duration and degree of the diabetic state, degree of acute hyperglycaemia, age
and lipid profile.
The enhanced ET-1-mediated contraction in arteries from patients with type 1
diabetes contrasted with the ability of elevated glucose to inhibit such contractions in
rat mesenteric arteries. Short-term exposure of arteries from type 1 diabetic patients
to 20mM glucose did not, however, normalise the response to ET-1 in these vessels.
This suggests that the enhanced contractility in these patients is not simply an
adaptive response to an inhibitory effect of short-term hyperglycaemia.
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The demonstration of unaltered endothelium-dependent relaxation suggests that
endothelial cell function is largely intact in arteries from patients with established,
but well controlled, diabetes. This contrasts directly with the general consensus that
the ability of the endothelium to mediate vascular relaxation is impaired in large
conduit arteries from patients and animals with diabetes mellitus. Receptor
populations differ in arteries of different anatomical origin and, perhaps more
importantly, the factors that contribute to endothelium-dependent relaxation differ in
large compared with small vessels. This investigation confirmed functional
differences between large and small resistance arteries obtained from biopsies of
human, subcutaneous, gluteal fat, with large resistance arteries unable to relax in
response to the endothelium-dependent vasorelaxant, ACh. These results indicate a
heterogeneity in endothelial cell function between large and small resistance arteries
from human gluteal fat, which may be the result of variations in receptor population.
This emphasises the need to ensure careful selection of arteries from this source,
which can be achieved using physical and functional criteria identified, when
performing functional investigations. Relaxation in response to ACh results from the
release of relaxing factors following stimulation of muscarinic receptors on the
endothelium. In large conduit arteries, endothelium-dependent relaxation is mediated
almost exclusively by NO, whereas in smaller arteries, both NO and EDHF may
contribute. This investigation demonstrated that ACh-induced endothelium-
dependent relaxation of human subcutaneous resistance arteries is mediated by both
NO-dependent and NO-independent pathways. The NO/PG-independent response to
ACh, which accounted for the majority of the relaxation to ACh, had characteristics
consistent with EDHF-mediated relaxation. It is probable that the impaired
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endothelium-dependent relaxation generally observed in large conduit arteries in
diabetes results from reduced NO activity/availability. This attenuation was not
observed in resistance vessels in the present study and is probably due to the fact
that, unlike large conduit arteries, NO has a limited role as a mediator of
endothelium-dependent relaxation in these vessels.
The exact nature of vascular alterations in diabetes is not completely understood.
However, it has been demonstrated that strict glycaemic control is associated with a
reduced risk of microvascular complications, suggesting that hyperglycaemia may be
an initiating factor in the development of such complications. A number of studies
have demonstrated that exposure of large conduit to high glucose concentrations
reduces ACh-induced endothelium-dependent relaxation. In the present study,
however, endothelium-dependent and -independent relaxation was not altered
following exposure of rat mesenteric, or human subcutaneous, resistance arteries to
acute elevations of glucose. This may be due to the different vessel types studied and
the fact that the pathways implicated in hyperglycaemia-induced endothelial cell
dysfunction, including the polyol pathway, free radicals, protein kinase C, all reduce
NO-mediated relaxation. The observation that NO plays a limited role in the
relaxation of resistance arteries may, therefore, account for the lack of effect of
hyperglycaemia on endothelial cell function in the present study. The presence of
type 1 diabetes did not alter the sensitivity of endothelium-dependent relaxation to
glucose exposure in human resistance arteries, but did affect endothelium-
independent relaxation. This suggested a change in signalling pathways within the
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vascular smooth muscle and may indicate that the balance of endothelium-derived
relaxing factors was altered in this condition.
The use of resistance arteries provides a valuable tool to investigate in vitro the
physiological and pharmacological control of the vasculature and the mechanism
responsible for altered vascular function in disease states. The requirement that blood
vessels must be freshly isolated restricts the number of investigations which can be
performed on vessel segments from a single animal and is even more problematic
when using human vessels, as the availability of such vessels can be both irregular
and unpredictable. Therefore, it would be advantageous if vessels could be stored
prior to experimentation without adversely affecting vascular function. Using a
readily available source of tissue, this study has clearly demonstrated that rat
mesenteric resistance arteries maintain stable responsiveness to vasoconstrictors and
the endothelium-dependent and endothelium-independent vasodilators, ACh and
SIN-1, respectively, when stored for up to four days in a simple PSS medium at 4°C.
This straightforward and reliable method should allow more efficient use of animal
tissues in the future and maximise the number of experiments which can be
performed using vessels from a human source.
In conclusion, these studies have demonstrated that, in contrast to conduit arteries,
endothelium-dependent relaxation is not impaired in resistance arteries isolated from
patients with either complication-free, type 1 or well-controlled, type 2 diabetes
mellitus. Investigation of the mechanisms of endothelium-dependent relaxation in
normal vessels of this size suggested that the contribution made by the endothelium-
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derived hyperpolarizing factor protects against diabetes-induced impairment in NO
activity. Furthermore, although distinct changes in contractile function were detected
in type 1 and type 2 diabetic groups, these changes did not mimic the contractile
changes induced by exposure to elevated glucose concentrations in vitro. This
demonstrates that the functional changes in resistance vessels from diabetic patients
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Abstract
Few studies using human subcutaneous resistance arteries acknowledge the possibility of functional heterogeneity in these vessels. Large
(~500 pm) and small (>200 pm) resistance arteries («=11) and veins (n = 5) were identified using physical, structural and functional
criteria in 14 biopsies of human gluteal fat. Endothelium-dependent relaxation was not evident in veins, while, unlike small resistance arteries
(Anax 95.74± 1.86%; — log IC50 7.28 ±0.09), large resistance arteries with an intact endothelium failed to respond to acetylcholine. These
results suggest that large resistance arteries may lack muscarinic receptors on the endothelium and emphasise the importance of careful vessel
selection and characterisation in studies using human resistance arteries. © 2001 Elsevier Science Inc. All rights reserved.
Keywords: Endothelium; Human resistance arteries; Acetylcholine; Vascular reactivity
1. Introduction
Isolated vessel studies have consistently shown that the
development of cardiovascular disease is associated with
impaired function of the endothelium (Vanhoutte, 1989;
Chan et al., 2000). Many of these investigations have used
vessels isolated from experimental animals, but since the
introduction of the small vessel myograph, an increasing
number of studies have been performed using arteries from
human subcutaneous fat. This approach has the advantage of
studying vascular reactivity directly in vessels from patients
and uses resistance arteries, which contribute significantly to
maintenance of blood pressure (Mulvany and Aalkjaer,
1990). Human subcutaneous resistance arteries have now
been used to investigate vascular dysfunction in a variety of
conditions, including hypertension (Angus et al., 1992),
diabetes (McNally et al., 1994; Cipolla et al., 1996; Mclntyre
et al., 1998a,b), glaucoma (Buckley et al., 1999), pre-
Corresponding author. Tel.: +44-131-537-1742; fax: +44-131-537-
1012.
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eclampsia (Aalkjaer et al., 1985), congestive heart failure
(Angus et al., 1993), hypercholesterolaemia (Lewis et al.,
1998) and Raynaud's disease (Smith et al., 1999).
In many studies, endothelium-dependent relaxation of
human gluteal resistance arteries is assessed using acet¬
ylcholine (ACh). This method has limitations, however, as
an early investigation demonstrated that, unlike small res¬
istance arteries (internal diameter <200 pm), large resist¬
ance arteries (internal diameter ~ 500 pm) from this source
fail to respond to ACh despite having an intact endothelium
(Angus et al., 1992). The mechanism responsible for this
functional variation was not identified, but could result from
heterogeneity in receptor populations and/or endothelium-
derived relaxing factor activity (Vanhoutte and Miller, 1985;
Shimokawa et al., 1996; Ohkubo and Chiba, 1988). This
variation in ACh-mediated relaxation in human gluteal
resistance arteries has significant implications for studies
of disease pathogenesis, particularly those which identify a
selective impairment in the responsiveness to ACh
(McNally et al., 1994; Lewis et al., 1998). Surprisingly,
however, many studies do not address the possibility that
ACh-insensitive resistance arteries may have been included
in functional investigations. This may be due to a lack of
0306-3623/00/$ - see front matter © 2001 Elsevier Science Inc. All rights reserved.
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awareness as functional heterogeneity in human subcuta¬
neous resistance arteries has not been investigated in detail
and is referred to only indirectly in a study of hypertension
(Angus et al., 1992). Consequently, the aims of this invest¬
igation were (1) to identify the mechanisms responsible for
the inability of large resistance arteries to relax following
stimulation with ACh, and (2) to describe a simple proced¬
ure to aid selection of the appropriate artery from the
different vessels isolated from human gluteal fat.
2. Materials and methods
This investigation made use of surplus vessels isolated
from biopsies taken for the study of vascular function in
insulin-dependent diabetes mellitus (IDDM), noninsulin-
dependent diabetes mellitus (NIDDM) or normal pressure
glaucoma (NPG). Biopsies were taken from 14 individuals
(age 58±2 years; range 43-69 years; sex 12 males, 2
females) who were either control subjects (n = 5) or were
suffering from NIDDM (« = 5), IDDM (« = 2) or NPG
(« = 2). We have previously shown that functional
responses of resistance arteries to noradrenaline (NA),
ACh, bradykinin (BK) and the nitric oxide donor 3'-
morpholinosydnonimine (SIN-1) are not altered in patients
with these conditions (Mclntyre et al., 1998a,b; Buckley
et al., 1999). All functional experiments were performed
on the day following biopsy, and preliminary studies (data
not shown) confirmed that responses to ACh and BK, but
not those to SIN-1, were abolished following removal of
the endothelium. The patients and controls enrolled for
these studies all provided informed, written consent and
the procedure was approved by the Lothian Research
Ethics Committee.
A biopsy of skin and subcutaneous fat [approximately 2
(L) x 1 (W) x 1 (H) cm] was taken under local anaesthesia
from the gluteal region of each individual (5 ml of 2%
lignocaine hydrochloride; Astra, Hertfordshire, UK). Ves¬
sels were dissected from these biopsies using light micro¬
scopy and were identified as either small resistance
arteries, large resistance arteries or veins by their distinct¬
ive physical characteristics: small resistance arteries have a
smooth adventitial surface, maintain their shape when
removed from physiological salt solution (PSS) and the
vessel wall is sufficiently transparent to allow distinction
between the media and lumen (Fig. la(i)); this contrasts
with veins which have a "furry" adventitial margin, do not
maintain their shape (i.e., they "roll up") when removed
from PSS and in which the margin between media and
lumen cannot be distinguished through the vessel wall
(Fig. lb(i)); large resistance arteries are identified by their
greater diameter, compared with small resistance arteries.
They maintain their shape when removed from PSS, but,
unlike small resistance arteries, have a "furry" adventitial
surface and the wall is not sufficiently transparent to allow
distinction between media and lumen (Fig. lc(i)). Mor¬
phological and functional studies were also performed on
veins to allow direct comparison with large and small
arteries. Although large and small diameter veins were
isolated, functional and morphological studies were per¬
formed using only those which were similar in size to the
small resistance arteries (Fig. 1).
2.1. Drugs
All salts were obtained from BDH (Poole, Dorset, UK).
NA hydrochloride, ACh chloride, calcium ionophore
A23187 and BK acetate were obtained from Sigma (Poole,
Dorset, UK). SIN-1 and endothelin-1 (ET-1) were obtained
from Alexis (Nottingham, UK). Stock solutions (10 ~ 3 M)
were prepared in distilled water, except for ET-1 and
A23187, which were initially dissolved in 50% methanol
and absolute ethanol, respectively, to give 10 5 and 10" 4
M stock solutions. Subsequent dilutions were made in
distilled water and final bath concentrations of methanol
and ethanol did not exceed 1.5% and 3% v/v, respectively.
Stock solutions of all drugs were frozen at — 20°C as 1 ml
aliquots and thawed as required.
2.2. Morphological investigations
Fifteen small and seven large resistance arteries, as well as
four veins (from 10, 7 and 4 individuals, respectively), were
fixed in 10% neutral buffered formalin, dehydrated in
ethanol and chloroform and embedded in paraffin for sub¬
sequent histological analysis. This procedure was performed
using both freshly isolated vessels and some which had been
used for functional investigation. Serial 3 pm transverse
sections were stained using haematoxylin and eosin and
immunocytochemical techniques. Smooth muscle and endo¬
thelial cells were detected using mouse anti a-smooth
muscle actin IgG (1/50 dilution; Novocastra Laboratories,
Newcastle upon Tyne, UK) and biotinylated ulex europaeus
agglutinin (1/100 dilution; Vector Laboratories, Peterbor¬
ough, UK), respectively. a-SMA IgG (but not ulex, which
was already biotinylated) was incubated with a biotinylated
secondary antibody (Dako Ltd., Ely, UK). Both smooth
muscle and endothelium were detected using a streptavi-
dine-biotin-peroxidase kit (Dako Ltd., Ely, UK) followed
by incubation with diaminobenzidine. Positive signals
appeared brown. Negative controls were obtained by omit¬
ting the primary antibody.
2.3. Functional investigation
Eleven biopsies (nine males, two females; age 58 ±9
years; four control, three NIDDM, two IDDM, two NPG)
yielded both large and small resistance arteries, while veins
were isolated from five male subjects (age 54 ±4 years;
three NIDDM, one IDDM, one control). Isolated vessels
were mounted as ring preparations on two 40-pm stainless
steel wires in a small vessel myograph (J. P. Trading, Aarhus,
P.W.F. Hadoke et al. / General Pharmacology 35 (2000) 119-127
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Fig: 1. Physical and morphological differences between small resistance arteries (A), veins (B) and large resistance arteries (C) isolated from biopsies of human
subcutaneous fat. Vessels were (i) photographed under light microscopy (scale bar=50 pm), while photomicrographs were taken following staining with (ii)
haematoxylin and eosin, and with antibodies against (iii) a-smooth muscle actin (iv) and ulex (for detection of the endothelium). Magnification x 200 for all
photomicrographs. The large resistance artery was fixed following functional studies in the wire myograph. This accounts for the rather distorted appearance of
this vessel and may also contribute to the relatively weak staining for a-smooth muscle actin and endothelium. This diagram is representative of results
obtained using 15 small and 7 large resistance arteries and 4 veins obtained from 10, 7 and 4 individuals, respectively.
Denmark). One wire was fixed to a movable micrometer,
while the other was_itttached to an isometric force trans¬
ducer. The vessels were immersed in PSS (composition
(mM): NaCl 119, KC1 4.7, CaCl2 2.5, MgS04-7H20 1.17,
KH2P04 1.18, NaHC03 25, K2EDTA 0.026 and D-glucose
5.5) at 37°C and perfused continuously with 95% 02 and
5% C02. The length of each vessel segment was measured
using a travelling micrometer eyepiece attached to a light
microscope. Following an equilibration period (30 min), the
vessels were subjected to a standard normalisation proced¬
ure (Mulvany and Halpern, 1977) in which each is exposed
to incremental stretches. Application of the Laplace equa¬
tion calculates the internal circumference (Z-ioo) the vessel
would have in vivo when relaxed and subjected to a
pressure of 13.3 kPa (100 mm Hg). The vessels were then
stretched to the optimum resting setting used for human
resistance arteries (0.9Z,)Oo; Angus et al., 1992; McNally
et al., 1994).
Vascular rings were equilibrated at their optimum
resting setting for 30 min and were then subjected to a
standard start procedure. This consisted of five consec¬
utive applications of vasoconstrictors. After each expo-
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sure, the artery was washed several times with PSS and
the responses were allowed to return to baseline. The
first, second and fifth contractions were produced using
NA-K [a 125 mM potassium solution (KPSS, made by
equimolar substitution of KC1 for NaCl in PSS) contain¬
ing NA (10 ~ 5 M)]. The third contraction was producing
using KPSS, while the fourth was obtained using NA
(10 ~5 M). This procedure confirmed the viability of each
artery and demonstrated the reproducibility of the vaso¬
constrictor responses.
Cumulative concentration-response curves were
obtained in all three vessel types using the receptor-
dependent vasoconstrictors NA (10 ^9—3 x 10 ~5 M) and
ET-1 (10_11-3x 10 - 7 M) and the receptor-independent
vasoconstrictor K+ (10-125 mM). Cumulative concentra¬
tion-response curves were obtained for the receptor-
dependent, endothelium-dependent relaxant agonists ACh
(10-9-3 x 10"5 M) and BK (10~ 10-3 x 10"6 M), the
receptor-independent, endothelium-dependent dilator,
A23187 (10~9-3 x 10 ~~6 M) and the endothelium-inde-
pendent nitric oxide donor, SIN-1 (10_9-3x 10 5 M).
Responses to vasodilators were obtained following con¬
traction of the artery with sufficient NA (3 x 10 "7-
3xl0~6 M) to produce 50-80% of the maximal
response to this agonist.
2.4. Statistics
All values are mean±S.E.M. for n experiments, where n
represents the number of subjects. Contractile responses are
expressed as milliNewtons per millimeter and relaxation as
a percentage of the pre-contraction with NA. The concen¬
tration of agonist required to produce 50% of the maximum
response (EC50) was obtained by fitting the Hill equation to
the data using curve fitting software (Fig P; Biosoft, Cam¬
bridge, UK). The results are expressed as the negative
logarithm of the EC50 (pf2 for vasoconstrictors, — log
IC50 for vasodilators). Maximum response and EC50 values
were compared using one-way analysis of variance followed
by a Tukey's post-hoc test and significance was assumed
when P< .05.
3. Results
Large and small resistance arteries, and small veins
isolated from the biopsies of subcutaneous fat were distin¬
guished using physical differences as described in the
Materials and Methods section.
3.1. Morphology
Small ( <200 |im) resistance arteries (Fig. la) had a
clearly defined media and adventitia when stained with
haematoxylin and eosin (Fig. la(ii)). Immunohistochemistry
demonstrated that the media comprised mainly smooth
muscle cells (Fig. la(iii)) with a monolayer of endothelial
cells lining the internal elastic lamina (Fig. la(iv)). In
contrast, veins failed to hold their shape, and distinction
between media and adventitia was less clear when stained
with haematoxylin and eosin (Fig. lb(ii)). However, the
venous media stained strongly for a-SMA (Fig. lb(iii)) and
the ulex antibody identified a clear endothelium lining the
lumen (Fig. lb(iv)). The large (~500 pm) resistance
arteries had more structural similarity with the small resist¬
ance arteries than the veins as they held their shape and had
clearly defined medial and adventitial layers following
staining with haematoxylin and eosin (Fig. lc(ii)). As with
both the small resistance artery and the vein, the media was
comprised mainly of smooth muscle cells (Fig. lc(iii)) and
an endothelial cell layer was detected on the luminal
surface (Fig. lc(iv)).
3.2. Normalisation
Normalisation of small resistance arteries was straight¬
forward with the effective transmural pressure exceeding
13.3 kPa after three to four stretches. In contrast, large
resistance arteries and veins did not maintain stretch as well
as small resistance arteries and required more (6-10)
equivalent stretches. The internal diameter of large resist¬
ance arteries (485±56 pm; n= 11) was bigger (P=.00005)
than that of the small resistance arteries (185 ± 16 pm) when
stretched to an effective pressure of 13.3 kPa (100 mm Hg).
Interestingly, although veins were selected, which appeared
similar in size to small resistance arteries, they were found
to have an internal diameter (410 ±93 pm; n = 5) similar to
the large resistance arteries when an effective pressure of
13.3 kPa was exerted. This is consistent with the tendency
of veins to distend more readily than arteries in response to
small increases in internal pressure (Bell and Emslie-Smith,
1980) and probably reflects the fact that the veins were
being studied under nonphysiological conditions to allow
direct comparison with arteries.
3.3. Vascular function
NA, ET-1 and KPSS produced concentration-dependent
contractions in all three types of vessel (Fig. 2). There was a
trend towards a greater response to all three vasoconstrictors
in the large resistance arteries, but in most cases, this did not
reach significance. Furthermore, this apparent difference
was lost when responses were corrected to take into account
differences in internal diameter (Table 1). The response to
NA (Fig. 2a) in the large resistance arteries {Emax 3.11 ±0.52
mN/mm; n = 11) was not significantly bigger than that
produced in small resistance arteries (2.02 ±0.36 mN/mm;
«=10; P=.17) or veins (1.65±0.24 mN/mm; n = 5;
P=.14). The sensitivity (pf>2) of large resistance arteries
to NA (7.40 ±0.14) was identical to that exhibited by veins
(7.40±0.14; P=1.00) and not significantly different from
that of small (7.01 ±0.17; P=.18) resistance arteries.





Fig. 2. Concentration-response curves to (a) NA. (b) endothelin-1 and (c)
K in small resistance arteries (®. n=10), veins (■, ;i = 5) and large
resistance arteries (A, n=ll) isolated from human subcutaneous fat
biopsies. Each point represents mean±S.E.M.
The contraction (£max) produced by ET-1 (Fig. 2b) was
stronger (P=.02) in large (3.35 ±0.60 mN/mm; n = 7)
compared with small (1.57 ±0.30 mN/mm; n = l) resistance
arteries, but not significantly different (P=.13) than the
response produced in veins (2.00 ±0.24 mN/mm; n = 5).
The difference between large and small resistance arteries
was lost when the results were expressed as a percentage of
the maximum response to NA-K (Table 1). The trend
towards greater sensitivity in large resistance arteries (pZT
9.05 ±0.16) and veins (9.19 ±0.20) compared with small
resistance arteries (8.61 ±0.17) was not significant (P=. 19
and P=.85, respectively).
As with NA and ET-1, the apparently greater £max to
KPSS (Fig. 2c) produced by large resistance arteries
(2.99 ±0.72 mN/mm; n = 7) was not significant when com¬
pared with small resistance arteries (1.39 ±0.49 mN/mm;
n = 7; P=.14) and veins (1.67±0.41 mN/mm; n = 7;
P=.31). Furthermore, the sensitivity (pD2) to this con¬
strictor in large resistance arteries (1.53 ±0.04) was not
different to that in small resistance arteries (1.51 ±0.04;
P=.90) and veins (1.58±0.06; P=.71).
BK-mediated relaxation (Fig. 3a) was similar in small
(Pmax 88.35±4.76%; -log IC50 7.49 ±0.15; n = 9) and
large (£max 78.67±3.92%; P=.26; -log IC50 7.88±0.17;
P=.ll; n = 11) resistance arteries. In contrast, relaxation of
veins in response to BK (£max 21.68 ±5.60%; n = 5) was
significantly smaller than responses produced in the small
(P=.0001) and large (P=.0001) resistance arteries,
although the sensitivity of this response was similar ( — log
log IC50 8.20 ±0.30; n = 4; P=.09 and .57, respectively).
Exposure to ACh (Fig. 3b) did not produce an active
relaxation in large resistance arteries or veins despite dem¬
onstrating its ability to relax small resistance arteries (£max
95.74±1.86%; —log IC50 7.28±0.09; «=11). Conversely,
A23187 (Fig. 3c) caused similar relaxation responses in
large (£max 67.00±8.37%; -log IC50 6.63 ±0.20) and
small (£max 76.00 ± 11.52%; P=.84; -log IC50
6.76 ±0.23; P=.66; n = 6) resistance arteries but only
evoked relaxation in two out of five veins. The relaxation
responses in the two veins, which responded to A23187
(£max 52.88% and 91.18%; — log IC50 6.82 and 6.37), were
similar to those produced in large and small arteries by
this ionophore.
Table 1
Maximum contractile responses (£■„,,„) of small and large resistance arteries
and veins to NA and ET-1
Emax (% NA-K)
NA ET-1
Small resistance artery 102.84±5.42(10) 92.98 ±10.96 (7)
Vein 96.12±3.41 (5) 124.19 ±35.56 (5)
Large resistance artery 104.61 ±5.11 (11) 111.90 ±21.23 (7)
Data aremean ± S.E.M. of (n) observations and are expressed as a percentage
of the maximum response produced by NA-K (a solution containing 125
mM K + and 10 ~ ~ M NA) to control for variations in vessel size.






































Fig. 3. Concentration-response curves to the vasodilators (a) BK, (b) ACh (c) A23187 and (d) SIN-1 in resistance arteries (w, n = 9-10), veins (■, n = 5) and
large resistance arteries (A, n = l-\\) isolated from human subcutaneous fat biopsies. Each point represents mean±S.E.M.
All three vessel types relaxed in response to SIN-1 (Fig.
3d). The magnitude (Emax 100.15 ±2.75; n= 10) and sensitiv¬
ity (— log IC50 5.98 ±0.18) ofthis response in large resistance
arteries were similar to those produced by small resistance
arteries (98.70±2.64%; n = 9; P-.99; and 6.19±0.14;
P=.55; respectively). However, while SIN-1 produced a
response of similar magnitude (109.00± 18.52%; n = 5;
P= .69) in veins, the sensitivity of this response (— log IC50
5.52 ±0.11) was significantly lower (P= .04) than in small,
but not large (P= .23), resistance arteries.
4. Discussion
This investigation confirmed functional heterogeneity
between large and small resistance arteries obtained from
biopsies of human, subcutaneous, gluteal fat, with large
resistance arteries unable to relax in response to the
endothelium-dependent vasorelaxant, ACh. Functional ana¬
lyses suggested that this was the result of the endothelial
cells of large resistance arteries, unlike those in their
smaller counterparts, lacking muscarinic receptors. These
results highlight the importance of correct identification of
resistance arteries isolated from gluteal fat biopsies. Com¬
parison of small veins and large and small resistance
arteries obtained from this source has provided both
physical and functional criteria for ensuring selection of
the required vessel type.
Vasorelaxant responses evoked by ACh result from the
release of relaxing factors following stimulation of muscar¬
inic receptors on the endothelium (Furchgott, 1983). In
conduit arteries, NO is the principle endothelium-derived
relaxing factor released by these agonists (Huang et al.,
1995), whereas in smaller arteries, both NO and EDHF may
contribute (Shimokawa et al., 1996). Preliminary studies in
our laboratory show that ACh acts by stimulating release of
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both NO and an NO-independent factor (possibly EDHF)
from the endothelium of human small resistance arteries
(Mclntyre et al., 1998c).
The lack of response to ACh in large resistance arteries
was consistent with a previous investigation (Angus et al.,
1992) and could, conceivably, be due to: (i) physical
damage to the endothelium; (ii) reduced responsiveness
of the smooth muscle to relaxant factors; and/or (iii)
absence of muscarinic receptors from the endothelial cell.
Damage to the endothelium, as a result of either vessel
preparation or cardiovascular disease, is unlikely; immuno-
histochemistry demonstrated an intact endothelial layer in
large resistance arteries, while responses to other endothe-
lium-dependent relaxants (BK, A23187) were similar to
those obtained in small resistance arteries. Similarly,
although diabetes (Chan et al., 2000) and glaucoma (Buck¬
ley et al., 1997) are associated with abnormal endothelial
function in some anatomical territories, the lack of response
to ACh in large resistance arteries cannot be attributed to
the presence of these conditions in some of the biopsy
donors. Firstly, there were no differences in response to
ACh in large resistance arteries obtained from healthy
controls and those from patients with diabetes or NPG.
1 Secondly, one small and one large resistance artery were
isolated from each biopsy and there was no evidence of
| endothelial dysfunction in any of the small resistance
arteries. These results are consistent with demonstrations
j by ourselves (Mclntyre et al., 1998a,b; Buckley et al.,
1999) and others (Cipolla et al., 1996; Malik et al., 1999)
£ that diabetes and NPG do not alter endothelium-dependent
| relaxation in human gluteal resistance arteries. Reduced
responsiveness of the smooth muscle to relaxing factors is
also unlikely to account for lack of response to ACh in
large resistance arteries given that BK- and A23187-medi-
ated relaxation responses were similar to those obtained in
small resistance arteries. Furthermore, SIN-1-mediated
relaxation was intact, indicating that the smooth muscle
was able to relax in response to NO. These results are
consistent with the lack of response to ACh resulting from
an absence of muscarinic receptors from the endothelial
cells. The failure of these vessels to contract in response to
high concentrations of ACh (Fig. 3b) suggests that muscar¬
inic receptors are also absent from the smooth muscle cells.
Therefore, lack of relaxation to ACh is not the result of
contractile responses predominating over relaxation. This
situation contrasts with BK (Fig. 3a), which did produce a
contraction at high-concentrations. This is unsurprising as
receptor heterogeneity is well described in the endothelium
(Vanhoutte, 1989) and our conclusions correspond with
those of Angus et al. (1992) who reported that large
subcutaneous resistance arteries, which did not respond to
ACh, would relax when exposed to substance P. In order to
demonstrate unequivocally that muscarinic receptors are
absent from the large resistance arteries and veins, direct
investigation would be required using, for example, in situ
hybridisation and/or autoradiography.
The functional responses of subcutaneous veins were
evaluated, under identical conditions, to enable comparison
with small and large resistance arteries. Immunohistochem-
istry confirmed that the veins had an intact endothelium,
suggesting that their poor responsiveness to endothelium-
dependent dilators is indicative of endothelium-dependent
relaxation being less important in veins than arteries. It is
possible that some endothelial cell function would be
evident under more physiological conditions and investi¬
gations designed to assess venous function in vitro should
take this into account. However, these results are consistent
with data obtained using large systemic (saphenous, mam¬
mary, femoral, pulmonary, splenic) veins (DeMey and
Vanhoutte, 1982; Vanhoutte and Miller, 1985; Luscher et
al., 1988). The failure of ACh to evoke relaxation may be
due to a lack of the necessary receptors, but the small
response to BK and the variable response to A23187
suggest that eNOS activity may be less significant in
subcutaneous veins. This contrasts with some systemic
veins (saphenous, mammary), which, despite responding
poorly to ACh, relax significantly in response to A23187
(Luscher et al., 1988) although there is evidence of ana¬
tomical variation in this response (Luscher et al., 1988)). A
similar variation may account for the heterogeneity of the
response to A23187 in the veins used in the present study.
As with systemic veins (Luscher et al., 1988), exposure to
SIN-1 caused complete relaxation of human subcutaneous
veins. The sensitivity to this nitric oxide donor, however,
was lower than that of small resistance arteries, further
suggesting that the action of NO is less important in veins
than arteries from human subcutaneous fat.
Unlike conduit arteries (Martin et al., 1986), basal release
of endothelium-derived relaxing factors does not appear to
modulate NA-mediated contraction in small resistance arter¬
ies as responses to this agonist were not enhanced in
denuded vessels (Buckley et al., 1999). The larger max¬
imum response to NA in large resistance arteries compared
with small resistance arteries and veins is likely to be the
result of size differences, rather than variations in receptor
expression, as a similar difference was seen with potassium.
Furthermore, the relative size of the response to NA was
similar in these vessels when expressed as a percentage of
the response to NA-K to correct for variations in vessel size
(Lew and Angus, 1992). In contrast, the tendency towards
greater amplitude (£max) and sensitivity (pD2) of response to
ET-1 in large resistance arteries and veins is not simply due
to size variations. This may suggest heterogeneity in ET
receptor populations, but, alternatively, it is possible that the
inhibitory role of the endothelium on ET-1-mediated con¬
traction that has been reported in human small resistance
arteries (Buckley et al., 1999) is absent from large resistance
arteries and veins.
The demonstration of heterogeneous endothelial cell
function in small and large arteries from subcutaneous fat
biopsies has implications for investigations using this source
of tissue. This is emphasised by the fact that the results
126 P.W.F. Hadoke et al. / General Pharmacology 35 (2000) 119-127
obtained in these subcutaneous vessels are not ubiquitous.
For example, our own (unpublished) observations are that
large (first order), medium (second order) and small (third
order) rat mesenteric arteries all relax in response to ACh.
Therefore, it is likely that functional variations exist in
similar sized vessels from different vascular territories and
care must be taken not to extrapolate the current results to
other systems. Furthermore, while the present study distin¬
guishes between function in "small" (<200 pm) and
"large" (~500 pm) resistance arteries, it has not been
possible to determine an exact demarcation between arteries
which respond to ACh and those which do not. The
importance of this distinction is highlighted by studies in
which ACh-mediated relaxation is impaired in patients,
whereas responses to other dilators (BK, substance P,
sodium nitroprusside) are unaltered (McNally et al., 1994;
Lewis et al., 1998). Studies of resistance artery function
often use vessels with a mean internal diameter between 200
and 300 pm. Inclusion of a small number of arteries, which
do not respond to ACh, could have a significant effect on
the results of such investigations.
In conclusion, this investigation has provided criteria for
distinguishing between large and small resistance arteries,
and small veins, obtained from human gluteal fat on the
basis of physical appearance, differences in response to
transmural stretch and functional reactivity. It was demon¬
strated that heterogeneity of ACh-mediated, endothelium-
dependent relaxation in resistance arteries was probably the
result of large resistance arteries lacking muscarinic recep¬
tors on the endothelium. This suggests variation in endo¬
thelial cell receptor populations as resistance artery diameter
increases and indicates the importance of confirming that
arteries isolated from subcutaneous fat, particularly those
with internal diameter >200 pm, are responsive to both
ACh and another (e.g., BK, substance P or A23187)
endothelium-dependent vasorelaxant.
5. Summary
The nature of, and mechanisms responsible for, func¬
tional heterogeneity between small (internal diameter < 200
pm) and large (internal diameter ~ 500 pm) resistance
arteries obtained from human subcutaneous fat have not
been elucidated. This investigation aimed to identify the
cause(s) of these functional differences and provide criteria
for distinguishing between the different vessel types isolated
from biopsies of human gluteal fat. Small (n= 11) and large
(n = 11) resistance arteries and veins (n = 5) were isolated
from 14 gluteal biopsies. Using small vessel myography,
isometric responses were obtained to cumulative additions
of vasoconstrictors (NA, potassium and ET-1) and endothe¬
lium-dependent (ACh, BK and the calcium ionophore,
A23187) and -independent (SIN-1) vasodilators. Immuno-
histochemical analysis confirmed that all vessels had an
intact endothelium. Responses to vasoconstrictor agonists
were similar in large and small resistance arteries and veins.
Small resistance arteries relaxed in response to ACh (£max
95.74 ± 1.86%), BK (88.35 ± 4.76%), A23187
(76.00± 11.52%) and SIN-1 (98.70±2.64%). Large resist¬
ance arteries were selectively unresponsive to ACh, despite
exhibiting similar responses to BK (78.67 ±3.92%; P= .26).
A238 1 7 (67.00 ± 8.36%; F>=.84) and SIN-1
(100.15±2.75%; P=.99). In contrast, only SIN-1 caused
equivalent relaxation (109.00± 18.52%; P=.69) in veins.
These results indicate a heterogeneity in endothelial cell
function between large and small resistance arteries from
human gluteal fat, which may be the result of variations in
receptor population. This emphasises the need to ensure
careful selection of arteries from this source, which can be
achieved using physical and functional criteria identified,
when performing functional investigations.
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Selective enhancement of sensitivity to
endothelin-l despite normal endothelium-
dependent relaxation in subcutaneous
resistance arteries isolated from
patients with Type I diabetes
Carol-Ann MdNTYRE*, Patrick W. F. HADOKE*, Brent C. WILLIAMS*,
R. Mark LINDSAYf, Andrew I. ELLIOTTf and John A. McKNIGHTf
'Department of Medical Sciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU,
Scotland, U.K., and {Metabolic Unit, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU,
Scotland, U.K.
Type 1 diabetes mellitus is associated with abnormal vascular function, but few studies have
documented its effects on human resistance arteries. This study aimed to determine whether
endothelial cell and smooth muscle cell function was impaired in resistance arteries isolated from
patients with this condition. Biopsies of subcutaneous gluteal fat were taken from 12 patients
with Type I diabetes (age 32.3+ 1.9 years; duration of diabetes 13.9 + 2.5 years) and 12 matched
controls (age 31.5±2.2 years). Levels of glycosylated haemoglobin were higher (P < 0.0001) in
patients (9.38 + 0.35%) than in controls (5.48+0.1 I %), but most (I I out of 12) patients showed no
evidence of microvascular disease. Small resistance arteries were isolated from the biopsies, and
isometric responses to vasoconstrictors and vasodilators were measured in a small-vessel
myograph. The magnitude and sensitivity of responses to noradrenaline and potassium were not
different in diabetic patients compared with controls. In contrast, the sensitivity (pD2; negative
logarithm of the concentration of the vasoconstrictor required to produce 50% of the maximum
effect), but not the magnitude, of contraction in response to endothelin-l in vesselsfrom patients
(8.87 + 0.12) was significantly (P = 0.02) greater than in those from controls (8.40 + 0.13).
Endothelium-dependent (acetylcholine, bradykinin, A23 187) and -independent (3'-morpholino-
sydnonimine) relaxation responses were unaltered in patients with Type I diabetes. These
results suggest a selective alteration in receptor activity in the endothelium, and contrast
strikingly with the considerable evidence of impaired endothelium-dependent relaxation in
Type I diabetes. The present study indicates, therefore, that endothelial cell function is largely
maintained in resistance arteries from patients with well controlled Type I diabetes. The
increased response to endothelin-l supports .the possibility that more significant abnormalities
would be evident in patients with severe microvascular complications.
Key words: endothelium, human resistance arteries, Type I diabetes, vasoconstriction, vasorelaxation. ;
Abbreviations: ACh, acetylcholine; ET-1, endothelin-l; NA, noradrenaline; pD.,, negative logarithm of the concentration of
vasoconstrictor required to produce 50% of the maximum effect; PSS, physiological salt solution; KPSS, PSS in which NaCl has
been replaced bv an equimolar concentration of KC1; SIN-1. 3'-morpholinosvdnonimine.
introuuliiun
There is compelling evidence to indicate that the ability
of the endothelium to mediate vascular relaxation is
impaired in large conduit arteries from patients and
animals with Type I diabetes mellitus [1,2]. Similarly,
contractile function may also be altered in these vessels,
although the nature of this alteration remains contro¬
versial. These abnormalities have serious consequences,
as impaired function of conduit arteries has been im¬
plicated in the increased risk of atheroma in patients with
Type I diabetes [2].
A significant proportion of the morbidity and mor¬
tality associated with Type I diabetes results from
complications such as retinopathy, nephropathy and
neuropathy [3]. There is considerable evidence that, as
with atheroma, these microvascular complications are the
result of vascular dysfunction [4], There have been
relatively few studies of microvascular function in
patients withType I diabetes, however, and consequently
both the nature and the causes of any dysfunction remain
controversial [5]. It seems unlikely that Type I diabetes
would produce the same pathophysiological changes in
conduit and resistance arteries, as it is well established
that these vessels are functionally distinct. Receptor
populations vary in arteries of different anatomical origin
[6] and, perhaps more significantly, the factors that
contribute to endothelium-dependent relaxation differ in
large compared with small vessels. Endothelium-depen¬
dent relaxation is mediated almost exclusively by nitric
oxide (NO) in conduit arteries [7], whereas the con¬
tribution of a putative endothelium-derived hyper-
polarizing factor becomes increasingly significant as the
diameter of the vessel diminishes [8].
The few studies of vascular function using resistance
arteries isolated from either patients with Type I diabetes
[9] or animal models of this condition [10] have suggested
impaired endothelium-dependent relaxation. Surpri¬
singly, however, the dysfunction detected in human
arteries [9] was specific for responses to acetylcholine
(ACh), a conclusion that has been challenged by pre¬
liminary data from a more recent study [11]. The impact
of Type I diabetes on contractile function in resistance
arteries is also controversial: contraction of human
resistance arteries appeared to be unchanged or impaired
in patients with diabetes [9,11], whereas responses to
noradrenaline (NA) were enhanced in mesenteric arteries
from diabetic rats [10]. The present investigation aimed
to clarify the impact of Type I diabetes on resistance
artery function by studying both contractile and relaxant
responses in resistance arteries taken from patients with
this condition. Endothelin-1 (ET-1) was included in the
Investigation, as this potent vasoconstrictor, which can be
released from damaged endothelial cells, has been im¬
plicated in the pathogenesis of vascular complications in
Type I diabetes [12], but its effects have not been studied




Twelve patients (seven male, five female) with Type I
diabetes, and 12 age- and sex-matched healthy controls,
with no history of diabetes, were recruited for the study.
Patients were selected on the basis that they had no
history of cardiovascular disease and were taking no
major drugs other than insulin. Controls were recruited
from the general population and had no history of
cardiovascular disease or diabetes. Six patients and four
controls were smokers, and three patients were also
taking oral contraceptives. All patients provided in¬
formed written consent, and the study protocol was
approved by the Lothian Research Ethics Committee.
For each subject, blood pressure was measured three
times (sitting, left arm; sitting, right arm; standing, left
arm) to obtain mean values for systolic and diastolic
pressure. The presence of retinopathy was assessed using
dilated pupil ophthalmoscopy, while neuropathy was
tested by measuring vibration in the toe. The presence of
microalbuminuria was assessed in patients by calculation
of the albumin/creatinine ratio.
Preparation of arteries
A biopsy of skin and subcutaneous fat (approx. 2 cm
long x 1 cm x 1 cm) was taken from the gluteal region
under local anaesthesia (5 ml of 2% lignocaine hydro¬
chloride; Astra, King's Langley, Herts., U.K.). Resistance
arteries were dissected from the biopsy and mounted as
ring preparations on two 40 fj.m stainless steel wires in a
small-vessel myograph (J. P. Trading, Aarhus, Den¬
mark). One of these wires was fixed to a movable
micrometer, while the other was attached to an isometric
force transducer. The vessels were immersed in physio¬
logical salt solution [PSS; composition (mM): NaCl, 119;
KC1, 4.7; CaCl,, 2.5, MgS04-7H20, 1.17; KH2P04,
1.18; NaHC03, 25; K„EDTA, 0.026; D-glucose, 5.5],
which was maintained at 37 °C and perfused continu¬
ously with 95%0,/5 % C02. The length of each vessel
segment was measured using a travelling micrometer
eyepiece attached to a light microscope. Following an
equilibration period (30 min), the length-tension charac¬
teristics were determined by subjecting each vessel to
incremental stretches and applying the La Place equation
as described previously [13]. This calculates the internal
diameter (/100) that the vessel would have in vivo when
relaxed and subjected to a pressure of 13.3 kPa (100
mmHg). The vessels were then stretched to their op¬
timum resting setting (0.9/loo) [10],
© 2001 The Biochemical Society and the Medical Research Society
Resistance arteries in diabetes
Table I Characteristics of control subjects and patients with Type I diabetes
Values are mean + S.E.M. All values are for 12 observations, except when indicated otherwise by n values quoted in parentheses, and were compared using Student's
unpaired r-test.
Parameter Controls Diabetic patients P
Age (years) 31.5 + 2.2 32.3 + 1.9 0.78
Duration of Type I diabetes (years) - 13.9 + 2.5 -
Blood pressure (rnrnHg)
Systolic 122±3 (10) 121 ±3 0.78
Diastolic 79 + 2 (10) 76 ±2 0.51
Glucose (mmol/l) 4.85 +0.07 (11) 13.84 + 1.84 (10) < 0.001
Glycosylated haemoglobin (%) 5.48 + 0.11 9.38 + 0.35 < 0.1
Serum cholesterol (mmol/l) 4.55 + 0.36 (11) 5.25 +0.28 0.13
Serum triacyiglycerol (mmol/l) 1.17 + 0.19 (11) 1.72 + 0.38 0.22
Serum creatinine (yimol/l) 75.6 + 3.6 (11) 68.8 + 2.4 0.12
Serum albumin (g/l) 42.08 + 0.63 38.4 + 3.3 0.38
Urea (mmol/l) 3.98 + 0.34 4.23 + 0.19 0.52
Protocol
Arterial rings were equilibrated at their optimum resting
setting for 30 min, and were then subjected to a standard
start procedure. This consisted of five consecutive appli¬
cations of the vasoconstrictors NA and potassium (K+).
After each exposure, the artery was washed several times
with PSS and the responses were allowed to return to
baseline. The first, second and fifth contractions were
produced using NA/K+ [a 125 mM KT solution (KPSS;
made by equimolar substitution of KC1 for NaCl in PSS)
containing 10 yiM NA]. The third contraction was
produced using KPSS, while the fourth was obtained
using 10 fiM NA. This procedure confirmed the viability
of each artery, and demonstrated the reproducibility of
the vasoconstrictor responses.
Cumulative concentration-response curves were ob¬
tained using the receptor-dependent vasoconstrictors
NA (1 nM-30 yxM) and ET-1 (0.01 nM-0.3 y/M) and
using elevated K" concentrations (10—125 mM), which
cause receptor-independent contraction by depolarizing
the vascular smooth muscle. Responses to vasodilators
were obtained following contraction of the arterywith a
submaximal concentration of NA (3 yrM). Cumulative
concentration-response curves were also obtained for the
receptor-dependent, endothelium-dependent agonists
ACh (1 nM-30 yzM) and bradykinin (0.1 nM—3 yrM), the
receptor-independent, endothelium-dependent calcium
ionophore A23187 (1 nM-3 yiM) and the endothelium-
independent nitric oxide donor 3'-morpholinosydnoni-
mine (SIN-1; 1 nM-30 yxM).
Statistics
All values shown are mean +S.E.M. for n experiments,
where n represents the number of subjects. Contractile
responses are expressed inmN/mm, and also as a
percentage of the maximum response to the third
stimulation with NA/K+ (% NA/K+). Relaxation is
expressed as a percentage of the precontraction with NA.
Sensitivity values were obtained by fitting the Hill
equation to the data using curve-fitting software (Fig P;
Biosoft, Cambridge, U.K.). These are expressed as the
negative logarithm of the concentration of the agonist
required to produce 50 % of the maximum effect (pD, for
vasoconstrictors; — logIC50 for vasodilators). Com¬
parisons of maximum responses and sensitivities were
achieved using Student's unpaired r-test, and significance
was assumed when P < 0.05. •
Drugs
All salts were obtained from BDH (Poole, Dorset, U.K.).
NA hydrochloride, ACh chloride, bradykinin acetate
salt and A23187 free acid were obtained from Sigma
(Poole, Dorset, U.K.). ET-1 and SIN-1 were obtained
from Alexis (Nottingham, U.K.). Stock solutions (1 mM)
were prepared in distilled water, except for ET-1, which
was initially dissolved in 50% (v/v) methanol to give a
10 yrM stock solution, and A23187, which was initially
dissolved in ethanol to give a 0.1 mM stock solution.
Subsequent dilutions were made in distilled water, and
final bath concentrations of methanol and ethanol did not
exceed 1.5 % and 3 % (v/v) respectively. Stock solutions
were frozen as 1 ml aliquots at — 20 °C and thawed as
required. Any residual solution was discarded at the end
of the experiment.
RESULTS
The characteristics of the subjects recruited for this
investigation are given in Table 1. Eleven of the patients
with diabetes had no history of macrovascular or
microvascular complications, nor any evidence of retino¬
pathy or neuropathy. One patient had proliferative






Figure I Cumulative concentration-response curves to the
vasoconstrictor agonists (a) ET-I, (b) NA and (c) KC1 obtained
using arteries from control subjects (■) and patients with
Type I diabetes (□)
Values are means ± S.E.M. (n = 12).
ratio (functional responses of arteries from this individual
were not different from those from the other 11 patients).
Urinary albumin/creatinine ratios (1.11 +0.26 mg/
mmol; n = 12) were within the normal range (0.0-3.5
mg/mmol), indicating normal renal function.
Gluteal resistance arteries isolated from patients and
with Type I diabetes and controls in response to NA,
potassium (K+) and.ET-I
Results are expressed as a percentage of the maximum response to NA/K+. All
values are means ± S.E.M. (nm= 12), and were compared using Student's
unpaired r-test ,
Maximum contraction
(% of contraction to NA/K+)
Vasoconstrictor Controls Patients P
NA 115.4 ±3.2 108.3 ±2. 0 0.09
r 71.9± 6.7 84.1 ±7.8 0.22
ET-I 103.7 ±5.9 104.5 ±6.03 0.92
controls were of a similar size (mean internal diameter
224 + 22 /cm and 195 + 9 /cm respectively; P = 0.24). All
arteries produced concentration-dependent contractions
in response to the three vasoconstrictors. The sensitivity
(pD,) to ET-1 (Figure la) in arteries from patients with
diabetes (8.87+ 0.12) was significantly (P = 0.02) greater
than that in arteries from controls (8.40 + 0.12), but the
maximum contractions were similar (3.85+0.66 and
3.39+0.39 mN/mm respectively; P — 0.56). In contrast,
sensitivities (pD„ values) of arteries from patients to
NA (6.73 ±0.11) and KPSS (1.50+0.04) were similar to
those of arteries from controls [6.98+0.14 [P = 0.19)
and 1.47 + 0.03 (P = 0.55) respectively]. Maximum
contractile responses to NA (Figure lb) and KPSS
(Figure lc) were also similar in patient (4.06 ±0.71
and 3.26 ±0.61 mN/mm respectively) and control
[2.67±0.47 mN/mm (P — 0.46) and 3.39±0.39mN/
mm (P = 0.56) respectively] arteries. No differences were
detected between control and diabetic groups when
values for maximum contractions were expressed as
a percentage of the maximum contraction in response to
NA/K+, in order to control for variations in the size of the
arterial rings (Table 2).
The four vasodilators used all produced concentration-
dependent relaxation in arteries precontracted with a
submaximal concentration of NA. Responses to vaso¬
dilators in arteries from the three diabetic patients taking
oral contraceptives were not different from those ob¬
tained in arteries from the rest of the patient group.
Arteries from control subjects produced near-maximal
relaxation in response to ACh (97.2± 1.0 %; Figure 2a),
bradykinin (94.3±2.2%, n —8; Figure 2b) and SIN-1
(93.8 ±4.4%; Figure 2c). Similar responses were pro¬
duced in arteries from patients with Type I diabetes
[95.9±1.8% (P = 0.50), 91.7±2.2% (n = 9) (P = 0.38)
and 95.5±3.2% (P = 0.76) respectively]. A23187 pro¬
duced a smaller relaxation than the other three vaso¬
dilators, and did not achieve a definite maximum in the
concentration range used (Figure 2d). However, the peak
relaxation was similar (P = 0.21) in arteries from patients
© 2001 The Biochemical Society and the Medical Research Society
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Figure 2 Cumulative concentration-response curves to the vasodilator agonists (a) ACh, (b) bradykinin, (c) SIN-1 and (d)
A23I87 obtained using arteries from control subjects (■) and patients with Type I diabetes (□)
Values are means + S.E.M. for (a) n = 12, (b) n = 8, (c) n = 8—10, and (d) n = 11—12.
Table 3 Sensitivity (— log ICS0 values) from concentration-
response curves obtained to various vasodilatory agonists
All values are mean ±5.E.M. for n = 12, unless indicated otherwise by numbers
In parentheses, and were compared using Student's unpaired f-test Sensitivity
values for A23I87 are only approximate, as the response to this agonist did not
reach a maximum in the concentration range used.
Sensitivity (— log ICS0)
Vasodilator Controls Patients P
ACh 7.30 ±0.09 7.23 ±0.12 0.63
Bradykinin 7.69 ±0.15 (8) 7.95 ±0.15 (9) 0.29
A23I87 5.96 ±0.18 (9) 6.10 ±0.16 (6) 0.61
SIN-1 5.87 ±0.21 6.22 ±0.22 0.26
with diabetes (72.0 + 6.8, n = 7) and controls (81.5+3.4,
n — 9). The sensitivity (— log IC50) of relaxation to ACh,
bradykinin, SIN-1 and A23187 in diabetic patients was
similar to that in controls (Table 3).
Functional responses to vasodilators (maximum relax¬
ation and — logIC50) and vasoconstrictors (maximum
contraction and pD2) did not correlate with age, duration
of diabetes, plasma glucose or levels of glycosylated
haemoglobin.
DISCUSSION
This investigation has made two striking observations in
resistance arteries from patients with Type I diabetes: (i)
a selective enhancement of ET-l-induced contraction,
and (ii) normal endothelium-dependent (and endo-
thelium-independent) relaxation. This indication of a
limited, selective abnormality in endothelial cell function
contrasts directly with the dramatic impairment of
endothelium-dependent relaxation generally reported in
Type I diabetes. These results indicate that endothelial
cell function is largely maintained in subcutaneous
resistance arteries from patients with well controlled
Type I diabetes.
Damage to the endothelium often results in increased
release of ET-1. Consequently, the elevated plasma [14]
and tissue [15] concentrations of this peptide in patients
suggest that damage to the endothelium is a feature of
Type I diabetes. Similarly, urinary concentrations of ET-1
are elevated [16], and its release from resistance arteries
is enhanced [17], in diabetic rats, while increased release
of ET-1 possibly contributesho the down-regulation of
glomerular ET receptors [18]. The precise role of ET-1 in
the development of vascular complications, however,
remains unclear. Functional data obtained using arteries
from diabetic rats are contradictory, and there is evidence
that the duration of diabetes has a significant impact on
both ET-l-mediated contraction and endothelial cell
function [12].
The selective enhancement of ET-l-mediated con¬
traction in arteries from patients with Type I diabetes
suggests altered function of the ET receptors in the
endothelium and/or smooth muscle cells. This contrasts
with results from studies using diabetic animals, in which
increased ET-l-mediated contraction was just one com¬
ponent of a non-specific enhancement of contractile
function, possibly mediated by altered second messenger
activity [19,20], Unaltered responses to NA and KPSS in
the present study indicated that vascular remodelling, or
a general abnormality in second messenger systems, was
not responsible for the increased response to ET-1.
Endothelium-derived relaxing factors have a modulatory
effect on the ET-l-mediated contraction of human
subcutaneous resistance arteries [21], Consequently, re¬
moval of the endothelium results in an increase in
sensitivity (but not in maximum contraction) of ~ 10%
[21]. The current investigation suggests that this modu¬
latory function of the endothelium has been partially lost
in arteries from patients with Type I diabetes. As the
ability of the endothelium to mediate relaxation was not
impaired, this may suggest down-regulation of endo¬
thelial ETB receptors. This is strikingly similar to results
obtained using resistance arteries from patients with
hypertension [22] and normal pressure glaucoma [21].
Alternatively, the enhanced ET-l-mediated contraction
may be a consequence of up-regulation of ETA and/or
ETb receptors on the vascular smooth muscle cells.
Further studies would he required to identify the exact
mechanism(s) responsible for the enhanced response to
ET-1.
Our demonstration of unaltered responses to NA is
consistent with data obtained in the isolated forearm
[23,24] and in resistance arteries from patients with Type
I diabetes [11], The observation of increased angiotensin
Il-mediated contraction in the latter study supports the
contention that contractile abnormalities detected in
these arteries are the result of specific alterations in
receptor function. This contrasts directly with a previous
investigation of resistance artery function in Type I
diabetes, which reported a non-specific decrease in
contractile function (usingNA, angiotensin II and KPSS).
It is possible that this impaired contraction was due to a
slightly (but not significantly) lower media/lumen ratio
in arteries from the diabetic patients [9].
Endothelial cell dysfunction in animal models of
diabetes has been indicated by impaired endothelium-
dependent relaxation in conduit and resistance arteries
[1]. Similar abnormalities have also been reported in the
forearm [23] and brachial arteries [25] of patients with
Type I diabetes. These results are challenged, however,
by similar investigations which have found responses to
endothelium-dependent relaxants to be unchanged
[26,27] or even enhanced [28]. The present study used a
group of patients with established but generally well
controlled diabetes: "This compares with a study of
conduit arteries in vivo [29] which demonstrated that a
similar group of patients [with established diabetes (12
years duration) but no microvascular complications] had
both structural and functional abnormalities in the aorta
and the radial and carotid arteries. The unaltered res¬
ponses to receptor-dependent (ACh, bradvkinin) and
receptor-independent (A23187), endothelium-dependent
dilators in the present study demonstrate that endo¬
thelium-dependent relaxation was not impaired. Fur¬
thermore, the maintained response to SIN-1 indicated
that the ability of the vascular smooth muscle to relax in
response to exogenous NO was similarly unaffected.
These results are consistent with studies in which
endothelium-dependent relaxation in the human fore¬
arm is only impaired in diabetes if patients also exhibit
microalbuminuria [24,26,30]. Furthermore, relaxation in
response to NO donors (usually sodium nitroprusside)
has been shown repeatedly (although not exclusively
[11,24]) to be unaltered in patients with this condition
[23,26,27,30]. Therefore it is probable that impaired
endothelium-derived NO activity in the micro-
vasculature is restricted to patients with evidence of
nephropathy. This would correspond with the dem¬
onstration that microvascular permeability is only in¬
creased in patients with long-standing Type I diabetes if
they also have severe microvascular complications [31].
Our results challenge a previous demonstration that
ACh-mediated contraction is selectively impaired in
resistance arteries isolated from patients with Type I
diabetes [9]. The difference between these studies is
unlikely to be due to differences in disease duration in the
diabetic groups. The duration of diabetes in the group
with impaired ACh-mediated relaxation (18 years [9])
was shorter than that in patients who demonstrated
normal responses to this agonist (24 years [11]). In
contrastwith our study, almost all (nine out of ten) of the
individuals in the patient group used byMcNally et al. [9]
had evidence of retinopathy, possibly indicating that
endothelium-dependent relaxation is only altered in
patients with both diabetes and more established micro¬
vascular disease. Methodological variations are, however,
a more likely reason for these discrepant results. In
particular, we have found that some (larger) arteries
obtained from subcutaneous biopsies fail to relax in
response to ACh, but produce a 90-100% relaxation in
response to bradykinin [32]. The inadvertent inclusion of
a small number of these arteries in the diabetic group
could explain both the specific decrease in ACh-mediated
relaxation and the variable size and sensitivity of this
response reported in the previous study [9].
In conclusion, the present study has demonstrated an
enhanced response to ET-1, despite normal endothelium-
© 2001 The Biochemical Society and (he Medical Research Soaety
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dependent relaxation, in subcutaneous resistance arteries
from patients with Type I diabetes. This suggests that
endothelial cell function is largely intact in these arteries
from patients with established, but well controlled, Type
I diabetes. The increased response to ET-1 may result
from altered ETB receptor function on the vascular
endothelial cells, and could support the contention that
endothelial cell dysfunction is more pronounced in
patients with severe microvascular complications. It
remains possible that endothelial cell function is altered
in resistance arteries in other vascular territories, and also
in subcutaneous arteries, from patients with Type I
diabetes and associated microvascular complications.
Further investigations, such as the recent preliminary
report from Malik et al. [11], should confirm the
relationship between resistance artery function and the
severity of microvascular complications in patients with
Type I diabetes.
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Endothelium-derived hyperpolarizing factor and potassium use
different mechanisms to induce relaxation of human subcutaneous
resistance arteries
'C.-A. Mclntyre, 'C.H. Buckley, 'G.C. Jones, 'T.C. Sandeep, 'R.C. Andrews, 2A.I. Elliott,
3G.A. Gray, 'B.C. Williams, 2J.A. McKnight, 'B.R. Walker & *'P.W.F. Hadoke
'Department of Medical Sciences, Western General Hospital, University of Edinburgh, Edinburgh; 2Metabolic Unit, Western
General Hospital, University of Edinburgh, Edinburgh and 'Department of Biomedical Sciences, Hugh Robson Building,
University of Edinburgh, Edinburgh
1 This investigation examined the hypothesis that release of K * accounts for EDHF activity by
comparing relaxant responses produced by ACh and KC1 in human subcutaneous resistance arteries.
2 Resistance arteries (internal diameter 244+ 12 ^m, « = 48) from human subcutaneous fat biopsies
were suspended in a wire myograph. Cumulative concentration-response curves were obtained for
ACh (10~9-3 x 10-5 M) and KC1 (2.5-25 mM) following contraction with noradrenaline (NA; 0.1-
3 iim).
3 ACh (Emax 99.07 + 9.61%; -LogIC50 7.03 ±0.22; n = 9) and KC1 (Emax 74.14±5.61%;
— LogIC50 2.12 ±0.07; n= 10)-induced relaxations were attenuated (.P<0.0001) by removal of the
endothelium (Emax 8121 ±5.39% and 11.56±8.49%, respectively; n = 6-7).
4 Indomethacin (10 /tm) did not alter ACh-induced relaxation whereas l-NOARG (100 ^m)
reduced this response (Emax 61.7±3.4%, /><0.0001; n = 6). The combination of ChTx (50 nM) and
apamin (30 nM) attenuated the L-NOARG-insensitive component of ACh-induced relaxation (Emax:
15.2± 10.5%, R<0.002, n = 6) although these arteries retained the ability to relax in response to
100 fj.M SIN-1 (Emax 127.6± 13.0%, n = 3). Exposure to BaCE (30 /tm) and Ouabain (1 mM) did not
attenuate the l-NOARG resistant component of ACh-mediated relaxation (Emax, 76.09 ±8.92,
P = 0.16; n = 5).
5 KCl-mediated relaxation was unaffected by l-NOARG + indomethacin (Emax; 68.1 ±5.6%,
P = 0.33; n= 5) or the combination of l-NOARG/indomethacin/ChTx/apamin (Emax;
86.61 + 14.0284, P~0.35; n~6). In contrast, the combination of l NOARG, indomcthacin, ouabain
and BaCE abolished this response (Emax, 5.67±2.59%, PcO.OOOl, n = 6).
6 The characteristics of KCl-mediated relaxation differed from those of the nitric oxide/
prostaglandin-independent component of the response to ACh, and were endothelium-dependent,
indicating that K+ does not act as an EDHF in human subcutaneous resistance arteries.
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Abbreviations: ACh, acetylcholine; BSA, bovine serum albumin; ChTx, charybdotoxin; EDHF, endothelium-derived hyperpolar¬
izing factor; EDTA, ethylene diamine tetraacetic acid; F, Female; KPSS, high potassium physiological salt solution;
l-NOARG, NG-nitro-l-arginine; M, Male; NA, noradrenaline; NO, nitric oxide; PG, prostaglandin; PSS,
physiological salt solution; SIN-1, 3'-morpholinosydnonimine
Introduction
The vascular endothelium modulates agonist-dependent
relaxation by releasing substances such as nitric oxide (NO)
and prostaglandins (PGs) (Furchgott & Vanhoutte, 1989). In
some vessels, particularly those with a small diameter
(Shimokawa et al., 1996), a component of the endothelium-
dependent relaxation is insensitive to nitric oxide synthase
and cyclooxygenase inhibition (Nagao et al., 1992; Brandes et
al., 1997). This component appears to be mediated by
hyperpolarization of the vascular smooth muscle cells
(Brayden, 1990), suggesting the existence of a distinct
'Author for correspondence at: Department of Medical Sciences.
University of Edinburgh. Western General Hospital, Crewe Road.
Edinburgh, EH4 2XU; E-mail: phadoke@srvO.med.ed.ac.uk
endothelium-derived hyperpolarizing factor (EDHF) (Taylor
& Weston, 1988; Feletou & Vanhoutte, 1997).
The identity of EDHF has yet to be confirmed, although
activity of this factor has been attributed to epoxyeicosa-
trienoic acids (Hecker et al., 1994), endocannabinoids
(Randall et al., 1996), hydrogen peroxide (Matoba et al.,
2000) and the presence of myoendothelial gap junctions
(Chaytor et al., 1998). A recent study suggested that release
of K* into the myoendothelial space accounted for EDHF
activity in rat hepatic and mesenteric arteries (Edwards et al.,
1998). In this study, EDHF-mediated responses (but not
those to exogenous K + ) were inhibited by using charybdo¬
toxin (ChTx) and apamin to block large (BKCa) and small
(SKCa) conductance calcium-activated potassium channels on
i
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the endothelium. In contrast, the combination of barium and
ouabain inhibited responses to K" as well as to EDHF,
suggesting that both EDHF and K~ cause smooth muscle
cell hyperpolarization through activation of inward rectifier
potassium channels (KIR) and Na"/K^-ATPases. Subsequent
studies have, however, challenged the identification of K* as
EDHF by demonstrating differences in the characteristics of
EDHF and K+-induced relaxation in rat mesenteric
(Doughty et al., 2000; Lacy et al., 2000), porcine coronary
and guinea-pig carotid arteries (Quignard et al., 1999).
Human resistance arteries have been used extensively to
examine the cardiovascular defects associated with the
development of a variety of different disease processes. A
large component of endothelium-dependent relaxation in
these arteries is mediated by EDHF (Nakashima et al.,
1993; Urakami-Harasawa et al., 1997; Wallerstedt &
Bodelsson, 1997) but the mechanism of this response has
not been elucidated. This investigation aimed to determine
whether K+ accounted for EDHF activity in human
subcutaneous resistance arteries by comparing the NO-
independent, PG-independent component of ACh-induced




Biopsies of gluteal skin and subcutaneous fat
(2 cm x 1 cm x 1 cm) were obtained under local anaesthesia
(2% lignocaine hydrochloride; Astra, Herts, U.K.) from 26
healthy volunteers (20 Male, six Female; age 46 ±3 years).
Written informed consent and approval from the Lothian
Research Ethics Committee were obtained. Each biopsy was
immersed immediately in cold (4°C) physiological salt
solution (PSS) of the following composition (mM): NaCl
119, KC1 4.7, CaCL 2.5, MgS04 1.17, NaHCOj 24, KH2P04
1.18, K2EDTA 0.026 and D-glucose, 5.5. Dissection of these
biopsies provided 48 resistance artery sections (mean internal
diameter 244+12 /rm) for pharmacological analysis. Ring
segments of these arteries, 2 mm in length, were suspended
on two 40 pm stainless steel wires in a small vessel myograph
for measurement of isometric force. The myograph bath
contained PSS maintained at 37°C and perfused with 95%
02/5% C02. Following an equilibration period of 30 min,
the resting tension-internal circumference relationship was
determined by stepwise radial stretching and the vessels were
set to their optimum resting level (0.9 Lioo, where L10o is the
internal circumference the vessels would have when relaxed
and subjected to a pressure of 100 mmHg; Mulvany &
Halpern, 1977). After equilibration for a further 30 min,
vessel viability was assessed using a standard start procedure
(Aalkjaer et al., 1987). This consisted of five consecutive
stimulations lasting 3 min, each followed by a 5 min washout
period. The first, second and fifth contractions were
produced using a high (125 mM) potassium solution (KPSS;
made by equimolar substitution of KC1 for NaCl in PSS)
containing 10 pM noradrenaline (NA). The third was
obtained with NA (10 pM) alone and the fourth with KPSS
alone. The functional integrity of the endothelium was
assessed by adding ACh (0.1- 10 ^m) to vessels contracted
with sufficient NA'(0.1-3 pM) to produce 60-80% of the
response KPSS.
The contribution of EDHF to ACh-mediated relaxation
Sixteen resistance arteries (internal diameter 183+15 pm)
from 14 male subjects (age 57+12 years) were used for this
part of the investigation. After the standard start procedure,
a cumulative concentration-response curve to ACh (0.001 —
300 /tm) was obtained following precontraction with a sub-
maximal concentration (0.1-3 ^M) of NA (to produce a
contraction of ~60-80% the maximum response to KPSS).
The artery was washed with PSS (37°C) and the procedure
repeated following incubation with either; (a) indomethacin
(10 ,uM for 45 min, n = 6), (b) NG-nitro-L-Arginine (L-
NOARG; 100 pM for 45 min, n = 6), or (c) L-NOARG
(100 pM for 45 min), plus charybdotoxin (ChTx; 50 nM for
10 min) and apamin (30 nM for 10 min, n = 6). Arteries were
exposed to only one antagonist except for two of those
initially incubated with indomethacin which were subse¬
quently exposed to the combination L-NOARG + ChTx + a-
pamin. Three of the arteries incubated with L-
NOARG +ChTx + apamin, were also exposed to a single
concentration (100 pM) of the exogenous NO donor, 3'-
morpholinosydnonimine (SIN-1) once the concentration-
response curve to ACh had been completed.
Comparison of K+ -induced relaxation with the EDHF-
mediated component of ACh-evoked relaxation
Thirty-two resistance arteries (internal diameter 273+ 14 pm)
obtained from 12 subjects (six male, six female; age
32 ±4 years) were used for this part of the investigation.
The endothelium was removed from some arteries by rubbing
the luminal surface with a single hair. Cumulative concentra¬
tion-response curves were obtained using ACh (0.001-
300 pM) and KC1 (2.5-25 mM), in intact (n = 9-10) and
denuded (n = 6-7) arteries, after pre-contraction (to produce
a contraction of ~60-80% the maximum response to KPSS)
with a sub-maximal concentration of NA (0.1-3 ^iM).
Responses to KC1 were repeated following incubation with
a combination of either (a) L-NOARG (100 ^M) +indo¬
methacin (10 pM; 45 min, n = 5); (b) L-NOARG
(100 pM) + indomethacin (10 pw for 45 min) plus charybdo¬
toxin (ChTx; 50 nM for 10 min) and apamin (30 nM for
10 min, n = 6) or (c) L-NOARG (100 ^m) +indomethacin
(10 pM for 45 min) plus BaCL (30 pM for 10 min) and
ouabain (1 mM for 10 min, n = 6). Concentration-response
curves to ACh were also produced in the arteries exposed to
the combinations described for groups (b) and (c).
Drugs
All salts were obtained from BDH Laboratory supplies,
(Poole, Dorset, U.K). All drugs were purchased from Sigma,
(Poole, Dorset, U.K.), except for 3' morpholinosydnonimine,
charybdotoxin and apamin which were obtained from Alexis
Corporation Ltd (Nottingham. U.K.). Acetylcholine chloride,
ouabain, barium chloride and noradrenaline bitartrate were
dissolved in distilled water; indomethacin in 1.5x10~3m
Na2C03 (final bath concentration of Na2C03 did not exceed
0.015 mM) and apamin in 0.05 M acetic acid (final bath
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concentration of acetic acid did not exceed 0.15 mM).
Charybdotoxin was dissolved in a Tris buffer (10 mM,
pH 7.5) containing 0.1% BSA, 100 mM NaCl and 1 mM
EDTA (final bath concentrations of NaCl and EDTA did not
exceed 5 and 0.05 mM, respectively). 0.01% BSA was added
to the myograph chamber before applying the Joxins. Stock
solutions were stored at — 20°C, thawed as required and
subsequent dilutions made in distilled water. The concentra¬
tions quoted are final molar concentrations in the organ bath.
Statistics
All values are presented as mean + standard error mean
(s.e.mean) from n experiments (where n represents the
number of subjects). Relaxation responses to ACh and KC1
are expressed as a percentage of the initial NA-induced
precontraction. The concentration of agonist required to
produce 50% of the maximum response (IC50) was obtained
by fitting the Hill equation to the data using curve fitting
software (Fig. P, Biosoft, Cambridge, U.K.) and is expressed
as the negative logarithm of the IC50 (—logIC50). Compar¬
isons of maximum relaxation and — logIC50 values were
made using Student's paired or unpaired r-test, as appro¬
priate, and significance was assumed when P<0.05.
Results
The contribution of EDHF to ACh-induced relaxation
ACh caused approximately 80-100% relaxation in intact
human subcutaneous resistance arteries following pre-con-
traction with a sub-maximal concentration of NA (0.1-3 /xm;
Figure 1). None of the inhibitors caused an increase in either
the resting tone of the arteries or the response to the pre¬
contracting concentration of NA.
Incubation with indomethacin (Figure la) did not alter the
magnitude (Emax, 97.56±1.83%, n = 6) or sensitivity
(— logIC5o, 7.24 + 0.20, n = 6) of ACh-evoked relaxation when
compared with controls (90.80±4.69%, P = 0.18 and
7.23+0.25 P = 0.96, respectively; n = 6). In contrast, exposure
to l-NOARG (Figure lb) resulted in a significant
(P<0.0001), although not total, reduction in maximum
relaxation (61.68 + 3.38%, n = 6) compared with controls
(91.55 + 3.95%, n = 6) with a corresponding reduction in
sensitivity (—logIC50, 6.41+0.10 vs 7.19 + 0.13, respectively,
P< 0.005; n = 6). Arteries exposed to the combination of l-
NOARG plus ChTx and apamin demonstrated almost total
attenuation of ACh-mediated relaxation (Emax, 15.2+10.5%,
n = 6) despite producing a full concentration-response curve
before exposure to these inhibitors (Emax, 92.59 + 3.65%,
P< 0.002; — logIC5o, 7170 ±0.30, n = 6). These arteries main¬
tained their ability to relax in response to exogenous NO, as
SIN-1 (100 /rM) caused complete relaxation in the presence of
l-NOARG, ChTx and apamin (127.6+13.0%; n = 3).
Comparison of K+ -induced relaxation with the EDHF-
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Figure 1 Cumulative concentration-response curves to ACh (10~9-
3 x 10~5 m) before and after incubation with the following combina¬
tion of inhbitors (a) the cyclooxygenase inhibitor indomethacin
(10 hm for 45 min), (b) the NO synthase inhibitor l-NOARG
(100 /tM for 45 min) or (c) l-NOARG (100 /tM for 45 min) plus the
K+ channel blockers ChTx (50 nM for 10 min) and apamin (30 nM
for 10 min). Results are shown as mean + s.e.mean, for («) arteries.
Relaxation responses were obtained using potassium in 10
arteries with an intact endothelium and responses to ACh
were also tested in nine of these. Typical relaxation responses
were obtained with ACh (Emax, 99.07 + 9.61%; — logIC5o,
7.03+0.224; n = 9), which produced a sustained concentra¬
tion-dependent relaxation (Figure 2). In contrast, although
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Figure 2 Comparison of ACh- and KCl-mediated relaxation, (a) Representative traces showing (i) relaxation responses of an
intact artery to acetylcholine and KC1 and (ii) the effect of removal of the endothelium on these responses, (b) Cumulative
concentration-response curves for (i) acetylcholine and (ii) KG obtained in arteries with and without an intact endothelium or in the
presence of l-NOARG (100 ^M) and indomethacin (10 /im) alone or combined with either ChTx (50 nM) and apamin (30 nM) or
BaCh (30 fiM) plus ouabain (1 mM). Results are shown as mean+ s.e.mean. for («) arteries.
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potassium also relaxed these resistance arteries (Emax,
74.14±5.61%, IC50, 6.09+ 1.17 mm; -logIC50, 2.12±0.07,
«=10), the response to this compound (Figure 2) was
inconsistent and was superseded by a reversal of the initial
relaxation response as the concentration of Kfcl rose (>15-
25 mm). As expected, removal of the endothelium virtually
abolished responses to ACh (13.34 + 6.16%, « = 7, /><0.0001)
but also abolished potassium-mediated relaxation (Emax,
15.53 + 9.18%, n = 6, P<0.001) (Figure 2).
The potassium-induced relaxation was not affected by
incubation with l-NOARG and indomethacin (Emax,
68.1 ±5.6%, P = 0.51; IC50, 5.74+ 1.86 mM; -logIC50,
2.34 + 0.15, P = 0.33, n = 5) or with the combination of l-
NOARG with indomethacin, ChTx and apamin (Emax,
86.61 + 14.02%; P = 0.35; IC50, 6.78±2.90mM; -logIC50,
2.68 + 0.52, P = 0.23, n = 6). Indeed the maximum relaxation
evoked by potassium tended to be larger in the latter group.
Exposure of vessels to the combination of BaCE and ouabain
resulted in an increase in basal tone of 0.40 + 0.17 mN
(equivalent to 16.6 + 7.4% of the maximum response to
KPSS; «=11). This tended to be larger in arteries used for
producing responses to ACh (22.4± 17.6% KPSS; n = 5) than
in those subsequently exposed to KC1 (12.0 + 5.6% KPSS;
n = 6). Once this contraction had stabilized, vessels were
contracted with sufficient NA (0.1-3/iM) to produce a
contraction 60-80% the size of the maximum response to
KPSS (responses to ACh obtained in one artery were
discarded as the combination of BaCE plus ouabain
produced a contraction equivalent to 80% of the response
to KPSS). Potassium-induced relaxation was totally abolished
by incubation with the combination of l-NOARG with
indomethacin, BaCE and ouabain (5.7 + 2.6%; n = 6;
P< 0.0001). In contrast, a considerable ACh-induced relaxa¬
tion remained evident following exposure to this combination
of inhibitors although there was a trend towards reduced
relaxation that did not achieve significance (Emax,
76.09 + 8.92%; P = 0.16; -logIC50, 6.47±0.23; P=0.11,
n = 5).
Discussion
Previous investigations have demonstrated that an NO/PG-
independent component of ACh-evoked relaxation is
mediated by EDHF (Nakashima et al., 1993; Urakami-
Harasawa et al., 1997; Wallerstedt & Bodelsson, 1997).
Studies in arteries from experimental animals have suggested
that K+ accounts for EDHF activity (Edwards et al., 1998).
In order to clarify whether K+ acts as an EDHF in human
arteries, this investigation compared potassium-induced and
EDHF-induced relaxation responses in subcutaneous resis¬
tance arteries isolated from biopsies of gluteal fat. The
characteristics of potassium-induced relaxation were different
from the EDHF-mediated response and, of significance, were
abolished by removal of the endothelium. Taken together,
this suggests that release of endothelium-derived K * into the
myoendothelial space does not account for EDHF activity in
human subcutaneous resistance arteries.
Comparison with previous investigations indicates that the
ChTx/ apamin-sensitive, NO-independent component of
ACh-evoked relaxation is mediated by EDHF. In rat
mesenteric arteries contracted with an a-adrenoceptor
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agonist, the NO-independent component of ACh-mediated
relaxation was caused by smooth muscle cell hyperpolarisa-
tion (Plane & Garland, 1996). This response is abolished by
the combination of ChTx and apamin (Zygmunt &
Hogestatt, 1996), probably by inhibition of BKCa and SKCa
on the endothelium (Doughty et al., 1999). The persistence of
a significant NO-independent (EDHF-mediated) relaxation in
response to ACh is consistent with previous studies of human
subcutaneous (Woolfson & Poston, 1990; Deng et al., 1995;
Hillier et al., 1998), omental (Ohlmann et al., 1997),
gastroepiploic (Urakami-Harasawa et al., 1997), coronary
(Nakashima et al.. 1993) and pial (Petersson et al., 1995)
arteries. Incomplete inhibition is unlikely to account for
residual relaxation as a lower concentration of l-NOARG
(3 x 10~5 m) abolished ACh-induced, endothelium-dependent
relaxation in the rat aorta, pulmonary and iliac arteries
(Nagao et al., 1992). Furthermore, incomplete inhibition of
ACh-mediated relaxation was not overcome by increasing the
concentration of l-NOARG (100-300 ,um; Brandes et al.,
1997) or by the combined application of two different l-
arginine analogues (Plane & Garland, 1996; Plane et al.,
1997). The failure of indomethacin to attenuate ACh-
mediated relaxation in the present study confirms that
prostanoids do not contribute to this response in the human
gluteal, subcutaneous resistance artery. This is also consistent
with previous studies, in our own and other laboratories, in
which indomethacin was shown to have no effect on ACh-or
bradykinin-mediated relaxation of human gluteal resistance
arteries when applied alone or in combination with NO
synthase inhibitors (Hillier et al., 1998; Buckley et al., 1999).
The mechanism of endothelium-dependent relaxation of
human resistance arteries may depend upon the origin of a
particular vessel, however, as bradykinin-mediated relaxation
of human omental arteries has an indomethacin-sensitive
component which becomes evident in the presence of an NO
inhibitor (Ohlmann et al., 1997).
The ability of exogenous potassium to relax human gluteal
resistance arteries compares with results obtained in
resistance arteries from experimental animals (Edwards et
al., 1998); Quignard et al., 1999; Doughty et al., 2000; Lacy
et al., 2000). The identification of K+ as an EDHF in the
earlier study was based on a comparison with the NO/PG-
independent component of the response to ACh (Edwards et
al., 1998); responses to both ACh and exogenous K+ were
abolished by inhibition of KIR and Na+/K+ ATPase,
indicating a common mechanism. Exogenous K+, however,
produced an endothelium-independent hyperpolarization of
smooth muscle cells that was unaffected by the combination
of ChTx and apamin. This is consistent with ACh stimulating
release of K+ from endothelial cells via ChTx/ apamin-
sensitive channels. In the present study, however, the
characteristics of potassium-induced and EDHF-mediated
relaxation were different: whereas the ACh-induced relaxa¬
tion was highly reproducible and sustained, relaxation
responses to potassium were more variable and reversed
readily at higher K* concentrations. This is consistent with a
recent study showing that exogenous K+ will only produce a
reproducible, sustained relaxation of rat resistance arteries if
they are bathed in a Kreb's solution lacking K* ions (Lacy et
al., 2000). More striking, however, was the demonstration
that, as in the rat mesenteric (Lacy et al., 2000) and renal
(Jiang & Dusting, 2001) arteries, potassium-mediated relaxa-
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tion of human subcutaneous arteries was abolished by
removal of the endothelium. This indicates an obligatory
role for the endothelium in K +-mediated relaxation, suggest¬
ing that it may be mediated by a further endothelium-derived
factor or is dependent upon myoendothelial gap junctions
(Doughty et al., 2000). Finally, the inability of barium and
ouabain to inhibit ACh-mediated relaxation, whilst abolish¬
ing responses to potassium, indicated that these compounds
caused relaxation via different mechanisms. This observation
contrasts with the study by Edwards et al. (1998) but is
consistent with data obtained in subsequent investigations
(Quignard et al., 1999; Lacy et al., 2000). The ability of
to relax only a proportion (~30%) of rat mesenteric
resistance arteries in one study (Doughty et al., 2000)
suggests that this response may even vary in different regions
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Preservation of vascular function in rat mesenteric resistance
arteries following cold storage, studied by small vessel myography
C.A. Mclntyre, B.C. Williams, 'R.M. Lindsay, 'J.A. McKnight & 23P.W.F. Hadoke
Department of Medicine and 'Metabolic Unit, Western General Hospital, and 2Department of Medicine, Royal Infirmary,
Edinburgh, Scotland
1 The use of isolated blood vessels to investigate the physiological and pharmacological control of the
vasculature is limited by the requirement to use freshly isolated vessels. Hence, the aim of this study was
to determine whether vascular smooth muscle and endothelial cell function could be preserved in
resistance arteries by storing them in physiological salt solution (PSS) at 4°C.
2 Third order mesenteric resistance arteries (mean internal diameter 237 ± 6 pm) were dissected from
the mesenteric bed of male Cob-Wistar rats. The vessel segments were mounted in a small vessel
myograph for measurement of isometric tension, and equilibrated at their optimum resting force.
Contractile responses to noradrenaline (NA; 1 x 10~9-3 x 10-5 m), phenylephrine (PE, 1 x 10"9-
3x 10~5 m), potassium chloride (KC1; 2.5-140 mm) and endothelin (ET-1, 1 x 10~"-3x 10~7 m) and
relaxant responses to acetylcholine (ACh; 1 x 10—9 — 3 x 10~5 m) and 3-morpholinosydnonimine (SIN-1;
1 x 10~9- 1 x 10~4 m) were obtained in arteries, immediately after dissection (day 0) and following one to
four days storage (day 1-day 4).
1 3 All arteries produced concentration-dependent contractions in response to each of the
vasoconstrictors. There were no significant differences in the magnitude or sensitivity (pD2) of the
vasoconstrictor responses between fresh and stored vessels.
4 Arteries precontracted with NA to approximately 80% of the maximum response, relaxed in a
concentration-dependent manner in response to ACh and SIN-1. Vessel storage for up to three days
resulted in no change in response to ACh or SIN-1.
5 Vessels analysed after four days of storage demonstrated a significant increase in sensitivity to ACh
and SIN-1 (—logIC50 (m) values; ACh; day 0, 7.46±0.13 vs day 4, 7.97 + 0.11, P<0.01 and SIN-1; day
0, 4.87 + 0.10 vs day 4, 5.52 + 0.08, P<0.01). There was also a significant increase in the maximum
relaxant response to ACh after four days of storage (% relaxation; day 0, 92.65 ±2.84 vs day 4,
100.36 + 0.36, P<0.05).
6 These results demonstrate that small resistance arteries remain viable if stored in PSS at 4°C for up to
four days, with no loss in endothelial cell function. The altered sensitivity to the vasodilators on day 4
suggests that vessels should only be stored for up to three days following dissection for analysis of
functional responses.
Keywords: Mesenteric resistance arteries; endothelium; vascular smooth muscle; cold storage
Introduction
—. Isolated blood vessel segments are used extensively to
^/investigate in vitro the physiological and pharmacological
control of the vasculature and the mechanisms responsible for
deranged vascular function in disease states. One of the major
limitations of this type of investigation is the perceived need to
use freshly isolated blood vessels. This is mainly due to the
well-documented fragility of the vascular endothelium, which
may be damaged both during isolation and storage (Kristek et
al., 1993; Torok et al., 1993), in contrast to smooth muscle
which can remain viable for up to eight days when stored at 2 -
6°C (Kristek et al., 1993). The requirement that blood vessels
must be freshly isolated restricts the number of investigations
which can be performed on vessel segments from a single
animal and is even more problematic when human blood
vessels are studied, since the availability of such vessels can be
both irregular and unpredictable. Consequently, a straightfor¬
ward and reliable method for storing vessels before experi¬
mentation is desirable and this idea has stimulated
investigations into both refrigeration (2-6°C; Shibata, 1969;
Carrier et al., 1973; Kristek et al., 1993; Torok et al., 1993) and
low temperature ( — 70 or — 190°C) cryopreservation of blood
vessel samples (Muller-Schwienitzer et al., 1986; Ku et al.,
1990).
Most studies carried out to date on the effects of storage of
blood vessels on vascular reactivity have been performed with
large conduit vessels (Shibata, 1969; Carrier 1973; Kristek et
al., 1993; Torok et al., 1993) rather than small vessels.
However, following the introduction of small vessel myo¬
graphy (Mulvany & Halpern, 1977), it has become desirable to
preserve vascular function in small resistance arteries for a
prolonged period of time. The aim of the experiments
described in this study was, therefore, to determine whether
vascular smooth muscle and endothelial cell function could be
preserved in resistance arteries by storing them in physiological
salt solution (PSS) at 4°C.
Methods
Experimental set-up
3 Author for correspondence at: Department of Medicine (RIE), The
University of Edinburgh, Royal Infirmary, Lauriston Place,
Edinburgh EH3 9YW.
Male Cob-Wistar rats (150-250 g) were killed by asphyxiation
with C02 followed by cervical dislocation. The mesenteric bed
was removed and placed in cold (4°C) PSS of the following
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composition (mm): NaCl 119, KC1 4.7, CaCl2 2.5, MgS04 1.17,
NaHC03 25, KH2P04 1.18, ethylenediaminetetra-acetic acid
di-potassium salt (K2EDTA) 0.026 and d-glucose 5.5. Third
order branches of the mesenteric artery (mean internal
diameter; 237 ±6 fim, 107 vessels from 32 rats^were dissected
from the mesenteric bed and cleaned of connective tissues
under a light microscope. One was used immediately after
dissection (day 0) whilst the others were stored separately (at
4°C, in vials containing 1 ml PSS) for up to four days (day 1 -
day 4).
The mesenteric arterial vessel segments were mounted in a
small vessel, dual chamber, myograph (chamber volume
12.5 ml) for measurement of isometric tension. Two myo¬
graphs were used in parallel, allowing investigation of four
vessels each day. Each vessel segment, approximately 2 mm in
length, was mounted on two 40 fim stainless steel wires, one of
which was attached to a force transducer and the other to a
micrometer. The length of each vessel segment was measured
by a light microscope, with the vessel segment bathed in PSS at
37°C, bubbled with 95% O, and 5% C02.
Following equilibration for 30 min, stepwise radial stretch¬
ing was performed to determine the lumen diameter necessary
for optimal force generation. This was achieved by applying
the LaPlace relationship as described by Mulvany & Halpern
(1977). The vessel segment was then stretched to achieve 90%
of the diameter expected if it had been relaxed and exposed to
a transmural pressure of 13.3 kPa (100 mmHg). This resting
tension has been previously shown to produce maximal force
generation in the rat mesenteric artery (Buus et al., 1994;
Falloon et al., 1995).
The vessel segment was allowed to equilibrate for a further
30 min before the viability was assessed by use of a standard
start procedure. This consisted of stimulating twice with KPSS
(125 mm, made by equimolar substitution of KC1 for NaCl in
PSS) containing 10~5 m noradrenaline (NA), then once with
KPSS alone and once with 10-5 m NA alone. Finally the vessel
segment was stimulated for a third time with NA-KPSS. The
vessel segment was activated for 2 min with each solution
followed by a 5 min washout period in PSS to allow full
relaxation. The measurement of viability is performed in these
vessels to determine whether the isolation and mounting of the
vessel damaged the arterial wall. This is achieved by
calculating the effective pressure induced by the contractile
agonist from the LaPlace relation (effective pressure = wall
tension/(internal circumference/ (27t)), which corrects the small
differences in the length and diameter of the vessel segments
(Mulvany & Halpern, 1977). Exposure of rat mesenteric
arteries usually produces a response >20 kPa and, by
convention, arteries are considered unviable (damaged) if the
effective pressure is less than 13.3 kPa.
Protocols
The ability of the vessel to respond to contractile and dilator
agents was investigated by producing cumulative concentra¬
tion-response curves (CCRCs). CCRCs were obtained for
noradrenaline (NA; 1 x 10~9-3 x 10-5 m), acetylcholine
(ACh; 1 x 10-9-3 x 10"5 m), 3-morpholinosydnonimine
(SIN-1; 1 x 10"9-1 x 10-4 m), phenylephrine (PE; 1 x 10~9-
3xl0_5M), potassium chloride (KC1; 2.5-140 mm) and
endothelin-1 (ET-1; 1 x 10~"-3 x 10~7 m). After each CCRC
the vessel was washed four times with PSS and allowed a
15 min equilibration period in PSS before exposure to the next
agent. Responses to vasodilator agents were determined
following production of a stable contraction with 3 fiM NA
(which induced approximately 80% maximum contraction).
Drugs
All salts were obtained from BDH Laboratory Supplies
(Poole, Dorset). Acetylcholine chloride, noradrenaline bitar-
trate, phenylephrine hydrochloride were from Sigma (Poole,
Dorset). SIN-1 was a gift from Dr K. Schonafinger (Cassella.
Germany) and endothelin-1 was obtained from Calbiochem-
Novabiochem (U.K.) Ltd, (Beeston, Nottingham).
All drugs were dissolved in distilled water with the
exception of ET-1. Endothelin stock was dissolved in 5%
ethanol. Further dilutions were made in 50% methanol/50%
distilled water, divided into aliquots and stored as 10~5 m
stock solutions at — 20°C. On the day of use a stock solution
was thawed and subsequent dilutions were made in distilled
water. These solutions were added directly to the PSS in the
myograph chamber to give the final dilutions.
Statistics
All values presented are mean ±s.e.mean for n experiments.
NA, PE, KC1 and ET-1-induced tension is expressed as a
percentage of the maximum contractile response to that agent.
The relaxation to ACh and SIN-1 is expressed as a percentage^
of the NA-induced precontraction.
Sensitivity to the agent is expressed as the negative log of
the effective concentration (m) of the drug required to produce
50% of the maximum effect (pD2 for vasoconstrictors and
— log IC50 for vasodilators). The sensitivity was calculated
from each concentration-response curve by fitting the Hill
equation by use of a curve fitting programme (Fig.P; Biosoft.
Cambridge, U.K.).
Student's independent samples t test was employed in the
statistical comparison between the sensitivity and maximum
responses (relaxation or contraction) of CCRCs in fresh and
stored vessels. Significance was assumed if P<0.05.
Results
The standard start procedure demonstrated that the vessels
analysed immediately following dissection were viable and that
this viability was unaffected by storage over a four day period
(Table 1). Indeed, all the arteries used in this investigation were-
shown to be viable. The arteries produced strong, concentra-l
tion-dependent, contractions in response to each of the
vasoconstrictors, NA, PE, KC1 and ET-1. The magnitude and
sensitivity of these responses were unaffected by storage (Table
2a).
The concentration of noradrenaline required to produce
approximately 80% of the maximum contractile response in
freshly isolated vessels was 3 fiM. This concentration was used
to precontract the tissues in order to assess the relaxant
properties of the vasodilator agents. The contraction produced
by this concentration ofNA was unchanged by storage for two
days but was significantly reduced on day 3 (Table 3).
However, the reduction observed on day 3 was not sustained
on day 4.
Following precontraction with 3 qM NA, ACh and SIN-1
both induced concentration-dependent relaxations which were
still evident after four days of storage. Storage of the vessels
for up to three days resulted in no change in the responses
induced by these agents (Table 2b). The magnitude and
sensitivity of the relaxations was unchanged until the fourth
day of storage, when the arteries demonstrated a significant
increase in the maximum response to ACh (Re0.05) and a
significant increase in sensitivity (PcO.Ol) to both ACh and














Table 1 The effect of prolonged cold storage on the


























Values are mean±s.e.mean, n numbers in parentheses. The
viability value is an indication of the effective pressure
developed by the artery in response to a solution containing
high concentrations of potassium (125 mM) and NA
(10~5 M), which produces a maximal contraction. It is
calculated from the LaPlace relation (effective pressure = wall
tension/ (internal circumference/ (2tt)) and is used routinely
to determine whether a vessel has been damaged during
isolation. In the present investigation measurement of
viability also provided an indication of whether prolonged
storage had caused a loss of viability. Rat mesenteric arteries
usually produce an effective pressure > 20 kPa and are
considered unviable if the effective active pressure developed
in response to NA-KPSS is less than 13.3 kPa (100 mmHg).
All the vessels mounted in the organ bath for the present

























SIN-1 (Table 2b). A trend towards an increased maximum
response to SIN-1 was also observed, but this was not
significant.
Discussion
The results of this study indicate that rat mesenteric resistance
arteries remain viable if stored in PSS at 4°C for up to four
days. The sensitivity of the arteries to the vasodilators, ACh
and SIN-1, remained stable following the first three days of
cold storage and thereafter increased on day 4, whereas
responses to vasoconstrictor agonists were unaltered.
Vasodilator function
Previous investigations have shown that cells in the vascular
wall undergo time-dependent alterations when stored at 4°C.
yThe severity and speed of these changes vary between different
cell types with the earliest alterations occurring in nerve fibres
and endothelial cells (Kristek et al., 1993).. These morpholo¬
gical alterations are accompanied by functional abnormalities,
with endothelium-dependent relaxation reduced after as little
as 24 h storage (Flanders et al., 1996). Similarly, cryopreserva-
tion, which involves storing the tissues in dimethylsulphoxide
(DMSO) at either —70 or — 190°C, produces endothelial cell
dysfunction (Ku et al., 1990). In addition to the problems this
poses for pharmacological investigation, such endothelial cell
dysfunction is a cause for concern for bypass grafting and
organ transplantation. Consequently the preservative effects of
a variety of solutions have been investigated. Whilst this has
produced evidence that some preservation solutions (Uni¬
versity of Wisconsin, St Thomas' Hospital) are better for
preserving endothelial function in rabbit aorta (Eberl et al.,
1993) and porcine hepatic artery (Flanders et al., 1996), the
reasons for these differences are unclear. Indications into the
protective action of these solutions are not provided by
comparison of their contents. University of Wisconsin
(Flanders et al., 1996) solution is a calcium-free, high
potassium solution which contains agents which inhibit free
radical generation (adenosine, allopurinol, glutathione) and
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Table 3 The effect of cold storage on the magnitude of
noradrenaline (3 /tM)-induced precontraction in rat mesen¬
teric resistance artery
Precontraction (mN mm ')
ACh SIN-1
Day 0 1.91+0.15 2.24 + 0. IS?
Day 1 2.47 + 0.23 2.47 + 0.17
Day 2 2.07 + 0.20 2.31+0.16
Day 3 1.45 + 0.15* 1.63±0.21t
Day 4 1.92 + 0.42 1.72 + 0.45
Values are mean + s.e.mean, n— 10. P<0.05 when compared
with precontraction value for day 0, *ACh and tSIN-1, by
use of Student's independent samples t test.
solution is a simple salt solution containing moderately high
concentrations of potassium and magnesium but not glucose
(Eberl et al., 1993).
In contrast to previous investigations with large conduit
arteries, our results demonstrated that the rat mesenteric
resistance artery retains endothelium-dependent vasodilator
function throughout the period of preservation. This suggests
that the endothelium in these vessels does not become
damaged as rapidly as the endothelium of rabbit aortae.
Indeed, the sensitivity to both endothelium-dependent and
-independent dilators was increased significantly after storage
for four days. The vasodilators used in this investigation both
act by the production of nitric oxide (Furchgott et al., 1987;
Feelisch & Noack, 1987); ACh induces vasodilatation by
stimulation of constitutive nitric oxide synthase (eNOS;
Fostermann et al., 1991) in the endothelium, whilst SIN-1
(the active metabolite of molsidomine) spontaneously releases
NO by a free radical process following base-catalyzed
hydrolysis to produce endothelium-independent relaxation
(Feelisch, 1991). NO production causes vasodilatation by
stimulation of soluble guanylate cyclase with the subsequent
elevation of cyclic guanosine 3':5' monophosphate (cyclic
GMP; Waldman & Murad, 1987), which lowers intracellular
Ca2+ concentrations in the smooth muscle cells. The observed
increase in sensitivity on day 4 to both ACh and SIN-1 in our
studies, with no accompanying change in sensitivity to
vasoconstrictors, suggests that the enzyme guanylate cyclase
could have become upregulated (Moncada et al., 1991).
It has been demonstrated that the basal release of NO from
the endothelium in vivo acts to reduce the sensitivity of the
vascular wall to agonist-induced dilatation (Busse et al., 1989).
This basal release is stimulated by shear stress activation of
eNOS (Nishida et al., 1992) and, therefore, is unlikely to occur
in the stored arteries. Consequently, it is possible that a
reduced basal release of endothelium-derived NO results in an
upregulation of guanylate cyclase. However, it should be noted
that endothelial cell dysfunction in stored rabbit aorta was not
accompanied by an increased sensitivity to sodium nitroprus-
side (Torok et al., 1993). Alternatively, the increased sensitivity
we observed to ACh and SIN-1 could be due to an increase in
permeability of the vascular smooth muscle cells to nitric
oxide. Previous investigations have suggested that increased
smooth muscle cell permeability may develop (Torok et al..
1993) and this may allow more efficient access of NO to soluble
guanylate cyclase in the vascular smooth muscle cells.
It is unclear why endothelial cell function is preserved in the
rat mesenteric arteries but not in larger vessels stored at a
similar temperature (Kristek et al., 1993; Torok et al., 1993;
Flanders et al., 1996). The size and origin of the vessels may be
important as endothelial cell function appears to vary
according to the diameter of the vessel (Haefliger et al..
1993), and upon its anatomical origin (Vanhoutte & Miller,
1985). Alternatively, the different storage conditions may be
significant as some preservative solutions appear to more
effective than others in maintaining the function of the
endothelium (Eberl et al., 1993; Vohra et al., 1997). Further
work is required to clarify the cause of these variations.
Vasoconstrictor function
The measurement of vessel viability is usually performed to
ensure that vessel preparation does not damage the vessel wall.
As an experienced myographer will rarely cause such damage,
the inclusion of this measurement in the present study further
demonstrated that prolonged storage did not impair viability.
Indeed, the effective pressure (viability) measurements were
remarkably consistent throughout the study (Table 1).
It has been suggested that the changes in contractile
function detected in stored vessels represent a balance between
the effects of endothelial cell and smooth muscle cell
dysfunction (Kristek et al., 1993). Consequently, the observed
increase in sensitivity of the rabbit aorta to NA after
preservation for three to four days (Shibata, 1969; Carrier et
al., 1973; Vohra et al., 1997) may be the result of earl^
endothelial cell dysfunction, as the vascular endothelium can
modulate the constrictor response to many agonists. This
would be similar to the increased reactivity to NA (Dohi et al.,
1990) documented following removal of the endothelium in
mesenteric resistance arteries from normal rats. Alternatively,
Kristek et al. (1993) suggested that storage leads to altered
calcium homeostasis, as a result of increased permeability and
membrane depolarization. As the time of preservation length¬
ens, the increased response to NA is probably balanced by an
attenuation resulting from gradual impairment of contractile
function.
Our investigation demonstrated that NA and PE-induced
contractions in the rat mesenteric artery were unaffected by
storage. It is possible that the conservation of endothelium-
dependent relaxation prevented the increased responsiveness to
these agonists observed by other investigators (Shibata, 1969;
Carrier et al., 1973; Kristek et al., 1993). Furthermore, the
maintenance of these responses indicated that a-adrenoceptor-
mediated vasoconstriction was not altered by storage.
Despite the maintained response to NA and PE throughout
storage, the precontracting concentration of NA (3 x 10"? mJI
produced responses that were reduced on days 3 and 4. Despite
the similarity of these measurements, the reduction was only
significant (when compared with fresh vessels) on day 3. It is
considered necessary to use a submaximal concentration of the
precontracting agent for investigation of responses to
vasodilators to prevent over-estimation of the sensitivity of
the tissue to these agents. However, at submaximal concentra¬
tions NA often produced a biphasic response with a slight loss
of tone after the initial contraction, after which the contraction
stabilized. This loss of tone appeared to be more marked on
days 3 and 4, accounting for the reduced contractile response,
but was highly variable. The lack of significance on day 4 was a
consequence of the variability of this biphasic response.
In contrast to NA, it has previously been shown that KC1-
mediated vasoconstriction is significantly reduced following
preservation for four days, but this reduction could be partially
attenuated if preservation was performed in a high potassium
Ringer solution (Shibata, 1969). This may be due to storage-
induced alterations in the smooth muscle cell polarization
state, as preservation has been shown to reduce significantly
intracellular potassium but increase intracellular sodium and
calcium (Carrier et al., 1973). Our results demonstrated that




such changes were not significant in the rat mesenteric artery,
as responses to KC1 were unaltered.
Contractile responses to endothelin-1 following prolonged
storage of the vessels have not been investigated previously.
However, various insults, including hypoxia, can lead to the
release of this potent vasoconstrictor by endothelial cells
(reviewed in Haynes & Webb, 1993), resulting in receptor
down-regulation and reduced sensitivity to this agonist (Clozel
et al., 1993). Consequently, it is possible that the endothelial
damage described in larger vessels following storage (Kristek
et al., 1993; Torok et al., 1993; Flanders et al., 1996), would
have caused reduced sensitivity to endothelin-1. The unaltered
response in the rat mesenteric artery to ET-1 in our studies
suggests that prolonged storage of this tissue does not lead to
significant release of ET-1 from the vascular endothelium. This
supports the argument that there is no significant endothelial
cell damage in these vessels after storage, which is consistent
with the results of our experiments with the vasodilator ACh.
Finally, the maintenance of the responsiveness to the
vasoconstrictors studied suggests that the contractile activity
of the smooth muscle was not attenuated during preservation.
Jhis is consistent with previous investigations carried out in
»^>abbit conduit arteries, in which contractile function to
exogenously applied vasoconstrictors was not reduced after
preservation for up to eight days (Shibata, 1969; Kristek et al.,
1993). Indeed, Shibata (1969) demonstrated that contractile
responses to NA in those vessels were only reduced
significantly after 10-12 days preservation and detectable
contractions were still present after twenty days storage in
Ringer solution.
In summary, no comprehensive studies have previously
been published in relation to the preservation of resistance
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